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Abstract 2
ABSTRACT
The influence of inoculum size on severity o f disease for those organisms which multiply in 
the host is uncertain and not often addressed: the infecting dose is not known in natural 
situations.
Experimental studies, where the dose is known, arc discussed, as well as different natural 
situations in which the relative dose can be inferred. The advantages and drawbacks of the 
various methods are debated. The following sections focus on two infections: salmonellae and 
malaria.
For salmonellae, natural infections are compared using indirect markers of dose: incubation 
period, attack rate and type of vehicle. No evidence of a dose-severity relationship is found for 
typhoid, whereas there is some evidence for such a relationship for the food-poisoning 
salmonellae. Analysis of typhoid volunteer data suggests a dose-severity relationship; the 
critical role of illness definition in determining the findings is discussed.
Malaria therapy for neurosyphilis provides a unique source of information on large numbers of 
human subjects in whom a disease was induced artificially. An extensive review of the malaria 
literature provides no conclusive evidence on the relationship between dose and severity. The 
original records for patients from the Horton hospital in Epsom are analysed. Among 589 non- 
immune patients receiving vivax and 81 receiving ovale, who were not treated within the first 
5 days, no consistent relationships are found between any direct measure of dose (mosquito 
number, sporozoite number, or trophozoite number) and any measure of severity including 
peak fever and parasitaemia levels. Dose is inversely proportional to prepatent period, and 
patients with longer prepatent periods are more likely to have tertian fever, undergo 
spontaneous recovery and not to get modifying treatment The implications of these findings 
for the pathogenesis of malaria and for natural malaria are discussed.
The final section explores more general issues of the relationship between dose and 
pathogenesis.
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The occurrence of infection or disease following exposure of a host to a pathogen depends on 
three factors: (1) host characteristics, such as genetic factors and immune status; (2) pathogen 
characteristics (virulence); (3) factors affecting the interaction of the pathogen and the host 
(especially the dose of the pathogen). The same three factors may have a role in determining 
severity of disease once it occurs, although the third is often relatively ignored in this context.
Textbooks of infectious disease (eg Mandell et al 1990, Gorbach et al 1992) devote long 
sections to descriptions of microbial virulence factors and host defence mechanisms, but the 
relationship between host and microbe is restricted to a discussion of the distribution of 
diseases, transmission routes and establishing causes of cases. Infective dose is considered only 
as "the number of organisms necessary to cause an infection" (Mandell et al 1990). We expect 
severity of disease to depend on host resistance and the virulence of the strain of pathogen 
involved. For those pathogens which multiply in the host, once infection or disease is 
established, does the initial infecting dose continue to have an influence?
Among the helminth infections in which the parasite does not proliferate within the host, the 
expectations of a relationship between dose and severity are clearer and the evidence is easier 
to obtain. Where there is no proliferation, the worm burden in the host should depend on the 
initial dose. Correlations between inocula and worm load have been demonstrated in natural 
infections with Ascaris lumbricoides and Trichuris trichiura (Wong et al 1991). (A simple 
relationship between inoculum size and burden cannot always be assumed however: in 
experimental infections of pigs with Ascaris suum, larger inocula gave rise to  the establishment 
of fewer adult worms (Andersen et al 1973).) Worm burden can be estimated either directly 
from the number of worms passed after treatment or indirectly from egg counts, though the 
egg production per female worm is higher when smaller numbers of worms are present (Croll 
et al 1982). Worm and egg numbers have been related to severity of disease. Thus hookworm 
egg counts have been related to the degree of anaemia (Stoll & Tseng 1925, Roche & Layrisse 
1966), and correlations have been found between egg counts and severity o f  illness for 
schistosomiasis mansoni (Cook et al 1974) and schistosomiasis haematobium (Forsyth & 
MacDonald 1965). In trichuriasis, worm load correlates with the amount o f  faecal blood loss 
(Layrisse et al 1967) and larger egg counts are associated with more diarrhoea, dysentery and 
growth stunting (Jung & Beaver 1951, Cooper et al 1986).
Among the pathogens which do proliferate in the host it is both less clear that dose would be 
expected to influence severity, and harder to study the relationship, since m ost of the host
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burden of pathogen will have arisen from subsequent multiplication.
More is known about the effects of dose in the stage of establishment of disease: attack rates 
and incubation periods have both been correlated with infecting dose (Sartwell 1966, Armenian 
& Lilienfeld 1983, Esrey et al 1985). The evidence for this comes principally from 
experimental infections in animals and humans. For example, human volunteer experiments 
have found increasing attack rates and/or decreasing incubation periods with increasing 
challenge doses of typhoid (Homick et al 1970), food poisoning salmonellae (McCullough & 
Eisele 1951 a,c), cholera (Homick et al 1971), enteropathogenic E coli (Levine et al 1978), Q 
fever (Tigertt et al 1961), and malaria (Coatney et al 1950b). Some studies have failed to find 
a relationship, but the number of volunteers with each strain of pathogen is often small (eg 
Mahonney et al 1946, Havens 1946). In animal experiments the response recorded is usually 
death and dose is recorded in terms of the LD50, the dose required to kill 50%. With 
increasing doses the mortality rate increases and the latent period to death decreases (Meynell 
& Meynell 1958). Further evidence comes from observational data. For example, Sartwell 
(1966) noted longer median incubation periods for serum hepatitis occurring after infections 
transmitted by contaminated vaccines than those transmitted by contaminated blood or blood 
products. Other examples are given in Section 1 in relation to indirect methods of assessing 
dose.
Whether, having influenced the probability of infection or disease and the time at which they 
occur, the initial infecting dose continues to have an influence on subsequent events for those 
organisms which multiply in the host is largely unknown and not often addressed. Such 
information as there is has not been brought together, and the subject is not easy to look up: 
"dose" or related terms are not generally indexed, and dose-response effects may be mentioned 
in the context of studies with other aims. Knowledge of dose-severity relationships is, however, 
important, and not just in furthering our understanding of the pathogenesis o f infectious 
diseases.
The relationship is important in public health. If dose does determine severity, then an 
intervention which lowers infecting dose would usually be expected to be more effective 
against severe disease than against total disease. For example, a sanitary intervention which 
succeeded in lowering the dose of infecting organisms might decrease severe diarrhoeal disease 
while having little impact on mild disease (Esrey et al 1985) and this has obvious implications 
both for establishing and evaluating public health programmes. The relationship would also be
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relevant in assessing the usefulness of a partially effective vaccine. A sporozoite vaccine for 
malaria which only succeeded in removing a proportion of the sporozoites might only reduce 
total disease slightly, but if there is a dose-severity relationship it might make severe disease 
much less likely.
If a dose-severity relationship is not considered, factors which may influence dose may not be 
recorded and biases introduced by differences in dose will be missed (Hall & Aaby 1990). For 
measles, Aaby (1988) has shown that secondary cases in a household have more severe disease 
than index cases and this is likely to be due to differences in infecting dose. (The evidence for 
this is discussed in Section 1.) A study of measles in women in Los Angeles concluded that 
pregnancy increased the risk of hospitalization, pneumonia and death (Eberhart-Phillips et al 
1992). However, this study did not consider whether these women were primary or secondary 
cases in their households, and pregnant women, who may be more likely to have families with 
young children, may be consequently more likely to be secondary cases. Since the question 
was not considered, the influence (if any) of this potential confounder on the results cannot be 
assessed. Bias arising from a failure to consider dose as a possible risk factor for severe 
disease is likely to be a particular problem in community trials where there are few units of 
randomization, making chance differences between groups in factors influencing dose, such as 
household size, more likely (Hall & Aaby 1990).
In this thesis the dose-severity relationship will be considered both in general terms and in 
relationship to particular diseases. Since a major reason that infecting dose is often neglected is 
that the dose is rarely known (Greenwood 1987), the first section w ill consider different 
situations in which the dose is known or can be inferred. I consider a range o f experimental 
and observational methods of assessing dose-severity relationships, giving brief examples of 
their use and exploring their advantages and disadvantages. I give more weight to the 
observational methods because they are less obvious methodologically, they have potentially 
greater scope, and they create greater problems in interpretation. In the following two sections 
I apply some o f these methods to the study of two very different infections, salmonellae and 
malaria. These sections include both literature reviews and analysis o f raw data. Finally, I 
discuss the theoretical relationships between dose and the pathogenesis of disease.
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SECTION 1
METHODS OF INVESTIGATING 
DOSE-SEVERITY RELATIONSHIPS
1.1 Methods - Animal experiments 18
Two main methods exist for determining the relationship between infecting dose and severity: 
experimental and observational. In experimental situations, known doses of pure strains of 
organisms are given to animals or human volunteers under controlled conditions. Using 
observational methods, indirect measures of dose or relative dose are explored in natural 
situations. Experimental methods can provide "clean" data but are likely to be available for 
only a few infections and the results are not easy to generalize. Observational methods are 
necessarily indirect and are subject to a range o f  biases, but the results can be more directly 
applied.
ANIMAL EXPERIMENTS
Animal experiments have several advantages as well as the ability to control the inoculum size. 
Other variables such as environmental conditions, diet and genetic factors can all be tightly 
controlled, invasive measures of disease are possible, and infections can be observed untreated. 
In relation to pathogenesis, it can be particularly useful to observe the microbial load and the 
effects of disease in different organs. On the other hand there are numerous disadvantages, 
including the obvious difficulties of extrapolating findings in animals to people. Since the 
purpose of animal experiments is usually to further knowledge about human disease, the 
infections studied in animals are often not those which occur naturally in the species. Very 
large inocula are often used. These may be necessary to induce disease in the animal species, 
or at least to produce high response rates so that few of the inoculated animals are "wasted". 
For similar reasons inoculation often occurs by unnatural routes such as intraperitoneal or 
intracerebral injection.
In the small animals commonly used for experiments the only measurable outcome is often 
death. In these systems attack rate can be determined but not severity. The time to death may 
be recorded, but this reflects the incubation period rather than the severity of disease - which 
is, after all, the same in each case. It may also be possible to distinguish, for example from 
blood or stool samples, whether infection is established, thus giving two measures of outcome. 
But infection is not the same as disease, and it is levels o f severity o f symptomatic disease 
which are at issue here. This point is explored further in the Discussion.
In larger animals other measures are possible, but experiments are often very limited in size. 
When the dose is varied, often only a few animals receive each dose. These experiments are
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small for reasons of expense, logistics, and ethics. (Ethical considerations obviously influence 
all experimental infections: in this thesis I am considering experiments already carried out by 
other people.)
Although a major concern in animal experiments is often their artificiality, occasional 
experimenters move so far in the other direction, creating conditions whereby animals naturally 
transmit disease from one to another, that information on dose is lost Thus in Greenwood et 
al’s experimental epidemics in mice (1936), in which they created communities with shifting 
populations and watched epidemic spread, no more information on dose is provided than by 
natural epidemics. However, in Lurie’s experiments with tuberculosis in rabbits (1964) three 
different relative doses could be deduced, despite fairly natural transmission from infected 
animals: from the proportion of infecting rabbits with tubercle bacilli in their urine, the type of 
bedding used, and whether ultraviolet irradiation was used.
This work by Lurie (1964), designed to study mechanisms of resistance, highlights the 
potential problems in drawing conclusions on the effects of dose from experimental situations. 
Using controlled measures for determining inhaled dose from an aerosol he found, with bovine 
tuberculosis in rabbits, that the larger the infecting dose, the more fulminating the disease and 
the shorter the survival. These artificially infected animals had numerous primary foci in their 
lungs; indeed, in those infected by 2000-3000 bacilli the primary foci were so numerous that 
death occurred from simple consolidation of the lung. Even with small doses multiple foci 
occurred, on average one focus for every three highly virulent bacilli (representing the 
proportion of the inoculum reaching the alveoli). This is a marked contrast to the single focus 
usually found in rabbits (and people) who contract disease from exposure to tuberculous 
companions. Here, despite using the correct route of infection, and doses as low as 23 bacilli 
per rabbit, the disease produced was different in nature to that occurring following rabbit to 
rabbit transmission.
Many animal experiments use unnatural routes o f  infection and this can affect the results. 
Standfast and Dolby (1961) demonstrated different patterns of growth of Bordetella pertussis in 
mice when the bacteria were inoculated intranasally or intracerebrally. Intracerebral inoculation 
of monkeys with polio virus has demonstrated that larger doses produce more severe paralysis 
(Levinson et al 1943) but the relevance of this for an orally transmitted disease is difficult to 
ascertain. In studying host-parasite relationships in terms of bacterial dose, Meynell and 
Stocker (1937) argued that the stage of the challenge dose managing to penetrate the host was
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"less interesting" than the next stage, within the host tissues, and so used intraperitoneal 
injections for many of their experiments. However the dynamics of the first stage could affect 
not only the dose but also the host response and the pathogenesis in the next stage, so to draw 
conclusions about natural infections, natural routes of infection are preferable.
In some cases the disease in the animal is the focus of interest in itself. Here expense is the 
major limitation as, in commercial terms, it is generally only the diseases o f expensive animals 
which are worth investigating. For example, equine influenza was studied in ponies challenged 
by aerosol inhalation (Mumford et al 1990). Only 3 to 6 ponies were used in 4 dose groups 
and only 12 became ill. With increasing dose the incubation period decreased and the duration 
of viral excretion increased. The mean temperature of those with fever was higher in the 
highest dose group than the others.
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HUMAN EXPERIMENTAL STUDIES
Human experiments share the advantage of all experimental studies that the inoculum size can 
usually be Fixed with some accuracy. It is possible to control some other variables, for example 
the age and general health status o f the subjects and the vehicle of infection, and to measure 
others, such as gastric acidity, so that the analysis can be adjusted accordingly. They provide 
direct information on human diseases in their natural hosts. Subjects are usually infected by  
natural routes although not necessarily in naturally occurring doses. The major limitations 
derive from ethical constraints.
The scope of human experiments is very limited in terms of both the different diseases studied 
and the number of subjects employed. The main reasons why human studies employing 
varying doses have been carried out are to establish whether certain organisms are pathogenic 
(eg McCullough & Eisele 1951a,c,d), to establish a challenge dose for future vaccine studies 
(eg Homick et al 1970, Cash et al 1974) or to investigate possible routes of transmission (eg 
Havens 1946). The outcome of interest in each case is whether the subject becomes ill or not; 
severity of illness, if it is considered at all, is secondary, and patients are often treated early.
Because severity of illness is not the outcome of interest for the authors, the infotmation 
presented is often incomplete. For the studies carried out on human volunteers at the Center for 
Vaccine Development at the University of Maryland, Baltimore, I have inspected the original 
data for those infections where more than one dose of a single strain of organism was given to 
unvaccinated volunteers. Some, but not all, of this data has been published. Information was 
available for infections with Campylobacter jejuni. Shigella flexneri, E coli, and cholera. The 
methods are described in the published accounts mentioned below. Briefly, volunteers were 
kept in an isolated ward, randomised to dose, vaccination and treatment groups and challenged 
with the stated inoculum in a standard vehicle. All stools were collected, inspected and 
measured and other symptoms and temperatures were recorded. In general I have used 
summaries of the data rather than day to day accounts of the symptoms in order to extract the 
data given below. I have only used data from volunteers who had neither been vaccinated nor 
received previous challenges; they were often the controls for other studies. Earlier work by  the 
same group, much of which has been published, was carried out in prisoner volunteers. I have 
included this in the descriptions as appropriate.
1.2 Methods - Human experiments 22
Campylobacter jejuni
The information for Campylobacter jejuni has already been published (Black et al 1988). With 
strain A3249 the proportion of volunteers with positive stool cultures increased with increasing 
dose, but the proportion with symptoms showed no consistent relationship with doses ranging 
from 800 to 10* organisms. Overall only 13/72 were symptomatic. With strain 81-176 in doses 
from 10* to 2x10s, all 39 volunteers had positive stool cultures. Eighteen volunteers were ill, 
and again the attack rate did not appear to be dose-dependent. For neither strain was there a 
correlation between the challenge dose and the mean number of liquid stools passed nor the 
mean diarrhoea volume in ill volunteers.
Shigella flexneri 2a
Information is available on challenges using strain 2457T in 339 volunteers challenged over a 
period o f  more than 20 years. Most of the information is published (Dupont et al 1969, 1972, 
Levine et al 1977) and information on these earlier challenges is only available to me in the 
published accounts. The data is summarised in Table 1.2.1. In the two earlier reports, the 
lowest dose group had lower attack rates, but the lack of effect of dose on attack rate is more 
striking and there is little evidence of a correlation between dose and severity.
Escherichia coli
For all the available data with E coli, published and unpublished, the number of volunteers 
becoming ill at each dose with each strain is very small. The published data concerns mainly 
enteropathogenic (EPEC) strains, and the unpublished data mainly enterotoxigenic (E l EC) 
strains.
Information relating to different challenge doses is available for 4 strains of EPEC all derived 
from diarrhoea in infants (Levine et al 1978, 1985). With doses ranging from 106 to 1010 
almost all of the volunteers developed positive stool cultures and the attack rates for illness 
increased with dose. Measures o f  severity are only available for two of the strains. For strain 
E128010 (Levine et al 1985), diarrhoea stool volumes were similar for the 3 volunteers 
becoming ill after challenge with 10* organisms and the 3 ill after challenge with 1010. For 
strain E851/71 (Levine et al 1978 and unpublished data), 1/5 volunteers became ill after a dose 
of 106 organisms after an incubation period o f  63 hours and had 6 diarrhoea stools totalling
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437ml; 1/5 became ill after 10® organisms after 10 hours and had 2 diarrhoea stools totalling 
459ml; all 5 volunteers receiving 1010 organisms became ill with a mean incubation period of 
12 hours (range 9-13), had a mean of 5 diarrhoea stools (range 3-9), totalling a mean of 
1015ml (range 681-1403). Three in the high dose group also had vomiting.
For ETEC the available data on unvaccinated volunteers, almost all o f  it unpublished, is 
summarised in Table 1.2.2. Data are presented for all the strains where there were at least 2 ill 
volunteers in at least 2 groups and some measures of severity were available. Strain H-10407 is 
typed as O78:K80:Hl 1 and produces heat labile and heat stable toxins (abbreviated as 
LT+/ST+). It was originally isolated from a patient with copious dianhoea in Bangladesh. It 
has also been studied by Satterwhite et al (1978). Strain B7A (0148:H28) was originally 
isolated from a soldier in Viet Nam, is also LT+/ST+ and is described by Levine et al (1979). 
Strain TD 225-C4 (075:H9) came from a patient in Mexico City and is LT+/ST-. Strain 350- 
C1 (0159:H4) came from a patient in Kenya and is LT+/ST+. All challenges were given in a 
standard concentration of sodium bicarbonate. Antibiotics, usually neomycin, were usually 
given at 4 or 5 days, depending on the exact protocol used. Since neomycin can cause 
dianhoea all symptoms recorded are those occurring before the antibiotic.
Stool cultures were positive on almost all of the volunteers and attack rates generally increased 
with dose. There were no clear relationships between dose and severity of disease, measured in 
terms of number of dianhoea stools passed or total volume of diarrhoea, but the numbers in 
each group were small (Table 1.2.2).
Cholera
Much of the cholera data has already been published. Results from apparently the same 
prisoner studies are given in three papers: Music et al 1971, Homick et al 1971 and Cash et al 
1974. An amalgamation of their figures is given in Table 1.2.3. All doses were given with 
bicarbonate. The attack rate increased with dose and for Inaba 569B the proportion of subjects 
with dianhoea who required intravenous therapy increased with increasing dose (x2 trend 4.9, 
p = 0.03).
Much o f the more recent cholera data has also been published. The data available to me (in the
form o f experiment summaries) is presented in Table 1.2.4. The results using El Tor Inaba
P27459 and N16961 appear (in slightly different form) in Levine e t al 1981. Both strains were
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isolated from patients with cholera in Bangladesh. The classical strains were the same as those 
used in the earlier prisoner studies; both were originally isolated from cholera patients in India 
(Cash ct al 1974).
The challenge doses were given with 2g of sodium bicarbonate but it has been demonstrated 
(Music et al 1971) that 30 minutes after 2g bicarbonate the stomach pH in about half the 
investigated subjects becomes strongly acid again and in the other half remains near neutral, 
with no overlap between the groups. Those with prolonged buffering have much higher attack 
rates when challenged with cholera given with bicarbonate. Nalin et al (1978) showed that 
basal stomach acid production 24 hours before ingestion of cholera with bicarbonate correlates 
with disease severity, those with low acid having higher total volumes of diarrhoea. It is also 
known that blood group O predisposes to more severe disease (Levine et al 1981). The 
volunteers were randomised to the different groups, but as the numbers are small it is quite 
possible that the proportions with blood group O and low acid secretion were not evenly 
distributed between the groups. I have no information on the acid secretion in these volunteers, 
and the information available to me on blood groups is very incomplete so I have not been 
able to examine the effects of these factors in the results.
The data for the classical strains (Table 1.2.4) provide no evidence that higher doses lead to 
more severe disease - in contrast to the earlier studies with the same strains (Table 1.2.3). For 
Classical Inaba 569B, over the small dose range studied, there was little difference in severity 
between the groups. For Classical Ogawa 395 three of the four volunteers ill after receiving the 
lower dose, 105 organisms, had particularly severe disease, with very large stool volumes. The 
differences between the two dose groups were significant at the 5% level for the stool volume, 
the number of diarrhoea stools and the proportion of ill subjects with rice water stools 
(comparison of means using Kruskal Wallis non-parametric test and proportions with Fisher’s 
exact test).
For El Tor Inaba P27459 those receiving the lower dose again had larger stool volumes (p = 
0.03 Kruskal Wallis non-parametric test comparing group means). Other measures of severity 
were similar in the two groups. For El Tor Inaba N16961, as the dose increased the incubation 
period decreased, and the diarrhoea stool volume and number increased. These continuous 
variables were inspected on scatter plots and linear regressions were calculated between log 
dose and log incubation period, log stool volume and log number o f stools. The following 
correlations with log dose were obtained; log incubation period correlation coefficient (r) =
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-0.40 (95%CI -0.70 to 0.03); log stool volume r =  0.33 (-0.11 to 0.66); and log number of 
stools r = 0.22 (-0.22 to 0.59). With increasing dose the proportion of ill subjects with rice 
water stools increased (x2 trend 5.7, p = 0.02).
Overall the lack of correlation between dose and severity is striking, even when the dose varies 
by three logs. Gastric acidity is known to have a major effect on outcome, and it would be 
very interesting to adjust the results by basal acid secretion, to see if this is masking any effect 
of dose. The dose arriving in the small intestine could be crucial.
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Table 1.2.1. Comparison of outcome in non-immuniscd volunteers challenged with different 
doses of Shigella flexrteri 2a.The symptoms are given as a proportion of ill volunteers.
Source Dose N III (%) Stool +ve (%) Fever Diarrhoea Dysentery
Dupont et al 104 4 1 (25%)
1969
105 4 3 (75%)
10* 8 7(88%)
107 19 13 (68%)
10* 8 7 (88%)
total 104-10* 43 31 (72%) 29 (67%) 13/31 (42%) 27/31 (87%) 16/31 (52%)
Dupont et al 180 36 9 (22%) 6(17%)
1972
5000 49 28 (57%) 33(67%)
104 88 52 (59%) 66/87 (76%)
10s 24 14 (58%) 15 (63%)
Levine et al 100 36 14 (39%) 12 (33%) 7/14 (50%) 14/14(100%) 8/14 (57%)
1977
104 15 6(40%) 9(60%) 3/6 (50%) 5/6 (83%) 5/6 (83%)
Unpublished 100 8 4(50%) 5(63%) 3/4 (75%) 3/4 (75%) 4/4 (100%)
data, 1986 to
1991 105 40 21 (53%) 20/28 (71%) 17/21 (81%) 18/21 (86%) 19/21 (90%)
The definitions of ill. fever and diarrhoea ail vary:
- Dupont et ai 1969: III ■= fever (> 100°F), severe abdominal cramping, diarrhoea (2 2 loose stools/24 
hours), or bloody mucoid stools.
- Dupont et al 1972: HI = fever (2 100°F) + diarrhoea (2  4 watery stools/24 hours)
- Levine et al 1977: III« diarrhoea (2 3 loose stools/24 hours) or dysentery ±  fever (2101°F)
- Unpublished: III -  diarrhoea (2 1 liquid stool 2 300ml or 2  2 liquid stools totalling 2  200ml within 48 hours) 
or dysentery ±  fever ( 2 100°F)
Dysentery *  blood and mucus in stool
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Table 1.2*2. Summary of unpublished data from the Center for Vaccine Development, 
Baltimore, for different strains of ETEC. (Some of the data for strain B7A is published in 
Levine et al 1979)
Strain Dose N Stool
+ve
III
(%)
Incubation
period
(hours)
Median
(range)
No. O f 
diarrhoea 
stools. 
Median 
(range)
Volume of 
diarrhoea stools 
(ml) Median 
(range)
Severe
H-10407 10* 5 5 1(20) 70 7 552 0/1
1978-92 10* 5 5 2(40) 50 (48-52) 6 (2-10) 717(347-1087) 1/2
10* 34 34 25(74) 43(21-92) 8 (1-39) 1290(40-6100) 10/25
H-10407 5 x  10* 6 0 0(0)
clone
107 11 11 3(27) 31 (23-49) 15 (4-26) 1516(410-1536) 1/3
1979-80 5 x  10* 21 21 19(90) 40 (23-78) 11 (1-29) 1762 (30-9860) 12/19
B7A 10* 6 3(50) 25 (23-52) 8 (6-10) 795 (640-1300) 0/3
1977-80 10* 27 3/3 17(63) 44(14-124) 6(1-25) 600 (300-2150) 4/17
10'° 13 12 8(62) 15 (9-48) 5 (2-24) 580(218-3311) 3/8
TD 225-C4 10* 5 1 (20) 1 3 40+ 0/1
1977-80 10* 4 3(75) 7(2-8) 4(3-6) 326 (281-595) 0/3
10* 3 2(67) 5(3-6) 656(315-997+) 1/2
10’° 5 5 2(40) 10 (8-12) 4(2-5) 576 (393-759) 0/2
350-C1 10* 3 3 0(0)
1987 10* 4 3 0(0)
10’ 4 4 2(50) 19 (12-26) 1 (1-1) 272 (189-354) 0/2
10” 5 5 3(67) 18 (15-21) 2(2-3) 206 (10+-403) 0/3
A volunteer was counted as i l  if they had diarrhoea (ie stools which take the shape of the container) fulfilling at least 
one of the following criteria:
1 diarrhoea stool £  300ml or 2 diarrhoea stools totaling 2  200ml or s  3 diarrhoea stools or any amount of 
diarrhoea + vomiting or fever (2 100°F)
Severe illness was defined as diarrhoea stool 2 21 or £  11 + vomiting or fever
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Table 1.2.3. Results of volunteer challenges with two strains of classical cholera. All 
challenges were given with bicarbonate. From Music et al 1971, Homick et al 1971 and Cash 
et al 1974.
Strain Dose No. of volunteers with each outcome
Nil Carrier Diarrhoea Severe
diarrhoea
Inaba 569B 10 2 0 0 0
103 1 3 0 0
104 2 2 9 0
105 1 1 5 1
106 4 6 28 14
10* 0 0 1 1
Ogawa 395 10’ 1 0 1 0
10‘ 2 0 11 9
The outcomes are defined as follows: Nil - stool cultures negative; Carrier - stool culture positive, no diarrhoea; 
Diarrhoea - stool positive with at least one diarrhoea stool but not requiring intravenous fluids; Severe diarrhoea - 
stool positive with diarrhoea severe enough to require intravenous therapy.
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Table 1.2.4. Summary o f results of cholera challenges in non-immunized volunteers at the 
Center for Vaccine Development, Baltimore. All challenges were given with bicarbonate.
Strain Dose N Stool
+ve
ID (%)
El Tor Inaba 10s 5 5 3(60)
P27459
(1978) 10' 11 11 9(82)
El Tor Inaba 103 6 6 4(67)
N16961
(1978-82) 10’ 5 4 4(80)
10s 5 4 3(60)
106 12 11 11 (92)
Classical 1 .5 x10 ' 13 10 5(38)
Inaba 569B
(1990-91) 4 x  10” 15 15 10 (67)
10 x 10' 11 9 8(73)
Classical 105 6 6 4(67)
Ogawa 395
(1977-80) 10” 28 27 26 (93)
Incubation
period
(hours)
Median
(range)
Stool volume (ml) 
Median (range)
NO. Of 
diarrhoe 
a stools 
Median 
(range)
Rice
water
stools
25 (17-41) 3049 (1642-9856) 11 (8-18) 1/3
24 (18-50) 1313 (324-2755) 10 (3-28) 3 «
32 (29-40) 687 (422-1876) 6 (2-9) 0/4
39 (29-40) 1074 (590-1526) 6 (4-10) 0/4
19 (17-19) 2489 (2224-4656) 15 (9-21) 1/3
24 (14-55) 2751 (280-13100) 12 (2-39) 6/11
33 (19-60) 874 (394-1897) 6 (2-12) 0/5
51 (29-90) 712 (227-1741) 6 (2-15) 0/10
32 (16-72) 794(214-2810) 7 (2-16) 0/8
39 (19-48) 20940 (1410-44020) 46(9-87) 4/4
30 (7-104) 3050 (200-18270) 18(1-41) 9/26
Volunteers were classified as ill if they had positive stool cultures and diarrhoea (defined as a liquid stool - ie one 
which takes the shape of the container) of i  300ml or two liquid stools totalling & 200ml within 48 hours.
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OBSERVATIONAL STUDIES
Observational studies rely on indirect measures of dose. Because they refer to natural infections 
any results are more directly relevant to public health than those from experimental studies. 
Information is potentially available on a wide range of diseases, and very severe disease or 
death, if  it occurs, can be studied as an outcome.
The main disadvantages are that only proxy and imprecise measures of dose are available, 
measures of severity are often crude, and the data are often of poor quality. There are inherent 
biases in many of the methods, related to the proxy measures used. Methods o f  assessing dose 
or relative dose are the major problem. Some methods can be used for a range of infections 
but many are dependent on the route of infection.
General methods
Attack rate and incubation period
The attack rate and incubation period are associated with dose for many infections. As 
discussed in the introduction, the evidence comes mainly from animal and human volunteer 
experiments. An outbreak with a high attack rate and a short average incubation period is 
likely to have resulted from a high dose of infecting organisms. Of course alternative 
explanations are possible: the outbreak could be due to a particularly virulent strain of 
organism, or the population could be particularly susceptible. Nevertheless, comparing attack 
rates or incubation periods between outbreaks caused by the same organism provides a proxy 
method o f assessing dose. I have used these methods in comparisons of typhoid and of 
salmonella outbreaks (Section 2, and Glynn & Bradley 1992).
Within a single outbreak the problem of confounding by strain can be ignored. Attack rates by 
area may occasionally be available in large epidemics (Bernard 1965, Shaw 1922), allowing 
attack rates to be compared to a measure of group severity such as the case fatality rate. More 
detailed information can be obtained by comparing individual incubation periods with 
individual outcomes and this method is more widely applicable. Incubation periods can be 
estimated from point source epidemics so the method is especially suitable for food or water­
borne diseases. I have carried out a detailed analysis of a Salmonella typhimurium outbreak 
using this technique (Section 2, and Glynn & Palmer 1992). Other applications are possible.
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For example, an outbreak of illness, later identified as histoplasmosis, affected all 21 people 
who had been in a cave during a treasure hunt in Arkansas in 1947 (Washburn et al 1948, 
Grayston & Furcolow 1956). Incubation periods were recorded and did not correlate with 
disease severity. To give another example, the time between exposure and the onset of 
prodromal symptoms was recorded for 37 children with a known single exposure to polio in an 
epidemic in Alabama in 1941 (Casey 1942). There was no association between the incubation 
period and the outcome, categorized as non-paralytic, paralytic or death.
Incubation periods may also be known for individuals outside single outbreaks or in more 
prolonged epidemics which may not necessarily be due to a single strain. It is still possible to 
compare the incubation period with the outcome, but possible confounding by strain 
differences should be considered.
The inherent bias in using incubation period as a measure of dose is confounding by individual 
susceptibility. Host immunity and innate susceptibility would be expected to influence both the 
incubation period and the severity of disease, leading to an association which could be wrongly 
interpreted as evidence of a dose-severity effect. That an association between incubation period 
and severity does not necessarily imply a dose effect is illustrated by data from the Center for 
Vaccine Development, Baltimore. Among volunteers, about 40% of whom had been 
vaccinated, challenged with an identical dose of Shigella sonnei, incubation period was 
inversely related to the peak temperature (Mackowiak et al 1992). In the cholera data from 
unvaccinated volunteers discussed above (Table 1.2.4), incubation period was more closely 
correlated with outcome than was dose. For example, for El Tor Inaba N16961 where there 
was a large dose range, log stool volume was more closely related to log incubation period (r 
= -0.65, 95% Cl -0.84 to -0.32) than to log dose (r = 0.33, 95% Cl -0.11 to 0.66). Here the 
incubation period may reflect the dose reaching the small intestine as well as individual 
susceptibility to the effects of the toxin.
In some situations it is possible to adjust for factors known to influence susceptibility, such as 
age, prior exposure or vaccination, or the use of antacids and antibiotics. This is discussed 
further in the sections on salmonella and malaria. Residual confounding by known and 
unknown or unmeasurable factors is likely.
Observing the effect o f  an intervention
Another method of estimating the effects of different relative doses might be to assess the
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effects of an intervention aimed at lowering infecting dose. As emphasised in the introduction, 
if there is a dose-severity relationship, an intervention which lowers the dose would be 
expected to be more effective against severe disease than against mild disease (Esrey et al 
1985). To use this to investigate the effects of dose we would have to know what would 
happen to the protective efficacies against different levels of disease if there were no dose- 
severity relationship, which supposes a knowledge of the shape of the dose-response curve for 
the different levels of disease.
The shape of the curve can be predicted (Meynell & Stocker 1957) for a single pathogen given 
by a uniform method of inoculation to hosts of uniform resistance, assuming that the organisms 
in the inoculum act independently of each other. Where p  is the probability that each organism 
gives rise to disease and d is the infecting dose, the probability of a given host not getting the 
disease is (1 - p)d.
The probability of responses to different doses under these assumptions is shown in Figure 
1.3.1. If it is assumed that the probability that each organism giving rise to severe disease is 
smaller than its probability of giving rise to disease, then the probability of severe disease can 
be represented by the curve on the right. An intervention which lowers the dose received will 
lower the probability of getting both disease and severe disease but the protective efficacies 
against these different outcomes will not necessarily be the same - it will depend on the 
relation between the reduction in dose and the different parts of the two curves. In fact the 
protective efficacy will always be greater against the less likely event although the difference is 
sometimes negligible.
This very simplified model suggests that, following an intervention which lowers infecting 
dose, the protective efficacies against different levels o f  disease cannot be assumed to be the 
same even in the absence of a dose-severity relationship. Aspects of this simple model of 
infectious disease are discussed in the final section. In practice, the shape of the dose-response 
curve even for the level of illness which defines disease is not well established for most 
pathogens. It will depend on the pathogen, the method o f  inoculation and the hosts (Esrey et al 
1985). The finding that an intervention has a greater protective efficacy against severe disease 
than total disease in a study would therefore not necessarily imply that a dose-severity effect 
existed. Other alternative explanations are also possible, and the subject is explored further in 
relation to impregnated bednets and malaria (Section 3).
1.3 Methods - Observational studies. Food/water-borne transmission 33
Food- drink- or water-borne transmission
Amount o f food
Where the infecting organism is uniformly distributed in a food vehicle, and the food is eaten 
over a short space of time, the amount of food consumed should provide a good proxy marker 
of relative dose. This relationship can be used practically in investigating outbreaks: an 
increase in attack rate with increasing doses of a particular foodstuff can aid identification of 
the vehicle. For example, in an outbreak of disease due to Campylobacter jejuni following a 
school visit to a farm in Minnesota (Koilath et al 1985), the attack rate increased with 
increased raw milk consumption. However, among the 25 who were ill in this outbreak, there 
were no apparent associations between the amount of milk drunk and either the incubation 
period or the duration of illness.
In an outbreak of Hepatitis A traced to tuna sandwiches prepared by an infected person, all 7 
people who ate the sandwiches became ill, and the incubation period was inversely related to 
the number of sandwiches eaten (Istre & Hopkins 1985). In this small outbreak no associations 
were found between dose and severity of disease in terms of duration o f jaundice, number of 
symptoms or time off work.
Examples relating to salmonella and typhoid are discussed in Section 2. Unfortunately the 
amount of food is rarely recorded, and even when it is, the range of dose is likely to be small 
and the distribution of the pathogen in the food is unlikely to be uniform. People who eat 
larger amounts of the affected food may tend to eat larger (or smaller) amounts of another food 
which may be an effective buffer, or may differ in other ways from people who eat less, so the 
relationships between the amount of the vehicle consumed and the outcome may not be 
straightforward. Another potential problem in this type of study is recall bias. Since, intuitively, 
people may expect that larger doses will make them more ill, if  the vehicle is known, 
differential misclassification of exposure may result.
The time when food  is eaten
If a foodstuff is contaminated with bacteria and left at a temperature at which the bacteria can 
multiply, then food eaten later is likely to be more heavily contaminated. Again this is not 
often recorded: some examples of outbreaks where food was eaten at different times are given 
in Section 2.
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Type o f vehicle
It is likely that the concentration of pathogens in water is usually lower than that in food 
(Naylor 1983). For pathogens that can be transmitted by either food or water it is possible to 
compare outbreaks caused by the different vehicles. In Section 2 this has been done for 
typhoid, and the possible drawbacks of this approach are discussed.
Blood transmission
Whole blood or concentrated blood products
Blood products such as factor VIII concentrate are made by pooling blood from many donors 
and then dividing up the product between recipients. Blood products were not routinely heat- 
treated until 198S. In contrast, single units of whole blood come from single donors. It is likely 
therefore that infected units of blood contain a higher concentration of HIV or Hepatitis B than 
do vials of concentrate.
For HIV, severity can be measured by progression to AIDS or by changes in markers 
associated with this progression over time (Moss 1988). Studies following cohorts with known 
dates of seroconversion have found variable rates of progression to AIDS. A Swedish study 
(Giesecke et al 1988) found a much higher rate of progression among blood transfusion 
recipients than among haemophiliacs. This might suggest that dose influenced progression, but 
the transfusion recipients were older, and although age did not predict progression within each 
group in this study, in other studies cohorts have shown faster progression among older 
patients (Darby et al 1989, Goedert et al 1989). The two groups - haemophiliacs and blood 
transfusion recipients - will always be difficult to compare since the illness for which the 
patients required the blood transfusion, or associated illnesses, may influence progression.
Number o f vials o f Factor VIII
The Edinburgh haemophilia cohort provides uniquely direct evidence relating to inoculum size 
(Cuthbert et al 1990). Thirty-two patients with haemophilia A received doses of a single batch 
of factor VIII contaminated with HIV-1. Eighteen sereconverted and the number of vials they 
received was recorded. The number o f vials did not influence the time to seroconversion. 
Doses tanged from 9 to 109 vials: 7/9 receiving more than 30 vials reached CDC stage IV by 
5 years, compared to 3/9 receiving up to 30 vials (relative risk 2.3, 95% Cl 0.87 to 6.27).
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It might be possible to determine other groups of haemophiliacs all infected from the same 
batch in whom the relative dose could also be compared. Several large cohorts of 
haemophiliacs for whom the time of exposure is known are reported in the literature (Giesecke 
et al 1988, Darby et al 1989, Goedert et al 1989, Ragni et al 1990, Eyster et al 1989, Lee et al 
1989, Wolfs et al 1989, McGrath et al 1986). For some of these cohorts reports refer to types 
of blood product used, and Goedert et al (1989) in their multicentre cohort, extracted data on 
cumulative dose of factor concentrate, implying that these details are recorded. Both in the 
United States and in the United Kingdom it is possible to trace a particular factor concentrate 
batch to its recipients (Cuthbert et al 1990, Jason et al 1986).
For each individual in a cohort the batches and amounts of factor VIII received over the period 
before seroconversion could be identified. By comparing these results with the batches received 
by seronegative haemophiliacs from the same centre over the same period, it should be 
possible to determine which of the batches were infected (using methods analogous to those 
used to identify the vehicle in food poisoning outbreaks). Whether the number of vials of the 
infected batch influenced the outcome in groups all infected by a single batch could then be 
determined. This procedure would only be possible if, as in Edinburgh in 1984, the prevalence 
of HIV infection was low enough that each haemophiliac is likely to have been infected by 
only one batch.
Airborne transmission
Length or extent o f exposure to an agent in the environment
The duration of exposure to a single airborne source of infective agent should correlate with 
infective dose. In the Arkansas outbreak of histoplasmosis discussed above (Washburn et al 
1948), duration of exposure in the cave was positively associated with the severity of the 
outcome; however neither the definition of duration nor of severity were clearly stated and the 
incubation period was not related to the duration of exposure. In a review of histoplasmosis, 
which also lacks definitions, Grayston and Furcolow (1956) found that five severe epidemics 
followed exposure in enclosed situations, whereas for five less severe epidemics the situations 
were "open" for two, "partially open" for one, and "unknown" for two.
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Exposure to more than one infective case
Studies in military populations have shown that the acquisition rates for Group A streptococci 
increased with the number of carriers in a barrack group (Wannamaker 1954), the higher 
infection rates suggesting higher infecting doses.
Neither Top (1938) nor Stillerman and Thalhimer (1944) found higher attack rates for measles 
among susceptible contacts exposed to more than one primary case in the family. In the later 
study there were only 9 such contacts, and in both studies the overall attack rates were around 
80% and higher in the under fives so there was little scope for an increase. Both authors also 
considered duration o f exposure and found little difference in attack rate between contacts 
exposed throughout the illness and contacts o f those removed to hospital. However most 
transmission would be expected to have occurred before this time (Benenson 1990).
In a Kenyan study o f measles (Aaby & Leeuwenburg 1990), exposure to more than one index 
case affected the outcome: secondary cases exposed to 2-4 index cases had a case fatality rate 
(CFR) of 5/37 (14%) compared to a CFR of 18/303 (6%) for those exposed to only one index 
case (RR 2.47, 95% Cl 0.93-6.56, after adjusting for age).
Proximity to infective case
Studies of Group A streptococcal carriage in volunteers found that acquisition rates decreased 
with increasing bed distance from the nearest carrier (Wannamaker 1954). In an outbreak of 
scarlet fever in the Royal Naval School, Greenwich, Dudley (1923) found clustering of cases at 
one end of a large dormitory, and no cases among day boys. Other boys would have had 
contact with the infected cases at other times of day so this difference in attack rates suggests 
an effect of dose. The importance of proximity in effective transmission led to the development 
of rules for bed spacing to try to limit epidemic spread (Stallybrass 1931).
In Senegal (Garenne & Aaby 1990) secondary cases of measles living in closer proximity to 
the index cases had higher CFRs than those in separate huts and households but still within the 
same compound.
Index or secondary case in a household
Peter Aaby (1988, 1989) has argued that the secondary cases of measles in a household are 
exposed to a higher infecting dose than index cases infected outside and that this explains 
some of the variation in severity of this disease. Since 1978 a child health and nutrition project
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has been running in Guinea-Bissau, where measles case fatality rates can reach 25%. The 
failure to find the expected association between pre-morbid nutritional status and outcome from 
measles infection led to a search for other explanations. It was found that cases occurring in 
households with more than one case had a higher fatality rate than isolated cases (Aaby 
1988,1989). Other studies have been reanalysed to compare rates between multiple and single 
cases, and between index and secondary cases (Aaby 1989, Koster 1988, Bhuiya et al 1987, 
Garenne & Aaby 1990, Aaby & Leeuwenburg 1990, Pison & Bonneuil 1988, Lam b 1988, Hull 
1988) and generally confirm the results, giving case fatality rate ratios between secondary and 
index cases of around 2 or more.
The results are very unlikely to be due to chance; many studies individually had statistically 
significant results at least for the younger age groups (Aaby 1989, Koster 1988, Bhuiya et al 
1987, Garenne & Aaby 1990, Aaby & Leeuwenberg 1990). Ascertainment of measles cases 
was generally thorough - measles was well recognized in the communities (Garenne & Aaby 
1990) and where antibody levels have been checked lay diagnosis has proved reliable (Aaby 
1989, Koster 1988).
Younger children are more likely to be infected at home in many communities, and therefore 
become secondary cases; and younger age at infection has been widely shown to be associated 
with higher mortality (for example Hull 1988, Aaby 1989, Pison & Bonneuil 1988, Narain et 
al 1989, Gordon et al 1965). However the association persists within each age band, and is 
particularly strong in those under three years (Aaby 1988). In fact controlling for 
index/secondary cases may eliminate some of the association with age (Bhuiya e t al 1987).
Large households will tend to have more secondary cases and are particularly subject to the 
problems associated with overcrowding such as poor nutrition and hygiene. However the 
increased case fatality rate among secondary cases is found when the analysis is restricted to 
families with one index and one secondary case (Aaby & Leeuwenberg 1990). It may be 
argued that families may be less able to look after the second sick child, but in Guinea-Bissau 
there was no lower mortality among secondary cases whose mothers only had to  care for them, 
than among those whose mothers had to care for an index case as well (Aaby e t al 1988).
The proportion of secondary cases in studies in different communities in different countries 
correlates closely with overall case fatality rates for those communities (Aaby 1989). The 
different proportions of secondary cases are presumably due to different family structures, in
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particular the high rates of polygamy and extended families in West Africa, and to the local 
pattern of measles, whether it is endemic or epidemic. Secular changes in family size and 
living conditions in the developed world could contribute to the observed decrease in case 
fatality rates by changes in the proportion of secondary cases.
In urban areas where measles is endemic, siblings tend to be infected at a young age at 
different times. In rural areas, where epidemics occur, siblings are more likely to be infected 
concurrently and at higher ages. Using the median age of infection, Foster (1984) predicted 
CFRs for urban and niral areas of Nigeria of 6% and 2% respectively. In fact the opposite 
pattern is found and rates are higher in rural areas (Aaby 1988). The increased proportion of 
secondary cases in rural communities could explain this difference, though differences in health 
care facilities and living standards should also be considered.
An extreme pattern of exposure is seen in isolated communities where the whole population 
can be infected in a single epidemic with mortality rates around 20% (Morley 1969). The high 
mortality can be attributed to the lack of uninfected people left to look after the sick (Morley 
1969), and to the relatively high death rates in adults (Peart & Nagler 1954), but intensive 
exposure due to simultaneous infection could contribute. Similarly high case fatality rates occur 
in refugee camps (Toole & Waldman 1990) and could be explained by intensive exposure as 
well as by the poor conditions.
For measles, Aaby has inferred differences in infecting dose from the observed difference in 
outcome between index and secondary cases. The results are consistent in studies carried out 
by different investigators in different places at different times and do not appear to be 
explained by confounding factors. It should be possible to use this distinction between index 
and secondary cases to investigate dose effects in other infections transmitted by the same 
route. Possible studies range from correlational studies comparing the proportion of secondary 
cases in an outbreak to a marker of severity of the outbreak (such as CFR), through case- 
control studies comparing exposure status of severe or not severe cases of disease, to 
community based studies.
Several studies of chickenpox have compared severity of disease between index and secondary 
cases. Ross (1962) found a larger average number of pox per child in secondary cases than 
primary cases among the controls in a trial of gamma-globulin. The secondary cases were 
younger and the results were only presented in broad age categories (6-59 months and 60-143
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months). In recent trials of acyclovir treatment for chickenpox the case order in the family has 
been considered as a potential bias in the results and so has been recorded. Since the object of 
these papers was to assess the effect of acyclovir, the results relating to case order are 
incompletely presented. Dunkle et al (1991) studied 197 primary cases and 160 secondary and 
tertiary cases with a median age of 5, who received placebo. They reported that "the extent and 
duration of cutaneous disease were significantly greater in second or third cases in the same 
household than in first cases (p < 0.001), but the frequency and duration of fever did not 
differ". However, "in a regression model the maximum number of lesions could not be 
correlated with ... order of household occurrence". Balfour et al (1990), among SI primary and 
50 secondary cases with a median age of 7, randomized to receive acyclovir or placebo, found 
that secondary cases had more protracted disease. "They took significantly longer to begin to 
heal skin lesions (p = 0.005), to develop crusts (p < 0.005), and to experience cutaneous 
improvement (p < 0.01) in comparison with placebo-treated children who had primary cases." 
These results were not adjusted for age.
Less direct data are available that allow comparison of mortality rates of infections to measures 
of overcrowding. Crowded housing has been found to correlate with mortality rates in children 
from diphtheria, measles, tuberculosis and whooping cough (Payling Wright & Payling Wright 
1942). However, these results are too remote from measurements of dose and severity to be 
useful: overcrowding is not the same as measures of secondary or even multiple cases; 
incidence rates are likely to be higher in overcrowded conditions, and even where case fatality 
rates are available or can be calculated, they will be influenced by factors related to 
overcrowding such as poverty and malnutrition. In Liverpool in  the 1920s case fatality rates for 
diphtheria and scarlet fever decreased from the (crowded) central zone to the middle and outer 
zones (Stallybrass 1931). Children in the central zone acquired the diseases younger, and it is 
possible that less severe cases were under-reported in the central zone. In these data the 
proportion of secondary cases to primary cases was highest in the outer zone, emphasising that 
overcrowding does not necessarily correlate with a high proportion of secondary cases.
Amount o f excretion by the index case
Transmission experiments with Group A streptococci in man found that acquisition rates 
increased with increasing quantities of streptococci isolated from  the nearest carrier, and were 
higher in those exposed to nose carriers than throat carriers (Wannamaker 1954).
For measles, severe disease appears to lead to severe disease. In Kenya (Aaby & Leeuwenberg
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1990) among children under 6 years, the CFR for secondary cases exposed to an index case 
who died was 3/11 (27%), compared to 20/329 (6%) for those exposed to an index case who 
survived (RR 4.69, 95% Cl 1.64-13.41). This is consistent with intensity of exposure being a 
major factor if the assumption is made that fatal cases excrete more virus. It has been shown 
that children with severe measles excrete giant cells for longer (Schiefele & Forbes 1972).
Giant cells contain viral particles, but in another study (Dossetor et al 1977) viral culture was 
negative after the acute phase. Alternatively, this relationship could be due to confounding: 
families where one child dies may be the most likely to experience another death for socio­
economic or genetic reasons.
In Senegal (Garenne & Aaby 1990) the CFR increased with each generation of attack. The 
Sereer communities studied live in large compounds and as settlements are scattered have an 
epidemic pattern of measles. In larger compounds five or more generations of measles could be 
identified. Increasing CFRs from generation to generation were found, with odds ratios 
compared to the index cases, infected in the village, of 1.4 for the first generation of secondary 
cases, 2.4 for the second, 3.7 for the third, 5.5 for the fourth and 16.1 for the fifth and 
subsequent generations. The results were unchanged by controlling for the number of cases 
within the compound, so confounding by compound size is unlikely. If more severe cases 
secrete more virus this increase in severity could be explained by ever increasing exposure.
Family studies of tuberculosis in the USA in the 1930s and 1940s found higher attack rates 
when index cases were sputum positive than when they were negative (Putnam 1936, Brailey 
1940, Puffer et al 1942, Stewart et al 1943). This could be interpreted in several ways. If the 
sputum negative cases excrete low doses it may be an example of a higher infecting dose 
giving higher attack rates, as expected. However it may simply indicate that a proportion of 
cases classified as sputum negative were or had been at some point sputum positive, or that 
some family members of sputum negative cases were exposed to tuberculosis elsewhere. If 
secondary cases in families of sputum negative cases are actually infected elsewhere, outside 
the household, then their infecting dose may be lower than that of the true secondary cases of 
sputum positive cases. It is therefore possible that, one way or another, those who become ill 
after exposure to a sputum positive case in the family are exposed to a higher dose than those 
ill after exposure to an apparently sputum negative case.
In prospective studies in Williamson County, Tennessee, index cases were classified as (1) 
fatal and manifest sputum positive and (2) other manifest and latent apical, and the experiences
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of their household contacts were compared. Among coloured families (Puffer et al 1942) there 
were 22 deaths from 27 cases (81.5%) among the contacts of the first group and 2 deaths from 
5 cases (40.0%) among contacts of the second, during the period of observation (RR 2.04, 95% 
Cl 0.69-6.05). This difference may be due to the shorter period of follow up for the cases in 
the second group. Also, this group had a lower mortality rate from diseases other than 
tuberculosis so there may have been other differences between them and the first group.
Among white families (Stewart et al 1943) the case fatality rates were lower and were similar 
in the two groups of contacts: 5/18 (27.8%) in the first and 5/17 (29.4%) in the second. The 
second group again had a lower mortality rate for non-tuberculosis deaths.
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Figure 1.3.1. Probability of illness under the hypothesis of independent action, assuming 
uniform host resistance.
p = probability of outcome arising from each single organism 
d = dose (number of organisms)
Equation of curves = 1 - (1 - p)d
Probability of outcome for different doses:
Dose Left hand curve Right hand curve
"disease" "severe disease"
(P = io-5) (P = 10^)
10* 0.0952 0.00995
10s 0.632 0.0952
10* 0.99995 0.632
Intervention lowering dose from 103 to 10*. Protective efficacy: 
vs disease = 1 - 0.0952/0.632 = 84.9% 
vs severe disease = 1 - 0.00995/0.0952 = 89.5%
Intervention lowering dose from 10* to 10s. Protective efficacy: 
vs disease = 1 - 0.632/0.99995 = 36.8% 
vs severe disease = 1 - 0.0952/0.632 = 84.9%
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INTRODUCTION
Some information is available on all three of the factors (host characteristics, pathogen 
characteristics, and factors affecting the interaction) that determine the outcome when a host is 
challenged with salmonellae. Different strains o f mice have different susceptibilities to S 
typhimurium and this is dose-dependent. Selective breeding has shown that susceptibility is 
under genetic control, and three different genes have been identified (O’Brien et al 1980). As 
well as varying in susceptibility, different in-bred strains have different latent periods to death 
(Hormaeche 1975).
Salmonella infections are more severe at the extremes of life (Parker 1990) and in some mouse 
strains the males are more susceptible (Gowen 1960). Reinfection with typhoid can occur 
(Matmion et al 1953) but is thought to be rare (Homick et al 1970). Vaccination provides 
some protection from typhoid, with estimates of vaccine efficacy around 50 - 75% for the 
more commonly used vaccines (Parker 1990). However, when infection occurs in vaccinated 
individuals the severity of the illness is unaltered (Homick et al 1970). Other host factors may 
also be important, for example debility, malnutrition (Blaser & Newman 1982) and the taking 
of antibiotics (Homick & Woodward 1966).
The presence of the Vi antigen has been shown to be an important determinant of virulence for 
typhoid and paratyphoid. Both Vi positive and Vi negative strains are ingested by human 
neutrophils but Vi positive strains manage not to activate the intracellular oxidative killing 
system of the leucocyte (Parker 1990). In volunteer experiments Vi positive strains produced a 
higher proportion of infected and symptomatic cases. It has also been found that different 
strains of S typhi produce different amounts of the Vi antigen (Old 1990). Among the other 
salmonellae, virulence is thought to depend on the lipopolysaccharide cell wall, the O antigens, 
and factors coded for by plasmids (Old 1990).
The pathogen-host interaction, is influenced by factors affecting the delivery of organisms - the 
vehicle and route of infection - as well as the infecting dose itself. The initial dose and the 
vehicle interact with host factors to influence the number of organisms reaching the intestine 
(Blaser & Newman 1982). High gastric pH and fast gastric transit times would both increase 
the proportion of the inoculum which survived passage through the stomach. Vehicles with a 
high buffering capacity would raise the gastric pH, but their effectiveness will depend on the 
host response, as was discussed for cholera (Music et al 1971). In experimental infections the
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route of entry will be important, and aerosol transmission has been suggested in some 
salmonella outbreaks in infants.
While using the term "infecting dose" to mean the initial inoculum, it is the dose delivered to 
the intestines which will have the direct influence on outcome. Some of the variation in 
incubation period between individuals given the same dose may be due to the factors altering 
the number of bacteria that reach the intestine. Indirect measures o f dose which involve the 
point of consumption of organisms - the amount of food consumed, the time when the food is 
eaten and the type o f vehicle - all reflea the intial inoculum. The incubation period and attack 
rate reflect the dose in the intestine, as they depend on the host response. If dose does 
influence severity, measures which reflect the dose in the intestine would be expected to show 
a closer association with severity than measures reflecting the initial inoculum. (As mentioned 
in Section 1, confounding by strain and by host susceptibility will also tend to increase 
associations between incubation period or attack rate and severity.)
I chose the salmonellae for study because they are important pathogens and it has been 
suspected for some time that dose does influence severity (Miner 1922) but the evidence as 
quoted (eg Blaser & Newman 1982, Esiey et al 1985) is far from complete. The available 
published evidence has not previously been pulled together.
After a short review of the published evidence from experimental infections I review reported 
outbreaks of salmonella infections in the form of an analysis comparing severity by indirea 
measures of dose within and between outbreaks. Then I present an analysis o f a single large 
outbreak and finally an analysis of data from volunteer experiments with typhoid from the 
Center for Vaccine Development, Baltimore.
To comply with U niversity o f London regulations I should like to po in t out that m uch o f the m aterial on salmonellae 
was included in m y M S c thesis (MSc awarded January 1992). The MSc thesis contained a b rie f review  o f the anim al 
literature, a descriptive review  o f published typhoid and salmonella epidemics, a study comparing published typhoid 
epidemics, a study com paring published salmonella epidemics and an analysis o f a single salm onella outbreak.
For the PhD the lite ra ture  was searched more thoroughly. The descriptive review  contains more epidemics and the 
comparison o f pub lished typhoid epidem ics has been extended from  52 to 69, so the analysis was re-done. For the 
single outbreak the analysis was also re-done a fte r incorporating some further data from the o rig ina l questionaires. A l 
sections have been extensively rew ritten and the analysis o f experim ental typhoid data has been added.
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PUBLISHED EXPERIMENTAL EVIDENCE
When human volunteers were infected with S typhi, it was found that the attack rate increased 
and the median incubation decreased with increasing challenge doses (Table 2.2.1). The 
authors stated that there was no association between dose and severity of symptoms but no 
details were given (Homick et al 1970). I have not found other published experiments in which 
human volunteers have been given different doses of typhoid.
McCullough and Eisele (1951a-d) gave varying doses of several non-typhoid salmonellae to 
volunteers in experiments designed to test pathogenicity and to determine the minimal infective 
dose. As the dose increased, the proportion with positive faecal cultures and, at higher doses, 
with clinical disease both increased, but there were too few ill volunteers with each strain for 
any further conclusions on dose and severity to be drawn, and interpretation is complicated by 
the use of many volunteers for more than one feeding.
Small animal experiments with salmonellae have been dominated by experiments testing 
models of microbial infection (eg Meynell & Stocker 1957) and, later, examining immunity 
and the genetics of host resistance (eg Hotmaeche 1975). The models themselves are examined 
in the final Discussion (Section 4). In this section those experiments which give information on 
dose and severity will be discussed.
In a series of experiments, giving S typhimurium by intraperitoneal injection to mice, Meynell 
and Meynell (1958) found that the geometric mean time to death was inversely, linearly related 
to the logarithm of the dose of bacteria, at least for doses above the LD50. In some of the 
experiments where doses less than the LD50 were used there appeared to be a flattening of the 
curve so that the latent period to death was less clearly dependent on dose. This was 
interpreted as meaning that fatal infections at low doses are initiated by only one organism, but 
the confidence intervals were wide. Furthermore, by measuring the bacterial load in mice killed 
at various stages after inoculation, and in dead mice, it appeared that the whole inoculum 
multiplied exponentially until a constant critical load was reached and the mouse died.
The relationship between dose (above the LD50) and latent period to death has been shown 
consistently by other workers using different strains of mice and different salmonellae (eg 
Schutze et al 1936, Robson & Vas 1972, Hormaeche 1975). The more recent experiments were 
designed to study the genetics of resistance, so inbred strains of mice were used. The pattern
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for doses less than the LD50 remains unclear, partly because large numbers of mice are needed 
in order to get sufficient dead mice for latent periods to be calculated. In Hormaeche’s results 
(1975) the numbers in each group are small: four experiments using doses around or less than 
the LD50 suggest a levelling off of the log-dose/latent period curve, whereas three others do 
not. An inverse relationship between dose and time to death has also been found for chicks, 
using intravenous S Stanley (Rao & Chauhan 1987) and in some but not all experiments with 
intraperitoneal S typhimurium (Milner & Shaffer 1952, Shaffer et al 1957).
Experiments on the multiplication of salmonellae in vivo by measuring counts in the liver and 
spleen of mice killed at intervals after inoculation have shown that the growth rate depends on 
the virulence of the organism (as determined by the LD50, the proportion of mice dying, or the 
mean time to death) (Collins 1969) and on the strain of the mouse (Hoimaeche 1975). The 
growth rate was found to be constant over a range of challenge doses but direct measures were 
not made for small doses in the early stages of infection (Collins 1969). Examination of the 
curves given in Collins’ papers suggests that the growth rate may be greater after large doses 
in the early stages (Collins 1972a,b), and certainly infections by different routes show different 
initial growth rates before the "constant” phase is reached (Collins 1969). In one of 
Hormaeche’s experiments the time to death was disproportionately shorter for the very high 
doses suggesting an increase in growth rate (Hormaeche 1975) but this was not seen in 
Meynell’s experiments (Meynell & Meynell 1958). Infections with low doses which would not 
have been fatal show an initial rise in bacterial counts followed by a fall (Meynell & Meynell 
1958, Collins 1972b).
Even if the growth rate is constant, it is compatible with a dose-severity relationship, since the 
point from which the curve starts its rise varies with the initial dose (Hormaeche 1975,
Meynell & Meynell 1958). This correlates with the inverse relationship between dose and time 
to death. Low doses allow more time for mobilization of host defences before lethal numbers 
of organisms are reached, and it might be expected that the defences would be more effective 
against smaller loads.
The time to death reflects the incubation period as well as any differences in length of 
symptomatic illness, so the relationship between dose and time is expected. The report of one 
of Collins’ experiments with specific pathogen-free mice given oral S enteritidis mentioned that 
all 10 receiving 2 x lO2 organisms survived, although half of them had "systemic infections”, 
whereas among the 20 given 2 x 10s or 2 x 10* organisms there were "many deaths" (Collins
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1972a). Whether the "systemic infection" was clinically apparent or not is not clear. In small 
animals it is not easy to measure levels of severity of illness shon of death, but in one study of 
chickens the duration of diarrhoea was found to increase after higher doses of S erueritidis 
(Humphrey et al 1991).
With calves, morbidity can be assessed more easily and there is some evidence of a dose- 
severity relationship in experiments which were designed to study pathogenesis. Unfortunately, 
since calves are expensive, the numbers used tend to be small. DeJong and Ekdahl (1965) gave 
three different doses of S typhimurium to 12 calves either orally, in milk, or conjunctivally. 
After 10" organisms 3/4 died. All 4 who received 10* were ill but recovered, and the 4 who 
received 106 had positive faeces but were asymptomatic. Using the same strain of S 
typhimurium, Robinson and Loken (1968) found more prolonged excretion of bacteria after 
larger oral doses in asymptomatic Jersey calves at two different ages.
Wray and Sojka (1978) gave S typhimurium phage type 1 (var 5) orally in a nutrient broth to 
Jersey calves. The numbers were small, especially in the low dose groups. Their results suggest 
an increased case fatality rate and more prolonged symptoms at higher doses. (Their 
measurements of duration of signs and of excretion are difficult to interpret as they are 
determined both by recovery and death.)
Smith and Jones (1967) gave S Dublin in two different doses to a mixture of Ayreshire and 
Jersey calves. Sixteen received 10‘° organisms; all died and the mean time to death was 4.1 
days (SE = 0.4). Six received 107 organisms; all had signs of illness, and one died on the 
seventh day.
Typhoid occurs naturally only in man and there is no good animal model (Homick et al 1970). 
Using large doses, a typhoid-like illness can be induced in chimpanzees. Experiments using 
chimpanzees use very small numbers and I have found only one study in which different doses 
were given to more than one animal per group (Edsall et al 1960). The bacteria were 
inoculated into bananas which were then given to the chimpanzees. The attack rate increased 
with dose and it was noted that "no clear cut obvious connection between challenge dose, 
immune response and the duration of the carrier state could be observed".
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Table 2.2.1. Relationship of dosage of S typhi, Quailes strain to disease (from Homick et al 
1970)
Dose 
(no. of 
organisms)
No. of 
volunteers
No. with 
disease (%)
Incubation period (days)
Median Range
10* 42 40 (95%) 5 3 - 32
10s 9 8 (89%)
107 32 16 (50%) 7.5 4 - 56
10s 116 32 (28%) 9 6 - 33
103 14 0 (0%)
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ANALYSIS OF REPORTED OUTBREAKS OF SALMONELLA INFECTIONS
The indirect measures of dose which can be used in assessing natural infections were discussed 
in Section 1. Information on relationships between these measures of dose and outcome in 
reports of natural infections with salmonellae is very limited and I have therefore also made 
comparisons between outbreaks. Within outbreaks I have used four proxy measures of dose: 
amount of food, the time when food is eaten, attack rate and incubation period. Between 
outbreaks I have used three measures: type of vehicle, incubation period and attack rate.
The validity of the results depends on how well the proxy measures reflect the true dose. In 
the volunteer experiments reviewed above, dose was related to attack rate (Homick et al 1970, 
McCullough & Eisele 1951a-d) and incubation period (Homick et al 1970). These associations 
have also been found in natural outbreaks. Miner (1922) noted that the mean incubation times 
of three water-borne typhoid epidemics were about twice as long as those of two food-borne 
epidemics and thought that this was probably due to differences in dose. In a typhoid outbreak 
at a school picnic, 23 people became ill after eating contaminated chocolate icecream 
(Cumming 1917). Those who ate a mixture of types of icecream (and therefore probably less 
chocolate icecream) had longer incubation periods (mean 9.S days compared to 6.1 days, p <
0.001 Wilcoxon). In a large water-borne typhoid outbreak in Zermatt, information was 
presented by area according to the w ater supply (Bernard 1965). As the contaminated water 
became progressively diluted by other supplies, the attack rate by area decreased and the 
median incubation period increased. An outbreak of S enteritidis following a wedding in 
Connecticut affected 171 people (M intz et al 1991). Those who ate more of the contaminated 
Hollandaise sauce had shorter incubation periods. However, in a large outbreak of S 
typhimurium the attack rate was no higher in those who ate more than one piece of the chicken 
vehicle (Palmer et al 1990).
Blaser and Newman (1982) and Naylor (1983) draw attention to the apparent inverse 
correlation between attack rates and incubation periods for different typhoid outbreaks. These 
could be due to the common effects o f  dose, though variation in strain virulence between 
epidemics would give a similar result. Blaser and Newman (1982) presented data from 8 
typhoid epidemics where information was available on both median incubation period and 
attack rate. Analysis of their data (after excluding one epidemic where the incubation period is 
based on just two people, and correcting the attack rate for the Mon Ark epidemic) shows a 
non-significant linear correlation (r =  -0.63, b = -0.139, t = 1.81, p  > 0.1). Naylor (1983)
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presented similar data using the mode. He listed 7 epidemics wih sufficient information, 5 of 
which were included by Blaser and Newman and one of which has an attack rate of 100% 
based on the figures of only a subgroup of the people involved.
METHODS
I have used the proxy measures of dose in assessing whether dose influences severity of 
disease. Whilst varied measures of severity are used for within-epidemic analyses, for 
comparisons between epidemics the case fatality rate is used for typhoid and hospitalization 
rate for other salmonellae, for reasons discussed below.
Published reports were identified that gave data on severity and on a proxy measure of dose. 
They were found by searching the Bulletin o f  Hygiene, later Abstracts o f Hygiene (from 1926), 
The Lancet (1920-45), The American Journal o f Hygiene (1921-64), the British Local 
Government Board, Medical Officer’s Report (later the Reports to the Local Government Board 
on Public Health and Medical Subjects and then the Ministry o f Health Reports on Public 
Health and Medical Subjects, from 1900), the National Communicable Diseases Center, later 
the Center for Disease Control Salmonella Surveillance Reports (1964-76) and the Morbidity 
and Mortality Weekly Reports (from 1976): any references from these journals, or from already 
identified articles, which it was thought might contain sufficient data were followed up. For the 
analysis o f single epidemics, all identified reports that gave data on severity and on a proxy 
measure o f dose were included. Where the data were anecdotal the reports are only mentioned 
briefly, as there is likely to be a bias towards inclusion o f positive findings in a report.
For comparison between epidemics, the selection criteria for typhoid and for the other 
salmonellae differ because of the necessary use of different proxy measures of severity. Within 
the criteria, all located published outbreaks were included.
For typhoid, case fatality rate was chosen as an outcome measure which could be extracted 
from reports and could be compared between epidemics. As case fatality rates are much lower 
with antibiotic therapy, outbreaks occurring after 1945 were excluded. Common source typhoid 
epidemics were identified in the published literature and included in the study if they contained 
sufficient information on case fatality rate and attack rate o r  incubation period and involved at 
least eight cases. Outbreaks among hospital patients were excluded. As information on
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incubation period w as scarce, post-war epidemics where the incubation period was given were 
also identified. They have only been included in the analysis when case fatality rate is not 
being considered.
Correlations were sought between: attack rate (AR) and incubation period; attack rate and case 
fatality rate (CFR); and incubation period and case fatality rate. For reasons addressed in the 
discussion, the initial analysis was carried out unweighted (each epidemic canying equal 
weight regardless o f  size). As an attempt to separate epidemics with more accurate information, 
a subgroup of pre-war epidemics was identified where the population exposed was well defined 
(such as guests at a reception, or people supplied with milk from one farm). For this subgroup 
weighted analysis w as done using logistic regression. The models used were:
Logit AR = Constant + p(Incubation)
Logit CFR = Constant + P’(Incubation)
Logit CFR =  Constant + P” (AR)
For the food-poisoning Salmonellae I have again used attack rates and incubation periods as 
measures of dose. Fatalities from non-typhoid salmonellae are unusual, and descriptions of 
cases are not detailed enough for any symptom-based measure of morbidity to be used. The 
only readily available measure of severity is the number of cases requiring hospitalization.
Since this is obviously time- and culture-dependent I have only used epidemics reported in the 
National Communicable Disease Center (later Center for Disease Control) Salmonella 
Surveillance Reports. The hospitalization rate was taken as the proportion of cases who were 
hospitalized. Surveillance reports of common source outbreaks from the period 1964 to 1974 
were included if they contained sufficient information and involved more than eight people. 
Outbreaks involving hospital patients or mixed infections were excluded.
Correlations were sought between: attack rate and hospitalization rate (HR); median incubation 
period and hospitalization rate; and attack rate and median incubation period. The analysis was 
carried out using unweighted linear regression and logistic regression. The models used for the 
logistic regression are:
Logit HR = constant + P(AR)
Logit HR = constant + p’(incubation)
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RESULTS
Analyses of Single Epidemics
Amount o f food
For typhoid only two reports allow comparison of amount of food with outcome. In the 
outbreak following a school picnic the case fatality rate was 3/17 for those who had whole 
portions of the affected ice cream and 0/6 for those with half portions (p = 0.5 Fishers 2-tailed 
test) (Cumming 1917). The other report concerned a milk-borne outbreak involving 68 cases 
(Sirois 1942). The author noted that among those who were ill, those who only took milk in 
their tea or coffee had very mild attacks.
For the food-poisoning salmonellae I have found 11 reports which provide information on 
amount of food and severity. Mintz et al (1991) provide the most detailed breakdown of 
outcome by amount of food consumed, in an outbreak of 171 cases of S enteritidis infection 
due to contaminated Hollandaise sauce. As the amount of sauce used increased, there were 
increases in the proportion of cases with body aches, nausea and vomiting, the maximum 
number of stools passed per 24 hours, and acute weight loss, but not in duration of illness. 
Taylor et al (1984) describes a small family outbreak of S typhimurium in which the person 
who had eaten the most o f the affected vehicle died. In five other reports, although it is stated 
that those who ate more had more severe disease, no supporting evidence is given (Balice 
1958, Bierschenck 1962, De Blasi & Scotti 1950, Harding 1966, Gomez Lus & Gimenez 
Martinez 1965).
Four reports failed to And an association. In an S typhimurium outbreak affecting nearly 200 
people, there were no differences in the mean maximum stool frequency o r in the duration of 
illness for those who ate one or more pieces of the chicken vehicle (Palmer et al 1990). 
However, the attack rate was not related to the number of pieces of chicken eaten either, so the 
bacteria may have been unevenly distributed. (This outbreak is the subject o f  Section 2.4.) Two 
other negative reports refer to meat pies. In the first the pies were baked in  two separate lots 
on different days, so uniform contamination is unlikely (Miller et al 1955). In  the second, most 
of those who had severe disease had eaten the smaller pies but had kept them  unrefrigerated 
for 24 hours (Brockbank et al 1950). The last report refers to only six cases (D ’Aoust 1985).
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The time when food is eaten
In addition to the meat pie outbreak (Brockbank et al 1950), five anecdotal reports of food­
poisoning salmonellae suggest that food eaten later (after allowing time for bacteria to 
multiply) gave rise to more severe disease (De Blasi & Scotti 1950, Cook & de Costabadie 
1947, Semple et al 1968, Anonymous 1988, Möller 1955).
Attack rate and Outcome
In an extended water-borne typhoid outbreak in Bolton-upon-Deame in 1921, attack rates and 
case fatality rates were reported by district, and showed no particular pattern (Shaw 1922). I 
have found no other studies of salmonella where attack rate and measures of severity are given 
by area.
Incubation period and Outcome
In five reports of typhoid outbreaks individual incubation periods can be related to outcome 
(Cumming 1917, Desranleau 1946, Lumsden 1912, Bulstrode 1902-3, Mollohan & Reid 1967). 
In some, including the two larger outbreaks (Cumming 1917, Desranleau 1946), the proportion 
who died was larger among those with shorter incubation periods, but in none of the epidemics 
did the differences approach significance at the 5% level.
For the food-poisoning salmonellae the picture is rather different Of nine reports which give 
sufficient details, only one (Horwitz et al 1977) failed to find an association between 
incubation period and severity. In an outbreak of S newport food-poisoning in Sweden (Bille et 
al 1964) information was available on 161 people; those with shorter incubation periods had 
more severe illnesses. In a large outbreak of S thompson food-poisoning in Tennessee onset 
times were on average earlier in the 51 who were hospitalized than in 72 others (Fowinkle et 
al 1970). Balice (1958) describes a severe outbreak of S typhimurium in Italy. All 83 people 
who ate the affected food became ill and there were five deaths. The mean incubation period 
overall was 21 hours (range 8 to 30 hours), and for the five who died it was 14 hours. 
However, in an outbreak due to S newport where information was available for 105 cases, it 
was noted that the median incubation period was 29 hours overall, and 30 hours for those with 
"severe illness", defined by the number of different symptoms experienced. The number of 
cases in this group is not stated. It was also stated that there was no relationship between the 
length of the incubation period and the duration o f illness (Horwitz et al 1977). The other five 
reports all suggest an association, but are based on small numbers of cases or have small 
numbers of deaths as their only outcome measure (Miller et al 1955, Janeway et al 1971,
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Holmes et al 1967, Anonymous 1988, Hauser 1945).
Comparisons between Epidemics: Typhoid
Sixty-nine typhoid epidemics fulfilled the criteria, including eight post-war epidemics (see 
Appendix 1). Most were from Britain or the United States. Thirty-five were water-borne. 
Incubation periods were available for 27 epidemics, including 19 pre-1945 epidemics. The 
median incubation period was used whenever it was given. Attack rates were available for all 
but four of the epidemics.
The distribution of attack rates, incubation periods and case fatality rates are shown in Figure 
2.3.1. The associations between them are shown in Figures 2.3.2-3. A log scale is used for the 
attack rate as the distribution of attack rates is skewed to the right High attack rates were 
associated with short incubation periods but no significant correlations with case fatality rate 
were found.
Water-borne epidemics had longer incubation periods and lower attack rates. There was no 
difference in case fatality rates between water- and food-bome epidemics (Table 2.3.1). When 
the vehicle (water or food) was added to the regression equations, in a multiple regression 
model, the correlation between incubation period and attack rate was no longer significant, and 
the regression coefficient was reduced from -4.0 to -2.8 (95% Cl -6.1 to 0.5). There was still 
no association between case fatality rate and either attack rate or incubation period.
The analysis was repeated for circumscribed pre-war epidemics where the population exposed 
was well defined. Thirty-one epidemics fulfilled this criterion. No associations between 
incubation period, attack rate and case fatality rate were found in the unweighted analysis. 
Logistic regression analysis for this subgroup of circumscribed epidemics showed a negative 
association between incubation and attack rate based on 11 epidemics which were all food- 
bome (likelihood ratio statistic (LRS) 93.2, one degree of freedom (df), p < 0.001, proportion 
of deviance explained = 15%). Incubation period showed a just significant positive association 
with case fatality rate based on 13 epidemics (LRS 4.4, 1 d f. p = 0.04). There was no 
association between attack rate and case fatality rate.
There was a non-significant negative correlation between case fatality rate and the date of the 
epidemic. When the year o f  the outbreak was included in multiple regression or logistic
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regression models between case fatality rate and incubation period or attack rate the regression 
coefficients hardly changed.
Comparisons between Epidemics: Food-Poisoning Salmonellae
Sufficient numbers of suitable reports were available for analysis for four different salmonellae: 
S typhimurium, S enteritidis, S thompson, S infantis. Details of the epidemics are given in 
Appendix 2. All except one epidemic (of S typhimurium) were food-borne. Plots of 
hospitalization rates by attack rates are shown in Figure 2.3.4.
S typhimurium
Information was available for 16 epidemics. Linear regression showed no relationship between 
attack rate and hospitalization rate but logistic regression showed a positive correlation, giving 
the model:
Logit HR = -5.6 + 0.0406(AR) 
ie HR = e( i* *00iO6 *AR)
|  +  e (-5.6 ♦  0.040« I  AR)
This model explained 58.7% of the deviance. When the one large water-borne epidemic was 
excluded, the coefficient decreased to 0.0201 (SE 0.0058) but the model remained highly 
significant: LRS =12.5, 1 df, p < 0.001.
S enteritidis
The linear regression, based on 11 epidemics, did not show a significant association, but again 
logistic regression showed a positive correlation, giving the model below, which explained 
10.7% of the deviance:
Logit HR = -3.5 + 0.0223(AR)
After excluding the one outlying epidemic with a high hospitalization rate (Figure 2.3.4b) the 
association was lost.
S infantis
The linear regression model, based on seven epidemics was just significant, but is influenced 
by a small epidemic with high attack and hospitalization rates, (r = 0.75, b = 0.71 (95% Cl 
0.16-1.25), a = -7.96, t = 2.55, p = 0.05.) Logistic regression also showed a positive 
correlation, giving the model:
Logit HR = -3.6 + 0.0415 (AR)
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This explained 43.6% of the deviance. After excluding the small epidemic with the high attack 
and hospitalization rates, the coefficient in the logistic regression model decreased to 0.0237 
(SE 0.0094) and the strength of the association was reduced, but it remained significant (LRS 
= 6.2, 1 df, p = 0.01).
S thompson
The scatter plot (based on eight epidemics) shows no trend in the results, and neither linear nor 
logistic regression models had coefficients which were significantly different from zero.
incubation periods were only available for a few epidemics of each serotype. For S 
typhimurium, six epidemics contained information on both incubation and hospitalization rate: 
no association was found using linear or logistic regression. Even less information was 
available for the other serotypes.
DISCUSSION
For typhoid, the results confirm the suspected relationship between incubation period and 
attack rate. Since there is no evidence that more virulent forms of typhoid are found in food 
than in water, the long incubation periods and low attack rates found in water-borne epidemics 
suggest that the dose in these epidemics is, on average, smaller. By contrast, correlations 
between attack rate or incubation period and case fatality rates were not found (with one 
exception), even though both dose effects and any differences in virulence would be expected 
to lead to such correlations.
There are, however, limitations to the typhoid data. The attack rate depends on both full 
ascertainment of cases and correct ascertainment of those at risk, here taken as those exposed 
during the epidemic. Immune status was usually unknown. The most accurate estimates of 
those exposed are those obtained from circumscribed epidemics occurring after specific meals 
or at a camp where everyone can be traced and those who consumed a particular food or drank 
the water can be identified. Milk-borne epidemics where the numbers of people on the milk 
round is known give reasonable figures. Where the domestic water supply is the source, the 
rvimber of people using the supply is only an approximate estimate, and those who avoid being 
truly exposed by buying or boiling their drinking water is unknown. Also, it is unlikely that 
the whole o f the supply is significantly contaminated. (In the water-bo me typhoid epidemic in
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This explained 43.6% of the deviance. After excluding the small epidemic with the high attack 
and hospitalization rates, the coefficient in the logistic regression model decreased to 0.0237 
(SE 0.0094) and the strength of the association was reduced, but it remained significant (LRS 
= 6.2, 1 df, p = 0.01).
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The scatter plot (based on eight epidemics) shows no trend in the results, and neither linear nor 
logistic regression models had coefficients which were significantly different from zero.
Incubation periods were only available for a few epidemics of each serotype. For 5 
typhimurium, six epidemics contained information on both incubation and hospitalization rate: 
no association was found using linear or logistic regression. Even less information was 
available for the other serotypes.
DISCUSSION
For typhoid, the results confirm the suspected relationship between incubation period and 
attack rate. Since there is no evidence that more virulent forms of typhoid are found in food 
than in water, the long incubation periods and low attack rates found in water-borne epidemics 
suggest that the dose in these epidemics is, on average, smaller. By contrast, correlations 
between attack rate or incubation period and case fatality rates were not found (with one 
exception), even though both dose effects and any differences in virulence would be expected 
to lead to such correlations.
There are, however, limitations to the typhoid data. The attack rate depends on both full 
ascertainment of cases and correct ascertainment o f those at risk, here taken as those exposed 
during the epidemic. Immune status was usually unknown. The most accurate estimates of 
those exposed are those obtained from circumscribed epidemics occurring after specific meals 
or at a camp where everyone can be traced and those who consumed a particular food or drank 
the water can be identified. Milk-borne epidemics where the numbers of people on the milk 
round is known give reasonable figures. Where the domestic water supply is the source, the 
number of people using the supply is only an approximate estimate, and those who avoid being 
truly exposed by buying or boiling their drinking water is unknown. Also, it is unlikely that 
the whole of the supply is significantly contaminated. (In the water-borne typhoid epidemic in
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Zermatt, attack rates by area varied from less than 1% to over 25%, suggesting considerable 
variation in dose (Bernard 1965).) Full ascertainment of cases is also difficult, but again it is 
likely to be most complete for the most circumscribed epidemics where individuals are actively 
traced. Large epidemics rely on notification of cases which will be incomplete.
The incubation period can be estimated only for point source epidemics and then only if dates 
of onset of illness rather than dates of notification are available. Late cases may be missed and 
secondary cases may be mistakenly included (leading to under- and over-estimation of the 
median incubation period respectively). The median incubation has been used since the 
epidemic curve is approximately log-normal, and it is usually the measure quoted. For a few 
epidemics where only the mode or "average" was given, that was used instead; they are usually 
similar (see Appendix 1).
Identification of deaths from typhoid is probably more complete than identification of cases, 
leading to overestimation o f  the case fatality rate, to an extent which will vary from epidemic 
to epidemic depending on completeness o f case ascertainment. It is a crude measure of 
severity, particularly as the numbers are small in some of the epidemics, and unmeasurable 
factors associated with the place of the outbreak would be expected to influence how many die.
Too few of the epidemics give sufficient information on the age, sex, or immune status of the 
people involved for these variables to be taken into account. The year of the epidemic may be 
expected to be associated with the case fatality rate, but would only be associated with 
incubation period or attack rate if there was a change in the predominant strains or if  methods 
of investigating or reporting the outbreaks changed. Controlling for the year of the epidemic 
did not affect the results in the multiple regression analyses.
Epidemics could only be included in the study if they contained sufficient information. All 
identified epidemics which fulfilled the criteria were included, but they are not necessarily 
representative of all typhoid epidemics.
Although some of the data problems will lead to non-differential misclassification (and 
therefore to underestimation o f  associations) certain directions of bias appear likely: attack 
rates are likely to be unduly low in water-borne outbreaks due to both underestimation of cases 
and overestimation of susceptibles, and case fatality rates will be disproportionately high in 
epidemics with poor case ascertainment, which includes most of the water-borne epidemics. It
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was felt that the large epidemics were often more inaccurate and more likely to be biased than 
the smaller epidemics so calculations are presented both weighted and unweighted.
Turning to the data, the finding of the expected correlation between attack rate and incubation 
period suggests that the data are not so crude as to be useless. Similarly, for water-borne 
epidemics, although the low attack rates may be due to bias, the longer incubation periods are 
unlikely to be, and the finding fits with the expected low dose of organisms in water.
The case fatality rates were the same in water as in food-bo me epidemics. This could be true, 
reflecting no dose-effect, or could be due to bias giving falsely high case fatality rates in 
water-borne outbreaks. Attack rates did not predict case fatality rates. This could be true or 
could reflect the falsely low attack rates and high case fatality rates of less well investigated 
outbreaks. No association was found when consideration was restricted to circumscribed 
outbreaks. Incubation period did not predict case fatality rate in most of the analyses. Again, 
although this may be true both variables, and particularly case fatality rate, are subject to 
considerable error in measurement. The weighted analysis of the circumscribed epidemics 
produced a surprising positive correlation between incubation period and case fatality rate. This 
was only just significant.
Overall, the comparison of data between typhoid epidemics provides no evidence of an 
association between dose (as measured by incubation period, attack rate or vehicle) and 
severity (as measured by the case fatality rate). While the data are too crude for an association 
to be excluded, this finding contrasts with the outbreaks due to other salmonellae but fits with 
the conclusions from Homick et al’s volunteer studies (1970).
The results from food-poisoning salmonellae provide evidence of a correlation between attack 
rates and case-hospitalization rates. The evidence for incubation period was too rudimentary to 
be useful.
For the non-typhoid salmonellae the unweighted linear regression models are too simplistic as 
the epidemics range in size from 10 cases to several hundred (and to 14000 in the one water­
borne epidemic - see Appendix 2). Unlike the typhoid data, and with the possible exception of 
the water-borne epidemic, there is no reason to believe that the figures in the larger epidemics 
are any less accurate than those in the smaller epidemics, so it seems appropriate to weight the 
epidemics according to size. The logistic regression model has the added advantage that it does
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not require the variables to be normally distributed, which is more appropriate given the small 
numbers involved. For three of the serotypes of salmonella the coefficients were highly 
significantly different from zero, and for S typhimurium and S infantis around 50% of the 
deviance in the results was explained by the model.
The epidemics studied here are not necessarily representative of all epidemics in the USA as 
not all are reported, and only the reports containing sufficient information could be included. 
Although all of the epidemics came from one country over a short period, criteria for 
hospitalization may have varied between epidemics, probably leading to under-estimation of 
any correlation. However, the hospitalization threshold may be higher in a large epidemic, 
which would bias the results in the weighted analyses. Lack of data prevented controlling for 
age, though those at the extremes of age are more likely to be hospitalized and may also have 
different attack rates.
The results for food-poisoning salmonellae point to a positive correlation between attack rate 
and hospitalization rate at least for some types of salmonella. This is consistent with a dose 
effect whereby higher doses give higher attack rates and more severe disease, though differing 
virulence between different strains would give similar results. The results from the single 
epidemics tend to support the dose-severity correlation, though within an epidemic a 
correlation between incubation period and severity could be due to individual differences in 
susceptibility as well as dose.
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Table 2.3.1. Comparisons between food and water-bome typhoid epidemics
Vehicle No. Mean (95% Cl) p (t-test)
Incubation Water 8 18.5 (15.2-21.8)
period (days) Food 18 13.2 (11.0-15.4) 0.007
Attack rate Water 34 3.8 (2 3-6.3)
(%)’ Food 28 16.7 (10.8-25.9) < 0.001
Case fatality Water 32 10.3 (8.4-12.2)
rate (%)1 2 Food 26 11.4 (8.0-14.9)
1 geometric mean given
2 prewar epidemics only
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(c)
Figure 23.1. Typhoid epidemics used in the comparison study, (a) Attack rates for 65 
epidemics, (b) Incubation periods for 26 epidemics, (c) Case fatality rates for 61 pre 1945 
epidemics.
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Figure 2.3.2. The relationship between attack rate and incubation period for 23 typhoid 
epidemics. Each square represents an epidemic.
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Figure 2 3 3 .  The relationship between typhoid case fatality rate and (a) attack rate (for 58 pre- 
1945 epidemics) and (b) incubation period (for 19 pre-1945 epidemics). Each square represents 
an epidemic.
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Figure 23.4. The relationship between hospitalization rate and attack rate for four food­
poisoning salmonellae. Each square represents an epidemic. □  = epidemics of less than 20 
cases; a = epidemics of 20 - 100 cases; a =  epidemics of over 100 cases.
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ANALYSIS OF A SALMONELLA TYPHIMVRLVM  OUTBREAK
In this study I have investigated the associations between dose, incubation period and severity 
within a single large point source outbreak of Salmonella typhimurium.
In September 1986 an outbreak of Salmonella typhimurium affected delegates at a medical 
conference in Wales. The source of the infection was traced to chicken pieces served at a 
buffet lunch. Of 427 delegates at the conference, 360 (84%) returned questionnaires. O f these, 
26S attended the buffet lunch and 19S became ill. The initial questionnaires were sent out four 
days after the outbreak, and follow-up questionnaires including questions on duration o f illness 
and time off work were sent out about eight weeks later. The results of the outbreak 
investigation have already been published, and it was noted that those who had more than one 
piece of chicken had a similar attack rate to those who had only eaten one. Among those who 
became ill the authors noted that there was no difference in the mean maximum stool 
frequency or duration of illness in those under 45 years old who ate one or more pieces o f 
chicken and that only one of those who had eaten two pieces of chicken reported paraesthesia 
(Palmer et al 1990). I have examined the associations with chicken consumption in more detail, 
including the association between chicken consumption and incubation period, and have used 
the incubation period as a second proxy marker of infecting dose.
MATERIALS AND METHODS
The data from the outbreak were available to me in the form of an Epi Info data file. I was 
able to fill in some gaps in the data from the original questionnaires. The incubation period 
was taken as the time from serving the buffet to the onset of the first major symptoms 
(diarrhoea, vomiting, fever or abdominal pain). Four of the 195 cases were excluded because 
no onset dates or times were recorded (two) or because of inconsistencies in the dates given 
(two). Where only the date was recorded (12 people) the time was taken as the median onset 
time for that day.
Several different measures of severity of disease were available. The maximum stool frequency 
per 24 hour period, the maximum temperature reached, the duration of symptoms and the time 
off work were collected as quantitative variables. Whether the person was admitted to hospital 
and the presence or absence of a range of symptoms were recorded as binary variables. I have
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used all these measures. Information was also available on possible confounders: age, sex, prior 
antibiotic or antacid use, previous upper gastrointestinal tract surgery, achlorhydria, gastritis, 
peptic ulcer disease and immunosuppression.
Some of the questionnaires were incomplete and in presenting the results those with missing 
values for a particular variable were excluded. In each case I have stated on how many people 
a result is based.
When examining the data for correlations and fitting regressions, histograms were examined 
individually to see if they were normally or otherwise distributed (for example log normal). 
Scatter plots were compared on linear and log scales. On the basis of the histograms and the 
scatter plots, linear or log scales were chosen for the different variables, and a regression was 
fitted. The residuals from the regressions were examined to see if there was any remaining 
pattern or whether the model chosen explained all o f the association.
RESULTS
All the results refer only to the 191 ill people for whom incubation periods are available. Of 
the 130 people who recorded their sex, 38 were female. Ages were available for 173 people 
and ranged from 21 to 61 years (mean 37). Table 2.4.1 shows the proportions of those ill who 
suffered from different symptoms. Thirty-two (of 175 who responded to this question) recorded 
that they were admitted to hospital.
Figures 2.4.1 and 2.4.2 show the distributions of incubation period, and of four measures of 
severity: the maximum frequency of diarrhoea stools; the maximum temperature reached; the 
duration of symptoms; and the time off work. The maximum temperature reached was felt to 
approximate to a normal distribution, and the others to log normal distributions. This was 
confirmed by examination of normal probability plots.
Incubation period was negatively associated with all o f the markers o f severity (Figures 2.4.3- 
6). Regression lines were fitted after log transformation of those variables which were felt to 
be log normally distributed. The correlation and regression coefficients are given with each 
figure. Plots of the residuals showed no remaining patterns.
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Age and sex were considered as possible confounders. There was no association between age 
and incubation period. Among the measures of severity, age was weakly associated with 
maximum stool frequency but not with any of the others. Incubation periods were almost 
identical between the sexes and there were no significant differences between the means (or 
geometric means) of any of the measures of severity. Adding age or sex to the regression 
equations between incubation period and the measures of severity had little effect on either the 
significance of the associations found or on the regression coefficients.
Eight people who became ill had taken prior antibiotics or antacids. One of these had had 
previous upper gastrointestinal tract surgery. One additional person was receiving 
immunosuppressive treatment None reported achlorhydria. This group of patients may be 
considered as being particularly susceptible to infection. Patients in this group, considered 
either by subgroup or together as "susceptibles”, had geometric mean incubation periods and 
mean or geometric mean measures of severity which were similar to those for the other 
patients. Adding "susceptibility” to the regression equations hardly affected the regression 
coefficients. One patient reported gastritis, and one reported peptic ulceration without antacid 
use.
To see if incubation period predicted the outcome in terms of the symptoms suffered, the 
incubation periods were divided into tertiles and the proportion of patients suffering from each 
symptom, in each group was recorded. The results are shown in Table 2.4.2. As the numbers 
in some of the cells are small the validity of the results was confirmed using logistic 
regression. For most of the symptoms the proportion of people suffering from them increased 
as incubation period decreased. The proportion of people hospitalized also increased with 
shorter incubation periods (Table 2.4.2).
Younger people were more likely to vomit, have abdominal pain and headaches and be 
admitted to hospital, but were less likely to have diarrhoea. Women were more likely to vomit 
but there were no other differences between the sexes. Using multiple logistic regression, there 
was no evidence of confounding by age or sex in any of the associations with incubation 
period.
Twenty eight people ate two or more pieces of chicken. The geometric mean incubation period 
for those who ate two pieces was shorter than that for those who only ate one piece: 16.6 
hours (95 % Cl 13.5-20.5) compared to 20.7 (95% Cl 19.0-22.6), t = 1.97, p  < 0.05. There
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was no association between chicken consumption and any of the measures of severity. Neither 
were there any significant associations between chicken consumption and the frequency of 
occurrence of any of the different symptoms: the proportion suffering from muscle pains was 
larger in the group who had had two or more pieces (22/23 compared with 100/128, p  = 0.08 
Fisher’s two-tailed test) but none of the other measurements approached statistical significance 
at the 5% level.
The age distributions for those who ate one or two pieces of chicken were similar. More men 
than women ate two pieces o f chicken (13/86 compared to 2/35). Adjusting for age and sex did 
not affect the results of the analyses relating to chicken consumption.
DISCUSSION
In this large, point source outbreak most of the cases were doctors so the descriptions of 
symptoms are likely to be particularly accurate. The initial questionnaires were sent out only 
four days after the outbreak so recall of the symptoms and their timing, and of the food 
consumed, is likely to be good. There is no reason to suspect any particular bias in the 
responses. All the available measures of severity were analysed so the presentation of results is 
not biased.
It was striking that all the measures of severity were highly significantly negatively correlated 
with incubation period, and shorter incubation periods were associated with an increased 
proportion of patients suffering from most of the different symptoms recorded and with 
hospitalization. Is this relationship between incubation period and severity due to infecting 
dose?
The amount of chicken consumed provided another measure of dose which might be thought to 
be a better proxy for the actual infecting dose. Those who ate two pieces of chicken had on 
average shorter incubation periods. However, the amount of chicken consumed had no 
influence on severity of disease. And, as was noted in the previous report, the attack rates were 
similar for those who ate one or more pieces o f chicken (Palmer et al 1990). It is unlikely that 
the salmonellae would be uniformly distributed among the chicken pieces, so the number of 
pieces consumed provides only a crude measure of dose. And the difference in dose between 
one and two pieces is small compared to experimental studies which usually consider
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logarithmic increases. The lack of an association with attack rate suggests that the chicken 
consumption did not accurately reflect dose (McCullough and Eisele 1951acd, Blaser and 
Newman 1982). In this context the finding of a statistically significant association between the 
amount of chicken consumed and incubation period is surprising. This contrasts with the 
Connecticut outbreak of Salmonella enteritidis discussed in the Section 2.3 (Mintz et al 1991) 
where a uniform distribution in the Hollandaise sauce would be expected, and where amounts 
consumed might have varied several fold.
The incubation period may be a better proxy measure of dose, and has the added advantages of 
allowing measurement on a continuous rather than a categorical scale and over a larger range 
of values. However, incubation period will vary with individual susceptibility, and individual 
susceptibility can also be expected to influence the severity o f the disease, as discussed in 
Section 1.3.
It is not possible to control fully for individual susceptibility. Blaser and Newman (1982) 
identified eight factors which affect host susceptibility or the proportion of organisms actually 
reaching the intestine from a given inoculum: age, immune status, debility, prior ingestion of 
antibiotics, gastric pH, the rate of emptying of gastric contents, the type of vehicle, and the 
portal of entry. The last two can be ignored as they were identical for all of the patients. Age, 
prior antibiotic use and factors known to alter gastric pH were controlled for. Variations in 
host immune status, individual variations in gastric acidity and emptying, and the possible 
presence of other illnesses remain.
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T a b le  2.4.1. Symptoms reported by ill delegates.
Symptom % with symptom
Diarrtioea 98.4 (182/185)'
Abdominal pain 96.7 (175/181)
Fever 92.0 (161/175)
Headache 82.9 (141/170)
Muscle pains 80.6 (129/160)
Rigors 73.2 (115/157)
Vomiting 62.7 (99/158)
Mucus in faeces 49.5 (54/109)
Paraesthesia 21.1 (23/109)
Blood in faeces 10.4 (10/96)
'No. reporting symptonVno. responding to question
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Table 2.4.2. The proportion of patients suffering each symptom by incubation period, divided 
into tertiles.
Symptom or outcome Incubation period (hours) x 2 trend p value
< 16 £  16 to 5 22 >22
Diarrhoea 100.0% (61/61) 100.0% (65/65) 94.9% (56/59) 4.8 0.03
Abdominal pain 100.0% (61/61) 98.4% (60/61) 91.5% (54/59) 6.6 0.01
Fever 98.2% (56/57) 95.2% (59/62) 82.1% (46/56) 9.9 0.002
Headache 82.7% (43/52) 86.4% (51/59) 79.7% (47/59) 0.2 0.6
Muscle pains 84.3% (43/51) 83.3% (45/54) 74.5% (41/55) 1.6 0.2
Rigors 86.0% (43/50) 75.5% (40/53) 59.3% (32/54) 9.5 0.002
Vomiting 82.1% (46/56) 72.7% (40/55) 27.7% (13/47) 31.0 <0.001
Mucus in faeces 57.6% (19/33) 50.0% (20/40) 41.7% (15/36) 1.7 0.2
Paraesthesia 16.1% (5/31) 25.6% (10/39) 20.5% (8/39) 0.1 0.7
Blood in faeces 10.3% (3/29) 6.3% (2/32) 14.3% (5/35) 0.3 0.6
Hospitalized 32.2% (19/59) 17.5% (10/57) 5.3% (3/57) 13.9 <0.001
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No. o f  p e o p le
Figure 2 .4 .1 . Incubation periods for the 191 ill delegates in the S  typhimurium  outbreak.
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In c u b a t io n  p e r io d  (h o u r s )
Figure 2.4.1. Incubation periods for the 191 ill delegates in the S typhimurium  outbreak.
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(a)
N o .  o f  p e o p le
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(c)
D u r a t i o n  o f  s y m p t o m s  ( d a y s )
( b )
M a x i m u m  t e m p e r a t u r e  ( c e n t i g r a d e )
(d )
T i m e  o f f  w o r k  ( d a y s )
Figure 2.4.2. Distribution of four measures of severity of disease experienced by ill delegates 
following die S typhimurium outbreak, (a) Maximum number of diarrhoea stools per 24 hours 
(data available for 177 people), (b) Maximum temperature reached (data available for 107 
people), (c) Duration of symptoms (data available for 143 people), (d) Time taken off work 
(data available for 135 people).
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(•)
Incubation period  (hou rs) 
r = -0 .4 6  (95% Cl -0 .56  to -0 .33 ) 
b =  -0 .7 5  (95% Cl -0 .97  to  -0 .5 3 ) 
a =  1.99, t  = 6.8, p < 0.001
(c )
Incubation  period (hou rs) 
r = -0 .41  (95% Cl -0 .53  to -0 .26 ) 
b = -0 .4 0  (95% Cl -0 .63  to -0 .29 ) 
a = 1.50, t = 5.3, p < 0.001
(b )
r = -0.34 (95% Cl -0.50 to -0 .16 ) 
b = -1.42 (95% Cl -2.17 to -0 .67 ) 
a = 40.94, t  = 3.7, p < 0.001
(d)
r  = -0.54 (95% Cl -0.65 to -0 .41 ) 
b = -1.02 (95% Cl -1.29 to -0 .75 ) 
a = 2.14, t  = 7.4. p < 0.001
Figure 2.43. Relationship between incubation period and four measures of severity, for 
delegates in the S typhimurium outbreak. Linear regression results are shown with each graph.
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ANALYSIS OF EXPERIMENTAL TYPHOID DATA
In 1970 Homick et al summarised their experience of induced typhoid fever in volunteers. 
They established that larger inocula produced higher attack rates and, on average, shorter 
incubation periods (Table 2.2.1). They noted that "once illness occurred, the clinical courses 
were comparable regardless of the dose of the infectious inoculum". No further details were 
given and it is not clear from the paper how severity was judged nor whether any potential 
confounders such as age, race or vaccination status were considered when reaching this 
conclusion. Furthermore, the definition of illness apparently used to make this assessment 
included an oral temperature of at least 103°F for at least 24 to 36 hours; this would exclude 
mild cases and leave only a small range of severity available for assessment.
I have returned to the original files, held at the Center for Vaccine Development, Baltimore, 
and extracted data on all unvaccinated volunteers infected w ith a known dose of the Quailes 
strain of S typhi.
METHODS
The data now available were collected between 1959 and 1970. The studies were principally 
designed to test vaccines but I have considered only the volunteers who had not received 
vaccines or previous inoculations. The methods used in the challenges are described by 
Homick et al (1970) and in an unpublished manuscript by W E  Woodward. The volunteers 
were healthy male prisoners from the Maryland House of Correction. The typhoid strain used 
(the Quailes strain) was isolated in 1958 from the bile of a chronic carrier and was preserved 
in frozen milk. It is phage type D-l, possessing Vi antigen. It was administered in milk and 
volunteers were instructed to gargle before swallowing. In the  earlier experiments the dose 
used was varied, but from 1965 a dose of 105 (the estimated ID25) was always used. Some of 
the protocols for individual experiments are now missing and some are very brief. The 
published account refers to a standard protocol for these experiments, which included starting 
antibiotics (usually chloramphenicol) when the temperature w as at least 103°F for 24 to 36 
hours. One important change, however, is that from 1965 volunteers (other than those involved 
in food-handling) were seen as outpatients unless and until they became ill. The definition of 
illness resulting in admission was not always given, and the frequency with which the 
volunteers were seen while outpatients varied between once and twice a day. Inpatients had
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their temperatures recorded at 4 hourly intervals during the day, and symptoms and signs were 
recorded daily on checklists. There was no consistent effort to record the severity of symptoms. 
For each day a symptom was recorded as 0 (absent), ± (equivocal), or + (present); I classified 
± as absent. Although it might have been possible to record the duration of each symptom, it 
appeared that the charts were filled in more thoroughly at some times than others so little 
weight could be put on any findings. I have therefore simply recorded whether a symptom or 
sign was ever present during the illness. Laboratory measures such as culture results, 
immunological findings and blood counts are present too infrequently in the results to be used 
in this analysis, or as part of the definition of illness.
Defining illness
I wanted to use a less strict definition of illness than that used by Homick et al so as to 
include any cases of mild disease which may have occurred. If the definition of disease 
requires severe disease, and this is quickly followed by treatment, there is little scope for 
studying determinants of further variation in severity. On the other hand, if the definition is so 
mild that any intercurrent illness or a chance false recording is classified as typhoid, some 
patients will be misclassified. We know from Homick’s results that the attack rate is dose 
related. At high doses almost all patients fulfil a strict definition of disease, leaving few who 
could be misclassified. At lower doses fewer patients fulfil the strict criteria leaving many who 
might genuinely have mild disease or who might be misclassified. Misclassification of non­
typhoid as typhoid will tend to bias the results towards a greater proportion of less severe 
disease at low doses. Misclassification of mild typhoid as not typhoid will bias the results in 
the other direction (see discussion). I have used different definitions of illness to try and assess 
the extent of these biases.
Some of the inpatient charts recorded temperatures for several days pre-challenge. Examination 
of pre-challenge temperatures shows that the measurements tended to be high: peaks over 99°F 
were not unusual. However, after excluding those where rectal temperatures were used, only 
one pre-challenge temperature as high as 100°F was recorded, and none of these temperatures 
were sustained - there was considerable diurnal variation with a range of 1-2°F. This normal 
fluctuation and concern over chance wrong recordings suggested that a sustained fever would 
be a more suitable measure for defining illness than a single peak.
Another problem in defining illness is the use of out-patient monitoring in the later
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experiments. In some protocols patients were only admitted when temperatures over 101°F 
were recorded and in these same protocols the temperatures were only recorded once a day. In 
others, temperatures over 100°F were sufficient and in some (those where the patients were 
seen twice a day) the criteria were not specified. Outpatient temperatures would have been 
recorded during woricing hours, whereas the fluctuating temperatures on the 4 hourly charts 
were often at their highest in the evening, as expected (Petersdorf 1991). To incorporate both 
the peaks and duration, illness was defined as a temperature of at least 100°F for at least 12 
hours continuously and a peak of at least 101°F. I have not included symptoms in the 
definition because none are specific to typhoid (so would not help to exclude other diseases) 
and they occurred in different combinations.
Excluding those who started as outpatients leaves very few with the lowest dose resulting in 
illness (10s) but is the only way of being sure that all the patients who fulfil a definition of 
illness with a low threshold are included. For the 10s dose, attack rates using the low threshold 
were compared between inpatients, outpatients seen once a day and outpatients seen twice a 
day to see if patients with mild disease would be missed if outpatients were included in the 
analysis.
Using a definition with a higher threshold it is unlikely that patients will be missed if they 
started as outpatients. It is unclear from Homick et al’s paper if the defining temperature was 
required to be continuously above 103°F for 24 to 36 hours or if peaks over 103°F over this 
period were sufficient. The latter is more likely since the sample chart in the paper shows just 
two brief peaks over 103°F. Applying this criterion to the data gives much lower attack rates 
than those in the paper. For many of the records the notes record whether the patient was 
considered ill, though it is unclear if this was noted at the time of the experiment or later. 
Almost one third of those classified as ill do not fulfil the temperature criteria. Those who 
were treated with antibiotics were presumably regarded as ill at the time, (with the exception of 
one patient who was explicitly treated because of prolonged faecal excretion) and the paper 
notes that some were treated with fevers less than 103°F depending on their other symptoms. 
Using treatment as the definition of illness should minimize the false positives but will miss 
cases of mild disease and so will bias the results towards a failure to find a dose effect.
Although volunteers who were vaccinated during the studies were excluded, many o f the 
volunteers had served in the armed forces and so would have received typhoid vaccination at 
some time in the past. This was recorded and treated as a possible confounder. Other potential
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confoundcrs were age, race and year. Year was considered as a confoundcr because it was 
strongly correlated with dose and it is possible that changes in protocol other than in the dose, 
such as in the assessment of patients, could affect the outcome.
RESULTS
Information was available on 278 volunteers who had received inocula ranging from 103 to 10’ 
organisms. Ages ranged from 20 to 54 years (median 28), 116 were black and 153 white 
(unrecorded for 9). 102 had been in the military and it was unknown for 70. Among the 88 for 
whom the date of military service was available, service had finished a mean of 12 years 
previously (SD 5.9 years, range 0 - 2 5  years). Among those included as ill, military service 
finished at least 2 years previously, where recorded. All those challenged after 1965 received 
103 organisms, compared to only 5 of those becoming ill before 1965.
Attack rate
The attack rate was determined using two different definitions of disease: (1) temperature of at 
least 100°F for at least 12 hours and a peak of at least 101°F; and (2) treatment given. For the 
first definition, the few cases where only rectal temperatures were available were excluded, and 
any patients who, because they were outpatients, had insufficient charts to know whether they 
fulfilled the criteria, were counted as not ill. (If they were simply excluded the attack rate 
would be biased. This could be avoided by excluding the whole of that experiment, but that 
would severely limit the numbers available.) The case where the reason for treatment was 
stated to be faecal carriage was counted as untreated in the second definition. The attack rates 
by dose are shown in Table 2.5.1. The relationship between dose and attack rate was 
independent of age, race and military service. Using both definitions, age group, military 
service and, to a lesser extent, race were independently associated with attack rates. Attack 
rates (using definition (1)) were higher in the under thirties (56.6 % (82/145) compared to 
31.6% (37/117) in those 30 years or older, RR 1.79, 95% Cl 1.32-2.42); in those without 
military service (54.3% (57/105) compared to 31.3% (30/96) in those with military service, RR 
1.74, 95% Cl 1.23-2.45); and in Blacks (51.8% (59/114) compared to 39.4% (56/142) in 
Whites. RR 1.31, 95% a  1.00-1.72).
For those who received 10s organisms the attack rates were compared using definition (1)
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between inpatients, outpatients seen twice a day and outpatients seen once a day. The attack 
rates were similar in the three groups suggesting that few ill patients would be missed by 
including in the further analysis those who started as outpatients. For the subsequent results 
only patients meeting the definitions of illness are considered.
Incubation period
The incubation period was taken as the time to the first temperature of at least 100°F, as in the 
unpublished report. (A few patients had spikes of temperature over 100°F on the first or 
second day after challenge as shown in Homick et al 1970, figure 1: these were ignored.) The 
incubation period was log normally distributed and was inversely related to dose (Table 2.5.2) 
and the results were sim ilar using the two different definitions of illness. The correlation 
persisted when outpatients were excluded and was similar if the first temperature of 101°F was 
used rather than 100°F. There were no associations between age, race or previous military 
service and the incubation period, and adding these potential confounders to the regression 
equation produced little change in the regression coefficients.
Severity of illness
The severity of illness was assessed by several measures. The most objective measures related 
to the temperature: the peak temperature reached and the duration of temperatures over 103°F. 
Symptoms and signs were considered individually and as the total number occurring in each 
individual (the symptom score). The peak temperature and symptom score were approximately 
normally distributed. The duration of temperatures over 103°F was skewed to the right.
Illness defined using definition (1): 120 cases
The peak temperature was positively correlated with log dose (Table 2.5.3): r = 0.22 (95% Cl 
0.04-0.39), b = 0.13, (0.027-0.24). When outpatients were excluded (leaving oniy 12 patients in 
the 10s dose group, 49 in  all) the correlation was stronger: r = 0.44 (0.18 to 0.64), b = 0.28 
(0.16-0.45). The regression coefficients were hardly altered by adjusting for the age, race or 
military service, and became stronger after adjusting for year.
The time period when the temperature was continuously above 103°F was assessed from the 
temperature charts and so is presented in terms of the number of 4 hour periods. The duration 
was longer in the highest dose group (Table 2.5.3) but the correlation (with log number o f 4
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hour periods + 1) did not reach significance at the 5% level (r = 0.13, -0.05 to 0.31). After 
excluding outpatients the trend was stronger r= 0.31 (0.03-0.55). There was no evidence of 
confounding.
The symptom score increased with dose (Table 2.5.3): r = 0.27 (0.09-0.43), b = 0.39 (0.14- 
0.64). There was no evidence of confounding by age, race or military service, but the 
association was lost after adjusting for year (b = 0.27 (-0.12-0.65) and when outpatients were 
excluded: r = 0.13, (-0.16 to 0.40), b = 0.17, (-0.20 to 0.55).
The 18 individual symptoms are shown in Table 2.5.4. Only lymphadenopathy showed a 
significant increase with dose, but the proportion was highest in the middle dose group and the 
association was lost after adjusting for year in a logistic regression analysis. The trend for 
abdominal pain also approached significance but again was decreased by adjusting for year.
The results were little altered by stratifying by age group, race or military service. When 
outpatients were excluded the results were similar, with a non significant trend for 
lymphadenopathy, a significant trend for anorexia and no other results approaching significance 
at the 5% level. Excluding outpatients leaves few patients from the later years, and adjusting 
for year had little effect.
Because the symptoms sometimes started late, occasionally some days after a brief initial rise 
in temperature, relapses were defined as a recurrence of fever and symptoms occurring after 
completing a course of treatment. There was no correlation between dose and relapse rate in 
the full data set (Table 2.5.4) or after excluding the outpatients. Treatment was given more 
commonly in the higher dose groups, and this trend was more marked after excluding the 
outpatients and after adjusting for year. There was no other evidence of confounding in these 
relationships.
There was no evidence of associations between age, race or previous military service and any 
of the major outcomes: peak temperature, duration of temperature over 103°F or symptom 
score. Time from military service was only known for 28 cases (under definition (1)). There 
were no correlations between time from service and any of the major outcomes.
The year of the experiment was weakly positively associated with peak temperature, after 
adjusting for dose. There was no correlation with duration of high temperatures. The mean 
symptom scores were compared by year and by protocol among those who became ill after 10s
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organisms. There were no significant differences between the group«, and no evidence of a 
trend towards increased or decreased recording over time. Among all those who were ill, an 
inverse correlation between year and symptom score was lost after adjusting for dose. The 
signs (hepatomegaly, splenomegaly, jaundice, lymphadenopathy and rose spx>ts) were separated 
from the symptoms and considered separately as a more sensitive measure of how thoroughly 
the p>atients were assessed over time. The proportion of patients with at least one sign 
decreased with the year of experiment, even after allowing for dose.
Illness defined using definition (2): 115 coses
Six patients with only rectal temperatures recorded were included using this definition; all 
received 109 organisms. The peak temperature for these patients was estimated as the recorded 
temperature minus 0.7°F, based on the estimated difference between oral and rectal 
temperatures given by Petersdorf (1991). They were excluded from the analysis of duration of 
fever.
There was no correlation between log dose and peak temperature, including or excluding those 
with rectal temperatures, with or without adjusting for the confounders: r = 0.08 (-0.10 to 
0.26). There was no correlation between log dose and log duration of fever over 103°F: r = 
0.06 (-0.13 to 0.25). Again there was no evidence of confounding.
The symptom score increased with log dose: r = 0.25 (0.07 to 0.42), b = 0.33 (0.10 to 0.56). 
There was no evidence of confounding by age, race or military service, but the association was 
lost after adjusting for year. Among the individual symptoms a significant trend was only 
found for lymphadenopathy and this was lost after adjusting for year, no other trends with 
symptoms approached significance. Relapse rates were similar in all dose groupis. Treatment 
was, by  definition, given to all patients. Drugs other than chloramphenicol were gnoupied 
together and drug type was considered as a pjossible confounder: this had no influence on the 
results.
Exploration o f possible bias introduced by the definition o f illness
Taking the three main measures of severity - peak temperature, duration of temperatures over 
103°F, and sympHom score - bias introduced by the illness definition was explored further by 
compjaring the results obtained using definition (1) with those obtained by using two more 
definitions based on temperature: a temperature o f at least 101°F for 12 hours continuously 
(definition (3)); and a temperature peaking to at least 103°F over 36 hours (to approximate to
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the definition in the paper (Homick et al 1970) - definition (4)). The results are shown in 
Table 2.5.5.
DISCUSSION
The relationships reponed by Homick et al (1970) between dose and attack rate and incubation 
period were confirmed in this analysis and persisted after adjusting for potential confounders. 
The published report found no evidence of an association between dose and severity. Is this 
borne out by this more detailed analysis?
Some of the protocols are missing from the data, and some are very brief. I think all the 
patients included received the Quailes strain, although it is not always explicit in the notes. The 
criteria on which the assessments of the presence of symptoms and signs were based are not 
recorded. It is possible that they changed over the course of the experiments - certainly the 
charts were not always filled in by the same person. Although the total number of symptoms 
showed little systematic change over time or with protocol, after allowing for dose, the 
recording of signs decreased with year independently of changes in dose. Year has been treated 
as a confounder, but because it is so closely correlated with dose it is difficult to disentangle 
the two effects.
The bias introduced by the illness definition is potentially serious. The action of this bias can 
be illustrated in the following theoretical examples. Suppose there are 50 patients in a low dose 
and 50 patients in a high dose group and they become ill as shown:
Low dose High dose
Not ill 40 20
111 10 30
(Mild illness) (2) (6)
In this situation there is no dose-severity relationship and among those who are ill 20% have 
mild symptoms. Now suppose 10% of those who are not truly ill with the disease in question 
have mild symptoms and are classified as ill. This gives the situation:
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Low dose High dose
Not ill 36 18
111 14 32
(Mild illness) (6) (8)
The illness is now apparently severe in 24/32 (75%) of those who received the high dose and 
8/14 (57%) o f those who received the low dose: a spurious dose-severity effect. The illness 
definition used must have a high specificity to minimise this bias.
Now suppose that there is a dose severity relationship so that the "true" situation is as shown:
Low dose High dose
Not ill 40 20
111 10 30
(Mild illness) (6) (6)
In this scenario severe disease occurs in 80% after the high dose and 40% after the low dose, a 
relative risk of 2. If 50% of those with mild disease are misclassified as not ill we get:
Low dose High dose
Not ill 43 23
111 7 27
(Mild illness) (3) (3)
Severe disease is now seen in 89% after the high dose and 57% after the low dose, a relative 
risk of 1.6. The relative risk is biased towards no effect.
Table 2.5.5 shows that the biases are acting in the direction predicted: as the illness definition 
becomes stricter the correlation coefficients move towards zero. Only the correlation with 
number of symptoms persists in all definitions but this could be due to changes in assessing 
patients over the years. There was little evidence of correlations between dose and individual 
symptoms, apart from lymph adenopathy (which could again be due to year). In particular, 
symptoms and signs which might in themselves indicate severe disease - photophobia, 
hepatomegaly and splenomegaly - were no more frequent after higher doses.
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The correlation with peak temperature was less robust under different illness definitions. The 
results using the 1st and 3rd definitions suggest a correlation but there was no evidence of a 
correlation among those who were treated. The duration of temperatures over 103°F was only 
weakly correlated with dose, but this is perhaps not surprising since, following the protocol, 
patients were treated after a high fever of a certain duration. Relapse rates were similar at all 
doses.
The changes in results seen between the definitions depend on the classification of only a few 
patients. 12 patients included in definition (1) were not treated, and (excluding the patients 
with rectal temperatures) 1 patient was included in definition (2) who was not in definition (1). 
Of the 12, 9 had peak temperatures of at least 102°F. The three others had symptom scores of 
2, 5 and 6. The patient with the lowest score had a temperature over 100°F for over 24 hours. 
It seems likely that the majority if not all o f  these patients had typhoid. In fact some typhoid 
cases may be missed even by definition (1) as suggested by the one treated case who did not 
fulfil the criteria. Nine additional patients had peak temperatures of at least 101°F but did not 
meet the criteria for definition (1) and some o r all of these may have had typhoid. If all 
patients with peak temperatures of at least 101°F arc regarded as ill the regression coefficients 
obtained between dose and the three major symptoms are very similar to those under definition 
( 1 ).
In conclusion, the first definition seems to provide a reasonable compromise between 
sensitivity and specificity. The sensitivity o f  the other definitions is probably too low, but 
where trends persist under these definitions it gives weight to the findings. In these studies 
with the Quailes strain of S typhi, over the very large dose range used, there is some evidence 
of an effect of dose on peak temperature and number of symptoms, though the latter could be 
due to confounding by year. The correlations found were weak, and although they reached 
conventional levels of statistical significance this should be interpreted cautiously in view of 
the large number of comparisons carried out. There was little evidence of correlations between 
dose and duration of high fever, and dose did not predict the occurrence of individual signs or 
symptoms indicative of severe disease, nor o f  relapse.
This analysis has illustrated the problems o f  defining disease and thereby the difficulties of 
separating the known influence of dose on attack rate from the unknown influence of dose on 
severity of disease.
2.5 Salmonellae -  Analysis o f experimental typhoid data. Tables 86
Table 2.5.1. Attack rate by challenge dose. For illness definitions see text. For the second 
definition 4 patients who received 106 organisms (and only had rectal temperatures recorded) 
arc included in the 10s group. None of these 4 became ill.
Dose III by 1st definition III by 2nd definition
103 0/13 (0 %) 0/13 (0 %)
105 83/200 (41.5%) 72/204 (35.3%)
107 13/27 (48.1%) 13/27 (48.1%)
10* - 10® 24/25 (96.0%) 30/34 (88.2%)
X2 trend 33 (p < 0.001) 41 (p < 0.001)
Table 2.5.2. Incubation period by dose. Illness defined by definition (1).
Dose N Geometric mean incubation period in days (95% Cl)
105 82 9.35 (8.38 - 10.44)
107 13 7.40 (4.89 - 11.20)
o « • -A o to 24 4.69 (4.07 - 5.40)
2.5 Salmonellae - Analysis o f experimental typhoid data. Tables 87
T a b le  2.53. Relationships between dose and peak fever, duration of temperature above 103°F, 
and symptom score. Illness defined by definition (1).
Dose
10s 107 10* -10*
Peak temperature N 83 13 24
reached (°F)
Mean 103.81 103.62 104.40
95% Cl 103.60-104.02 103.13-104.10 104.07-104.73
Time above 103°F. N 80 13 23
(No. of 4 hour periods
+ 1) Geometric mean 3.2 2.6 4.8
95% Cl 2.5-4.0 1.4-5.0 3.4-6J
Symptom score N 83 13 24
Mean 7.7 8.9 9.2
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Table 2.5.4. The percentage of patients with each outcome, by dose. Illness defined by 
definition (1)
Outcome Dose X* trend P
10s 107 10* -10*
N -  83 N -1 3 N « 24
Anorexia 90.4 92.3 100.0 1.7 0.2
Nausea 51.8 46.2 66.7
Vomiting 31.3 38.5 41.7
Abdominal pain 74.7 92.3 91.7 3.6 0.06
Diarrhoea 27.7 38.5 45.8 2.6 0.1
Constipation 56.6 38.5 70.8
Hepatomegaly 14.5 23.1 12.5
Splenomegaly 7.2 0.0 8.3
Jaundice 0.0 7.7 0.0
Cough 59.0 53.8 54.2
Sore throat 38.6 61.5 54.2 2.2 0.1
Headache 97.6 100.0 95.8
Sweats 78.3 84.6 79.2
Malaise 78.3 76.9 91.7 1.4 0.2
Rigors 6.0 7.7 4.2
Photophobia 34.9 38.5 33.3
Rose spots 3.6 7.7 8.3
Lymphadenopathy 19.3 84.6 58.3 17.6 <0.001
Treatment 86.7 92.3 100.0 3.0 0.08
Relapse 19.3 23.1 26.1
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Table 2.5.5. Correlations between the three main outcomes and log dose under three different 
definitions of illness.
Outcome Definition (1)
£  100°F for 12 hrs 
+ peak > 101°F 
(N -120)
Definition (3) 
i  101°F for 12 hrs 
(N = 112)
Definition (4) 
Spiking over 103°F for 
hrs. (N -  78)
Peak r (95% Cl) 0.22 (0.04 - 0.39) 0.18(0.00 - 0.35) 0.17 (-0.05 - 0.38)
temperature
b (95% Cl) 0.13 (0.03 - 0.24) 0.09 (0.00 - 0.19) 0.07 (-0.02 - 0.16)
Log time over 
103°^
r (95% Cl) 0.13 (-0.05 -0.31) 0.09 (-0.09 - 0.28) 0.03 (-0.20 - 0.25)
b (95% Cl) 0.04 (-0.01 - 0.09) 0.03 (-0.03 - 0.08) 0.01 (-0.05 - 0.06)
Symptom r (95% Cl) 0.27 (0.09 - 0.43) 0.24(0.06 - 0.41) 0.22 (0.00 - 0.42)
score
b (95% Cl) 0.39 (0.14 - 0.64) 0.33 (0.08 - 0.57) 0.26 (0.00 - 052)
b' (95% C l)t 0.27 (-0.12 - 0.65) 0.09 (-0.29 - 0.46) -0.12 (-0.56 - 0.32)
* ie log (no. ol 4 hour periods when temperature > 103°F continuously + 1) 
t  partial regression coefficient, adjusted for year of experiment
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CONCLUSIONS
For typhoid the evidence from the volunteer studies suggests that there might be a correlation 
between dose and severity. No evidence for a relationship was found in the comparison of 
published epidemics. There are several explanations for this difference. The deficiencies of the 
published typhoid epidemic data and the inherent biases have been discussed at length. In the 
well controlled conditions of studies in selected volunteers using a large dose range of a single 
strain o f  typhoid it was only possible to demonstrate a weak effect. The failure to detect such a 
weak effect in the published studies with their more varied patients and probably smaller dose 
ranges is not surprising. We saw how, in the volunteer data, the correlation with peak 
temperature was lost when a strict definition of disease was used. In natural outbreaks mild 
cases are very likely to be missed.
The outcomes considered in the two studies were very different. In the volunteer studies two of 
the three major outcomes considered related to fever. Illness was defined on the basis of fever 
(even when treatment was the basis of the definition, treatment was given in response to fever) 
and attack rates were dose-related. High fevers are part of the same pathogenic process that 
determined "illness" and might also be expected to correlate with dose. Mortality in typhoid 
can arise in a number of different ways depending on different pathogenic processes, some 
remote from those which lead to diagnosis. Variation in host factors might be expected to be 
relatively more important These points are explored further in the final discussion.
For the food-poisoning salmonellae the evidence as a whole - from individual epidemics and 
from the comparison o f hospitalization rates - suggests that there is a dose-severity relationship 
at least for S enteritidis, S typhimurium, S inf antis, S newport and S thompson.
This contrast between a dose-severity effect for food-poisoning salmonellae and a weak effect 
(if any) for typhoid, is reflected in the differing response to challenge of subjects who are 
partially immune. In volunteer experiments with typhoid, vaccines gave protection against low 
but not high challenge doses, but once clinical disease occurred the severity o f the disease and 
the number of relapses were not altered by vaccination (Homick e t al 1970, Homick & 
Woodward 1966). This is consistent with dose influencing only the proportion of people 
becoming ill and not the severity o f the infection. However, for the food-poisoning 
Salmonellae, when subjects who had become ill were rechallenged, if  they became ill again the 
severity of the illness was usually less than that of the initial illness, despite higher challenge
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doses being used (McCullough & Eisclc 1951b). This change in severity with immunity is 
consistent with a dose-severity relationship.
SECTION 3
MALARIA
3 1 Malaria - Introduction 93
INTRODUCTION
Whether inoculum size influences severity of infection in malaria has been debated for many 
years. Malaria can vary in severity from asymptomatic parasitaemia to a fatal multisystem 
disease. Known variations in virulence between malaria species and strains and known 
variations between hosts in resistance due to immunity, nutritional status, age and red cell 
disorders are insufficient to explain the range in outcome (Warrell et al 1990, Hayes et al 
1992).
In theoretical terms, infecting dose might be expected to influence the severity of disease in 
malaria. During the blood stage of infection with malaria, the increase in parasite numbers is 
initially logarithmic (MaeGraith 1948). The rate of rise will be the same whatever the initial 
infecting dose, but since the infecting dose determines the starting point, the time taken to 
reach a given level of parasitaemia will be dose-dependent (Hamilton Fairley 1947). Following 
a low dose infection, the immune response, which is time-dependent, should start to take effect 
while the parasite load is still low, and might therefore be more effective in limiting the 
severity o f disease (Greenwood et al 1991, Marsh 1992).
The question has assumed new importance with the increasing use of insecticide-impregnated 
bednets (Bermejo & Veeken 1992). It has been suggested that the success of impregnated 
bednets in preventing clinical malaria but not parasitaemia in some studies could be due to a 
reduction in the sporozoite inoculum (Snow et al 1988, Greenwood et al 1991). Induced 
malaria can provide evidence of whether a dose-severity relationship exists, since the dose can 
be estimated. This section starts with a review of the published evidence available for induced 
malaria in man and animals in which it is possible to compare dose and outcome. This is 
followed by an analysis o f previously unanalysed data extracted from the records of patients 
given therapeutic malaria. Finally the results are discussed in relation to the pathogenesis of 
malaria and the findings from bednet studies.
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LITERATURE REVIEW
INDUCED HUMAN MALARIA
Malaria can be induced in man and other animals by one of three methods: by the bites of 
infected mosquitos, by injecting sporozoites extracted from mosquitos, or by injecting infected 
blood from a subject with malaria. All of these methods have been used at different times and 
all allow some degree o f quantification of the dose received.
Manson in 1900 fed infected mosquitos on his son to prove to a sceptical British public that 
mosquitos do indeed carry malaria (Manson 1900). Human volunteers have been used at other 
times, notably by Hamilton Fairley in Cairns, Australia (Hamilton Fairley 1947), and by 
Coatney in the United States (Coatney et al 1950a,b). However the bulk of the experience with 
induced human malaria comes from the use of malaria therapeutically in the treatment of 
neurosyphilis. The benefit to the patients was thought to come from the fever or from some 
other effect of the parasite, so the malaria was allowed to proceed often for ten or more 
paroxysms without treatment, unless the patient became too unwell (James 1931). This was 
obviously not without its dangers; one report gives a fatality rate of 10% for therapy with 
Plasmodium vivax in England (Whelen & Shute 1943). Other series found rates around 5%, but 
they could be as high as 15-20% in the early years (Fong 1937).
The benefit of malaria therapy to neurosyphilis patients is hard to assess as no formal trials 
were done. The outlook without the therapy was variable but often bleak. One study estimated 
that 3-12% of untreated paretics underwent spontaneous remissions but 42% were dead within 
a year of admission (Chemin 1984). A recent review estimates that with malaria therapy 10- 
60% of patients achieved remission, 10-50% showed partial improvement, and 15-40% failed 
to improve (Chemin 1984).
Malaria therapy was used from the early 1920s until after the second world war, when the 
introduction of penicillin gradually made it obsolete (Covell 1956). Malariologists at the time 
realised the potential importance of this therapy for furthering malaria research. Their interests 
centred on the life-cycle o f  the parasite and in particular the mechanism of recurrences, and on 
assessing the efficacy of different treatments. Among the large number of articles produced 
there is some information relating to the effects o f dose. In some cases dose effects are referred
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to specifically, in others I have derived the information from the data presented. Studies were 
identified using the Tropical Diseases Bulletin from 1925 onwards and following up 
references. All identified studies containing sufficient information have been included.
Many of the problems in interpreting the results recur in different studies so they are 
summarised below.
1) Problems of estimating dose in mosquito-induced infections
The most obvious way of assessing dose in infections caused by mosquitos is to count the 
number of bites or of mosquitos employed. This however assumes that all the mosquitos are 
infected and transmit the same number of sporozoites, neither of which is likely to be the case.
The problems of infecting mosquitos from donors known to have gametocytes is discussed at 
length in the early literature (James 1926, James 1931). Shute (1937) noted that in one 
experiment when 30 mosquitos fed on the same patient who was known to have gametocytes 
in the blood, subsequent dissection showed that three of the mosquitos remained negative and 
that the range in number of oocysts in the others was from 1 to 800. In another study (Shute 
1945) fifty mosquitos were fed on the same gametocyte carrier, 44 became positive, and the 
sporozoite counts in the salivary glands ranged from 11,450 to 219,450.
In MF Boyd’s studies in the USA, the mosquitos were dissected after use and the numbers 
given refer to infected mosquitos. In some of Boyd’s studies some mosquitos from each batch 
were dissected without having fed on patients and the number of oocysts in the stomach 
counted. This allowed classification of the batches into grades, but assumed that all the 
mosquitos in a batch were infected to the same degree (Boyd & Stratman-Thomas 1933b,
Boyd & Kitchen 1937b,c, Boyd 1940b).
Two American groups measured the degree of infection in the salivary glands of the mosquitos 
used in experimental infections in prisoner volunteers (Whorton et al 1947a, Coatney e t al 
1950a,b). Both used a scoring system for sporozoites. The salivary glands of the mosquitos 
used were afterwards scored subjectively for level o f  infection from 1+ to 4 or 6+. and the 
dose received by the volunteer was taken as the sum of pluses of the mosquitos involved. In 
summing the pluses from the mosquitos used, it was implicitly assumed that in terms o f  
sporozoite numbers two mosquitos scoring 2+ each were equivalent to one mosquito scoring
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4+. No actual sporozoite numbers were given, so the validity of this assumption cannot be 
assessed, even in terms of gland loads.
Neither the count in the glands nor the oocyst number are necessarily closely related to the 
number o f sporozoites inoculated. Recent experiments inducing mosquito salivation of P 
falciparum-infected Anopheles stephensi in vitro have suggested that the number of sporozoites 
ejected is considerably smaller than the number in the glands (Rosenberg 1990). Median counts 
of 15 sporozoites in the saliva were obtained from mosquitos with median gland counts of 
around 8000. The number ejected was highly variable, ranging from zero to nearly one 
thousand, however there was a positive correlation between the number ejected and the number 
in the glands.
Subsequent studies have given similar results. Beier et al found similarly low ejects (geometric 
mean ejects between four and six sporozoites of P falciparum) for both laboratory and 
naturally infected mosquitos using a capillary tube technique to gather saliva (Beier 1991 a,b). 
In different experiments, between 15 and 75% of infected mosquitos failed to transmit any 
sporozoites. Mosquitos with larger salivary gland loads were more likely to transmit 
sporozoites, and for An gambiae, but not An stephensi, there was some correlation between 
the gland load and the number of sporozoites transmitted. Using a similar technique with P 
berghei-infected An stephensi, Li et al (1992) found that the mean number of sporozoites 
ejected (32-36 sporozoites) was not influenced by previous probing of the mosquitos on rats.
Ponnundurai et al (1991) fed P falciparum-infected An stephensi on fresh mouse skin placed 
over blood to simulate noimal feeding more closely, and counted the sporozoites in the skin 
and in the blood. In these experiments 9 of 34 infected mosquitos failed to transmit any 
sporozoites, and the median number ejected was 8 (range 0-522). The sporozoite gland count 
did not correlate with the number ejected.
Two Anther, indirect studies have come to similar conclusions about inoculum size. 
Vanderberg (1977) calculated the number of sporozoites per An stephensi mosquito from the 
number o f  extra-erythrocytic forms o f P berghei in die livers of mice and rats at 42 hours after 
the inoculation. The mean numbers of extra-erythrocytic forms per mosquito were 24 in mice 
and 97 in  rats. There was a correlation between the mean intensity of salivary gland infections 
in the mosquitos and the mean number of extra-erythrocytic forms per mosquito in different 
experiments. Davis et al (1989) back-calculated from the level of P falciparum parasitaemia in
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four volunteers to find an average inoculum of 120 sporozoites from five mosquito bites, or 24 
per mosquito.
Overall, it appears that the inocula are very small, and that there is a weak association between 
inoculum size and salivary gland load. In Beier's experiments over 80% of the mosquitos 
transmitted fewer than 15 sporozoites, with only a few transmitting over 100. Given the 
variability in sporozoite inoculum between mosquitos, the variation in number of mosquitos 
used to induce malaria is small, and deductions on relative dose very crude. No studies relate 
oocyst number to eject size.
Another problem is the decrease in sporozoite numbers over time. In a batch of mosquitos all 
infected at the same time, the proportion with sporozoites in their glands gradually decreases 
(James & Shute 1926). Using P gallinaceum Porter et al (1954) showed that both the number 
of sporozoites and their infectivity decreased over time.
Boyd’s group refrigerated mosquitos while they were waiting to be used, after their infection 
had matured (Boyd & Stratman-Thomas 1934, Boyd et al 1936). They found that the 
proportion of successful infections fell with increased storage time above 20 days for P vivax 
and above 10 days for P falciparum (Boyd & Kitchen 1937b).
2) Problems of estimating dose with direct sporozoite inoculation
In principle, the most accurate way of knowing the number of sporozoites inoculated is to 
inject the sporozoites directly. Early in the practice of malaria therapy James et al (1927) 
described a technique for extracting sporozoites from mosquito salivary glands, and Shute 
(1937) gave a fuller description of the technique and added a method for determining the 
number of sporozoites injected. Shute did not mention whether any checks were made on the 
accuracy of the method, and problems were experienced by another author when he attempted 
to repeat it (Roy 1938). In addition, handling the sporozoites may have affected their viability, 
so the numbers recorded may be a poor approximation to the number of viable sporozoites.
3) Problems of estimating dose in trophozoite-induced infections
The commonest method for inducing malaria for malaria therapy was by Mood inoculation 
from one patient to another. Often strains of malaria were maintained for long periods by
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repeated subinoculations. As a known amount of blood was injected and parasite counts could 
be made on it, it was relatively easy to calculate the size of the inoculum. Of course, this does 
not provide direct information on mosquito-induced infections but it is trophozoites that are 
transferred in vertical transmission of malaria, and in malaria following blood transfusions.
The blood groups of donors and recipients are important: it has been shown clearly that the 
incubation period was longer in patients who received incompatible blood than in those who 
received the same amount of compatible blood (Polayes & Derby 1934, Myatt et al 1954). The 
early literature was summarised by Myatt et al (1954).
Horn (1929) studied the microscopic appearances of malaria parasites in a donor’s blood when 
exposed to incompatible serum. Several morphological changes were seen, including shrinking 
and breaking up of the parasites. This suggests that parasites were killed when an incompatible 
blood inoculation was given, so the dose received by the patient was effectively smaller.
Unfortunately, few of the studies which relate dose of trophozoites to outcome take blood 
group into consideration, and in the three studies that do consider blood group as well, the 
only outcome recorded is the incubation period (v. Assendelft 1934, Beltran & Sandoval 1946, 
Whorton et al 1947a). Studies which only report blood volume and neither blood group nor 
parasite number provide too crude an estimate of dose and are not included in this review.
4) Problems in interpretation arising from the pooling of results
In many of the papers, and particularly those by MF Boyd, the results quoted relate to more 
than one strain of malaria, and pool the results from primary and subsequent inoculations, and 
from both black and white patients. It is not always explicit in the papers that this has been 
done, and it only becomes apparent by comparison with other papers referring to essentially 
the same group of patients (compare Boyd & Kitchen 1937a with Boyd & Kitchen 1937b,e 
and Boyd 1941). In reporting the results I have tried to clarify this where possible.
5) Problems in interpretation due to the use of neurosyphilis patients
Whether induced malaria in neurosyphilis patients differed in any way from natural malaria 
was debated at the time (Winckel 1941, Boyd 1944a). Apart from the observed lack of latent 
infections following trophozoite inoculation and a feeling that trophozoite-induced infections
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were easier to treat, no major differences were noted. Not all of the patients given "therapeutic" 
malaria had ncurosyphilis, and the diagnoses were sometimes unspecified. I have specified 
whether patients or volunteers were used.
The relationship between dose and prepatent an d  incubation periods
P vivax
Mosquito-induced infections
Although many studies reported prepatent or incubation periods as outcomes in relation to the 
number of mosquitos used or the degree of infection in the mosquitos, few restricted their 
results to primary inoculations and single strains. Different strains may have different prepatent 
and incubation periods, and partially immune patients tend to have longer incubation periods 
(James 1931). All the larger studies which used non-immune patients and single strains showed 
inverse correlations between the estimated dose and the prepatent or incubation period, 
although with considerable variation between individuals.
For 746 patients bitten by between 1 and 30 mosquitos James (1931) found the number of 
bites to be negatively correlated with the number o f days of incubation (correlation coefficient 
given as -0.157 ±  0.025: the 0.025 is probably the standard error).
Coatney et al (1950b), using prisoner volunteers, found longer prepatent and incubation periods 
(time to first temperature of 101 °F) in those infected by the bites of one mosquito than among 
those bitten by ten (Table 3.2.1).
In a recent Chinese study, all the volunteers developed malaria, but whereas the 6 volunteers 
bitten by 10 mosquitos developed malaria within the usual incubation period, half of 24 
volunteers bitten by one mosquito developed malaria only after a long latent period. Among 
those with non-latent infections, the incubation periods were longer in those bitten by only one 
mosquito (Li et al 1989).
Whorton et al (1947a) used a scoring system based on salivary gland sporozoite loads in 
experimental infections of prisoner volunteers with the Chesson strain of vivax malaria; all the 
volunteers were white, and none had a previous history of malaria. Higher scores were 
associated with shorter prepatent periods.
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Coatney et al (1950a) used the St Elizabeth strain and a similar scoring system in 50 prisoner 
volunteers. The paper mentions that each mosquito was usually allowed to feed on three 
subjects in turn before being dissected, which may affect the results. The prepatent period was 
found to be inversely related to inoculum size. An additional three volunteers in the lowest 
dose group developed infections with latent periods of over 9 months.
Boyd and Kitchen (1938) presented data on patients bitten consecutively by the same group of 
mosquitos with a 3-4 day interval between each biting session. The first and third patients 
bitten by each group of mosquitos were thought to be fully susceptible to vivax malaria. (This 
arrangement of biting was designed to test the immune status of the middle patients.) Between 
the first and third sets of bites some of the mosquitos from the group died, so the patients 
bitten third were usually bitten by fewer mosquitos than those bitten first This, and any 
sporozoite depletion caused by time and the consecutive bites, should have ensured that the 
patients bitten on the third application received fewer viable sporozoites than those bitten on 
the first application. Although this study was probably not restricted to a single strain, the 
proportion of patients receiving each strain will have been similar in each group. The 47 
patients bitten on the first application had, on average, shorter incubation periods than the 43 
bitten on the third application.
Direct sporozoite inoculation
Few papers report the results of direct sporozoite inoculations. Mayne (1933) gave only erode 
assessments of the number of sporozoites, and there was a large degree of variation in the time 
for which the sporozoites were maintained in vitro before being used: no clear relationships 
with prepatent or incubation period were seen among the 10 patients studied. Two surprisingly 
recent papers report the results of sporozoite injections in psychiatric patients in Romania. 
Using a North Korean strain of P vivax, low doses were more likely to give rise to latent 
infections (Shute et al 1976). With the Chesson strain no latent infections occurred among the 
11 patients inoculated. Both the prepatent and the incubation periods were inversely related to 
inoculum size in the range 10-10,000 sporozoites (Ungureanu et al 1976).
One other paper gives some results for sporozoite inoculation with P vivax, using an indirect 
method. Hamilton Fairley (1947) compared infections in volunteers bitten by 11-21 mosquitos 
to a second group of volunteers infected by subinoculation of blood from volunteers in the first 
group during the first hour after the mosquito bites. All of the six volunteers in the first group 
and 3 of the six in the second group developed malaria. The recipient in each pair presumably
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received a smaller dose of sporozoites than the donor. For the three pairs where the recipient 
developed malaria the prepatent periods in the donors were 12, 10 and 12 days, and in the 
recipients 17, 13 and 36 days.
Trophozoite-induced infections
For trophozoite-induced malaria the main problem in interpreting results is that few studies 
take account of whether compatible or incompatible blood was used, as discussed above. Of 
the studies which use trophozoite number, most found an inverse relationship with incubation 
period (v. Asscndclft 1934, Whorton et al 1947a, Boyd 1940a, Kaplan et al 1946a, Hoch et al 
1940). In one small study no relationship was found (Grieg & Neill 1939), and Beltran & 
Sandoval (1946) found a correlation among those who received compatible blood but not 
incompatible blood.
In one of the larger studies it is clear that a single strain was used (Whorton et al 1947a). 121 
psychotic patients in Illinois were given the Chesson strain of P vivax intravenously. The 
incubation period (time to the first occurrence of a rectal temperature over 100°F) was shorter 
in those who received compatible blood, and was inversely related to dose within the 
compatible and incompatible blood groups (Table 3.2.2).
P falciparum
Mosquito-induced infections
Four papers by Boyd and Kitchen gave results of their experience of induced falciparum 
malaria using mosquitos (Boyd & Kitchen 1937a,b,e, Boyd 1941). The results in the 1941 
review anicle repeat those given in earlier papers and the results in the other papers seem to be 
based on largely the same group of patients. Most of the patients were Black, and most of the 
results refer to infections with five different strains. The first paper (1937a) states that both 
first inoculations and second inoculations were included; in the other papers this issue is not 
mentioned.
Successful take rates were around 60% and did not vary with the number of mosquitos 
employed (in the range 1-15) (Boyd & Kitchen 1937a,b). For the Coker strain and overall the 
prepatent period did not vary with the number of mosquitos used, but for the Long strain, 
larger numbers tended to give shorter prepatent periods (Table 3.2.3).
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Incubation periods are only given in one of the papers (Boyd & Kitchen 1937a) and are not 
divided by strain. The average time to the first elevation of temperature above 100°F showed 
an increase with increasing numbers of mosquitos, but the confidence intervals of the 
geometric means were wide and showed considerable overlap.
Jeffrey et al (19S9) divided their results by strain and found shorter prepatent and incubation 
periods with increasing numbers of mosquitos in neurosyphilis patients (Table 3.2.4).
Direct sporozoite inoculation
Covell et al (1949) reported the results of 30 intravenous inoculations with known sporozoite 
doses in patients receiving malaria therapy. They used a West African strain of P falciparum  
and each patient received the sporozoites from the glands of two mosquitos. All of the patients 
had received previous malaria therapy but that had taken place at least nine years earlier. For 
some, falciparum malaria had been used, but only European strains. Most of the patients had 
prepatent and incubation periods of 7 days. There was an inverse association between dose and 
incubation and prepatent periods (Table 3.2.5).
Trophozoite-induced infection
I have not found any papers which provide information about inoculum size (in terms o f  blood 
volume and parasite count or blood compatibility) in trophozoite-induced falciparum malaria.
P malariae
It proved difficult to transmit P malariae to mosquitos, at least to those commonly employed, 
so experience with mosquito-induced infections is very limited (Shute 1951). No paper gives 
the results and doses for more than a few patients (eg Ciuca 1964), so no conclusions can be 
drawn.
Only three papers give quantitative results for trophozoite infections with P malariae. Ciuca et 
al (1943) describe experience with 293 patients. They found that the parasite density in the 
donors’ blood did not reliably influence the incubation period in the recipient, but results were 
presented for only 10 patients.
Grieg and Neill (1939) found an inverse correlation between inoculum size and incubation 
period, but only nine patients were studied. Boyd’s results on 26 patients also suggest a
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negative correlation with prepatent and incubation period (Boyd 1940c).
The relationship between dose and severity of disease 
P vivax
Mosquito-induced infections
A few years after starting malaria therapy James (1926) noted that the number of mosquitos 
employed had no influence on the severity of infection. After nearly 30 years experience of 
malaria therapy, Shute (1951) commented "perhaps one of the most surprising findings is that 
the number o f sporozoites injected [in terms of mosquito bites] on a single occasion or on 
many different occasions does not seem appreciably to influence the severity of the disease, the 
duration o f  the attack or the gametocyte output". In other papers from this laboratory it was 
noted that patients infected towards the end of a batch of mosquitos - by which time the 
number o f viable sporozoites may be reduced - sometimes got "abortive” primary attacks with 
only two or three days of irregular fever, or only latent infections (James et al 1936, Shute 
1946a). No numerical evidence was provided for either statement.
Boyd and Stratman-Thomas (1933a) felt that the "clinical course of malaria and the possibility 
of spontaneous termination are related to the number of infected mosquitos applied", the 
duration o f  the initial remittent fever "being frequently proportional to the number of infected 
mosquitos applied." In lighter infections they felt that the patient was more likely to proceed 
directly to tertian fever and rigors. However in another paper that they published in the same 
year (1933b) the quantitative results did not support this impression. Neither the proportion of 
patients experiencing chills nor the proportion requiring medical intervention in the attack were 
related to the number of mosquitos used (Table 3.2.6). Further detail was given in the paper 
but the numbers in the subgroups become too small to be helpful. The results pool primary and 
reinfections of four strains of vivax malaria in Black and White patients, some of whom came 
from areas endemic for malaria.
Jerace (1934), recorded the number of mosquitos used for malaria therapy with Madagascar 
strain P vivax on 22 patients. He also recorded the time from first appearance of sporozoites in 
the glands until the mosquito was used. He found no association between either the number 
used (in the range 4-30) or the storage time, and the type of fever (quiMw) or tertian), the 
number o f spikes of fever, or whether the infection resolved spontaneously.
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In Boyd and Kitchen’s study (1938) where group« of three patients were bitten consecutively 
by the same group of mosquitos, those bitten on the first application had, on average, longer 
lasting attacks than those bitten on the third application. Among those bitten on the first 
application the duration of the attack was not related to the number of mosquitos used. It is not 
clear if all of the attacks recovered spontaneously.
In Boyd’s studies where he graded the load in the mosquitos according to the number of 
oocysts he looked at various measures of severity. In the first series (which explicitly referred 
to pooled results with more than one strain and primary and subsequent inoculations) the 
propxmion of patients experiencing chills, the proportion requiring induced termination of the 
infection, and the propxmion showing "renewed activity" all increased with the grade of 
infection of the mosquito lots used. The propxmion showing tertian fever during the infection 
decreased with grade (Table 3.2.7), (Boyd & Stratman-Thomas 1933b).
In a later series (Boyd 1940b), which used a different grading system in which Grade A lots 
had heavier infections than Grade C, there was little difference between the two group« in the 
propxmion of cases terminating spxmtaneously: 121/187 (65%) for A and 55/75 (73%) for C. 
Considering only those whose infections terminated spxmtaneously, there was a pxrsitive 
correlation between the duration o f clinical illness and the number of mosquitos employed 
(Grade A group: r = 0.14, 95% Cl 0.03 to 0.26; Grade C group: r = 0.22, 95% Cl 0.04 to 
0.39). Patients from group C tended to have fewer paroxysms of fever over 104°F, but the 
confidence intervals were wide. Fewer ptalients in group C had recurrences (33% compared 
with 42% in group A), but again this was not significant. These results are probably the pxxried 
experience from more than one strain and from primary and subsequent inoculations.
Among 13 volunteers bitten by one mosquito, the duration of the patent parasitaemia was 
related to the salivary gland spxjrozoite load of the mosquito. However all the attacks were 
interrupted by a dose of chloroquine (Coatney et al 1950b). Sioli et al (1939) noted no relation 
between the number of bites by mosquitos carrying the Madagascar strain and the character of 
the infection among 31 patients. Some of the patients had had previous inoculations.
Direct sporozoite inoculation
There is no direct evidence relating dose to outcome in spxnozoite inoculations for P vivax. In 
Hamilton Fairley’s study (1947), using subinoculation from one volunteer to  another shortly 
after the first bite, the pxtrasite counts at the time treatment was started were lower in the
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recipients than in the donors. He commented that treatment was "equally necessary on medical 
grounds" in two of the recipients, despite the relatively low counts. For the recipient with the 
lowest count treatment was started for non-medical reasons.
Trophozoite-induced infection
Polayes and Derby (1934) noted that there were no differences in the occurrence of initial 
remittent fever between patients who received compatible or incompatible blood in a group of 
121 neurosyphilis patients injected intravenously with 5ml donor blood. No other comparisons 
in the severity of the outcome were made. The species of malaria was not specified.
Wcthmar (1927) found that those who received compatible blood were less likely to have 
tertian fever (Table 3.2.8). Wendleberger (1930) found similar trends: quotidian fever was 
much more frequent in those receiving compatible blood, and pure tertian fever was found in 
almost all of those who received incompatible blood.
Hoch et al (1940) diluted the donors’ blood before intravenous injection to obtain small 
numbers o f parasites. Using calculated challenges of 100 to 1000 parasites of the McCoy 
strain, they reported no correlation between dose and the character of the infection. Analysis of 
their data for 21 successful inoculations with a known dose, shows no correlation between dose 
and the number of paroxysms, but after lower doses a larger proportion of patients had a 
spontaneous recovery. Blood groups were not mentioned in this report and some of the patients 
may have had previous malaria therapy.
Boyd (1940a) gave the results from primary inoculations in 31 patients inoculated 
intravenously. Several strains were used, the blood was not cross-matched, and in one third of 
the patients the attacks were interrupted by treatment. Following inocula of less than 6 million 
trophozoites the geometric mean duration of the clinical attack was 12.5 days (95% Cl 7.2 to 
22.0), compared to 16.4 days (95% Cl 11.3 to 24.0) following inocula of 6 million or more 
trophozoites .
Kaplan et al (1946b) reported measures of outcome in relation to the size of the trophozoite 
inoculum given intravenously. It is not clear whether a single strain was used. Among 121 
patients who had not had previous malaria the proportion experiencing tertian fever decreased, 
and the duration of remittent fever increased with increasing dose (Table 3.2.9).
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P falciparum
Mosquito-induced infections
For falciparum malaria, James et al (1932) felt that the effect of dose on the infection was 
"considerably greater ...in general the primary attacks of cases infected by the bites of many 
infected mosquitos are more difficult to control and are o f longer duration than of cases 
infected by the bites of only one or two insects". No numeric data were given, but the number 
of cases was said to be small.
Boyd and Kitchen (1937a) found that the duration of illness did not appear to depend on the 
number of mosquitos used. This paper probably refers to more than one strain and to both 
primary and subsequent inoculations, but it is not stated. Interpretation is difficult as 49 of the 
59 patients received treatment with quinine during the acute attack.
Direct sporozoite inoculation
Covell et al (1949) reported results of intravenous inoculations with known sporozoite doses in 
30 patients receiving malaria therapy. The authors commented that there was no evidence of an 
effect of dose on the severity of the clinical attack, though no figures are given. The patients 
were all treated early in the infection, with a variety of different treatments.
P malariae
There is very little information linking dose and severity for P malariae. Ciuca et al (1943) 
had experience with 293 patients, but only presented the results for ten; they found that the 
parasite density in the donors* blood did not influence the parasite density in the recipient In 
one of Boyd’s studies (1940c) 3/7 of the infections induced by doses of less than 5 million 
trophozoites required treatment compared with 14/19 of those produced by higher doses.
The relationship between dose, the response to treatm ent and relapse rates
P vivax
Mosquito-induced infections
Coatney et al (1950b), using the Chesson strain of P vivax, assessed the response to 
suppression by different doses of chlotoquine in prisoners bitten by mosquitos. Suppression
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was satisfactory in 4/9 receiving 30 bites and in 8/9 receiving only three bites. The attacks 
which occurred after the chloroquinc was stopped were, on average later and fewer in those 
who had received three bites.
Alving et al (1948), using the same strain in volunteers, found higher relapse rates after 
treatment in those who had been bitten by 80 mosquitos than in those bitten by 10 (Table
3.2.10).
Tiburskaja ct al (1968) compared relapse rates with the number of mosquitos used to treat 
patients in psychoneurological hospitals in Moscow. The results quoted pool their experience 
with 10 different strains over 25 years and are divided according to the initial incubation 
period. Among 141 patients bitten by between 1 and 12 mosquitos who developed malaria 
within the usual incubation period, the number of mosquitos used was not related to the 
number of relapses. Among the 95 who only developed malaria after a latent period of over 6 
months, those bitten by more mosquitos were more likely to have had a relapse within the 
follow up period which ranged from 8 months to 3 years (Table 3.2.11). It is not clear if the 
follow up period was similar in the different groups.
In one series from Coatney’s group (Coatney et al 1950b) each prisoner volunteer was bitten 
by a single mosquito carrying the Chesson strain and each attack of malaria was interrupted by 
a single dose of 0.3g of chloroquine. All the volunteers were followed for seven months. The 6 
volunteers who were bitten by a mosquito scored as 2+, according to the number of 
sporozoites in the glands, had a mean of 3.0 attacks (95% Cl 1.5 to 4.5). The 7 who were 
bitten by a mosquito scoring 4+ had a mean of 4.7 attacks (95% Cl 3.6 to 5.9).
Using the St Elizabeth strain of vivax malaria also in prisoner volunteers, Coatney et al 
(1950a) found an inverse relationship between inoculum size and the time of occurrence of 
"late activity" (latent infections or recurrences occurring after four months). In these 
experiments the inoculum was measured as the sum of pluses from the different mosquitos 
used. Overall, 177 of the 198 subjects experienced late parasitaemia, and a further 8 were lost 
from observation. The volunteers had received a variety of different treatments, both before 
inoculation and during the initial infection. The results for the 153 subjects for whom accurate 
onset dates were available are given in Table 3.2.12. It is not possible to separate the latent 
infections from the recurrences.
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Direct sporozoite inoculation
In Hamilton Fairley’s subinoculation experiments (1947), where the recipients were inoculated 
with blood from the donor shortly after the donor was bitten, all three donors but only one of 
the three recipients got secondary attacks.
P falciparum
Covell et al (1949), in reporting the results of 30 intravenous inoculations of sporozoites for 
malaria therapy, commented that there was no relationship between dose and the frequency of 
relapse, but no figures were given. The patients were given various different treatments early in 
the course of the infection.
The relationship between incubation period and severity o f disease
P vivax
Several authors have compared the incubation or prepatent periods with the outcome of the 
disease using various measures of severity. The prepatent period has been referred to as a 
measure of the "severity" of the infection (Alving et al 1948, Jones et al 1948), and when 
associations are found between the prepatent or incubation period and other outcome measures 
they are thought to be due to the effect of inoculum size (Boyd & Kitchen 1938, Craige et al 
1947). However, the confounding effects of variations in patient immunity and innate 
susceptibility must also be considered.
For mosquito-induced infection, Boyd found that shorter incubation periods were associated 
with longer attacks (Boyd & Kitchen 1938, Boyd 1940b). However neither paper gave any 
information on the strains used, the second paper gave no information on immunity, and the 
first paper pooled results from immunes and non-immunes. Confounding by strain and immune 
status is likely in these results. Incubation period was noted not to be associated with 
recurrences, but no evidence was presented (Boyd & Kitchen 1937d).
A Chicago group carried out a series o f  studies using Chesson strain vivax malaria in non- 
immune prison inmates in Stateville penitentiary. They found that the relapse rate after 
treatment was higher in those with shorter prepatent periods (Craige et al 1947, Alving et al 
1948, Jones et al 1948). Also, those w ith shorter prepatent periods were more likely to have
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more than one relapse and had a higher proportion of early relapses (Craige et al 1947). 
Tiburskaja ct al (1968) found that patients with initial latent infections had fewer relapses, but 
it appears that this group had a shorter period of follow up after the first clinical infection.
Among psychotic patients receiving trophozoite-induced infections, the Chicago group found 
that shorter incubation periods were associated with a longer duration of fever and a greater 
number of paroxysms (Whorton et al 1947b). Jerace (1934) gave results for 22 mosquito- 
induced and 30 trophozoite-induced infections. For trophozoite-induced but not mosquito- 
induced infections the incubation period was negatively correlated with the number of spikes of 
fever. For both types there was a tendency for longer incubation periods to be associated with 
spontaneous recovery and with tertian rather than quorum fever, but these associations were not 
significant at the 5% level. In Hoch et al's studies (1940) in which low doses of McCoy strain 
trophozoites were used, incubation period was not associated with the number of paroxysms or 
spontaneous recovery among 21 ill patients. No information on prior inoculations was given.
Shuie (1952) staled without supporting evidence that when the incubation period was only 2-3 
days, such as after the injection of large numbers of parasites intravenously, then the 
subsequent fever was more severe than when the incubation period is 9-14 days. (In the same 
article he stated that the incubation period in mosquito-induced malaria is not influenced by the 
number of parasites, despite evidence, including some from his own laboratory, to the 
contrary.)
P falciparum
One anecdotal report commented that there was no relationship between incubation period and 
severity of disease in malaria therapy patients (Raffaele 1951).
INDUCED MALARIA IN ANIMALS
Animal experiments have the advantage that infections are allowed to proceed further and 
invasive measurements of severity can be made. They have the disadvantage that the parasitic 
relationships studied are not generally those that occur in nature so their relevance to host- 
parasite relationships in human malaria is questionable. The main groups of animals used are 
birds, monkeys, and, more recently, rodents. Most of the experiments use blood inoculation
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and therefore trophozoite-induccd infections. Blood grouping is not mentioned.
Bird malaria
GH Boyd (1925) showed a clear negative correlation between the infecting dose and the 
"incubation period" (probably the prepatent period) using P praecox. He also found a 
correlation between the dose and the height of the peak parasitaemia, but no relationship 
between the dose and the length of the period of rise of parasite counts.
For adult ducks inoculated with P lophurae there was no clear dose-response relationship in 
terms of the peak parasitaemia or the proportion of fatal infections, although the period of rise 
in parasite numbers decreased with higher doses (Hewitt 1942). However, for young ducks, 
higher doses were associated with shorter prepatent periods, decreased time to the peak 
parasitaemia, increased height o f peak parasitaemia, more profound anaemia, a higher 
proportion of deaths, and decreased time to death (Hewitt et al 1942). Wolfson (1945), using P 
relictum in young ducks, also found higher peak parasitaemias and lower haemoglobin 
concentrations with increased doses.
Greenberg et al (1950) gave intravenous sporozoites of P gallinaceum to chicks. At lower 
doses the prcpatcnt periods were longer and more birds survived following treatment.
Monkey malaria
Rhesus monkeys were the usual species used for experiments. They show exquisite sensitivity 
to the monkey malaria P knowlesi: one parasite can cause a fatal infection. As the dose 
increases the time to death decreases. The variation is in the prcpatent period, the time from 
first appearance o f  the parasite being approximately constant (Coggeshall & Eaton 1938).
Using trophozoite-induced P cyanomolgi infections, Wolfson and Winter (1946) again found 
the prepatent period to be dose-related. Peak parasitaemia also increased with dose, but there 
was no dose-relationship with the time taken to reach the peak, nor with the duration of the 
infection.
Also using P cyanomolgi in rhesus monkeys, Schmidt et al (1982) found an inverse 
relationship between dose and prepatent period for both trophozoite and sporozoite-induced 
infections. In trophozoite-induced infections the time from patency to the peak and the height
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of the peak were independent of dose in the range 10s to 101. For sporozoite-induced infections 
the duration of the attack appeared to increase with inoculum size, but with wide variation.
By externalising the spleen, Coggeshall (1937) was able to measure splenomegaly in infected 
rhesus monkeys. With P knowlesi greater splenic enlargement was noted at lower doses, that is, 
when death was more delayed. For P inui no relationship between dose and spleen size was 
noted, but only six monkeys were used for the experiment and the dose range w as small.
Rodent malaria
Most of the experiments have been carried out using P berghei. For both trophozoite and 
sporozoite-induced infections, lower doses have consistently been shown to be related to longer 
prepatent periods (Fabiani & Orfila 1954, Arcoleo & Carrescia 1955, Vanderberg e t al 1968, 
Nussenzweig et al 1966) or longer latent periods to a given level of parasitaemia (Sengers et al 
1971a,b, Warhurst & Folwell 1968).
In most experiments almost all of the animals with patent infections died (Nussenzweig et al 
1966, Sengers et al 1971b). Ferraroni (1983) found that the proportion that died was dose- 
related. The time to death showed a variable relationship with dose. In some systems the time 
to death was bimodal, and dose did not influence whether the mice had slow or rapid deaths 
(Arcolco & Carrescia 1955, Sengers et al 1971b). However, within each group (slow or rapid) 
the time to death was dose-related (Sengers 1971b). In other systems there was a simpler 
relationship between increasing dose and decreasing survival times (Nussenzweig e t al 1966, 
Vanderberg et al 1968). In contrast to the monkey experiments, this appeared to depend on a 
decreasing period of patent parasitaemia as well as shortened prepatent periods w ith increasing 
dose (Nussenzweig et al 1966).
Using P vinckei, dose was again found to be negatively correlated with survival tim e (Cox 
1966). One small experiment failed to show this but used just two different high doses (Yoeli 
et al 1966).
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CONCLUSIONS
An inverse relationship between dose and prepatent or incubation period is found in both 
animal experiments and human induced malaria. A relationship with severity is suggested by 
the animal experiments but hard to demonstrate in the published human data. A few papers 
indicate a relationship, but much of the information comes from small studies and is often 
presented with incomplete information, and is marred by pooling of results from different 
strains, and immune and non-immune patients. The most consistent evidence is of a 
relationship between prepatent or incubation period and severity, but this could be due to 
confounding by host susceptibility or, in some studies, immunity. Some of these problems arc 
overcome in the following analyses of induced malaria data.
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Table 3.2.1. Experimental infections with Chesson strain P vivax (from Coatncy ct al 1950b).
No. of n Prepatent period (days) Incubation period (days)
mosquitos mean (95% Cl) mean (95% Cl)
10 96 11.77 (11.48-12.06) 12.16 (11.79-12.53)
1 15 13.93 (13.18-14.68) 14.00 (13.44-14.56)
Table 3.2.2. Influence of the compatibility of blood group and inoculum size on the incubation 
period of Chesson strain P vivax (from Whorton et al 1947a).
Inoculum (in 
millions of parasites)
n
1) Compatible blood
< 1 9
1 - 9 6
10 - 99 29
100 - 999 17
a 1000 5
2) Incompatible blood
< 1 4
1 - 9 6
1 0 -9 9 22
100 - 999 23
Incubation period (days) 
Mean (range)
5.4 (3 - 11)
2.2 (2 - 4)
2.0 (< 1 - 5)
0.9 (< 1 - 3)
0.5 (< 1)
8.8 (8 - 10)
8.3 (6-12)
4.2 (< 1 - 7)
3.7 (< 1 - 7)
3.2 Malaria - Literature review of induced malaria. Tables 114
Table 3.23 .  Days to first detection of parasites in the recipient compared with the number of 
mosquitos used for P falciparum. Geometric means and 95% confidence intervals are shown. 
(From Boyd and Kitchen 1937e)
No. O f  
mosquitos
Coker strain 
n mean
Long strain 
n mean
Overall (5 strains) 
n mean
1 5 12.9 (10.7-15.5) 8 10.6 (8.1-13.8)
2-5 17 11.6 (10.4-13.0) 2 11.0 (11.0-11.0) 23 11.4 (10.5-12.4)
6-10 18 12.5 (10.9-14.4) 28 10.8 (10.4-11.1) 46 11.4 (10.7-12.1)
11-20 2 13.5 (8.4-21.6) 11 9.9 (9.3-10.5) 17 11.0 (9.9-12.3)
Table 3.2.4. Prepatent and incubation periods in days by the number of mosquito bites for 
three different strains of P falciparum (from Jeffrey et al 1959).
No. of Panama strain McLendon strain Santee-cooper strain
mosquitos n median (range) n median (range) n median (range)
Prépaient period
1-10 15 11 (9-16) 14 13 (10-29) 7 10 (9-13)
11-20 31 10 (7-16) 11 12 (10-15) -
21 + 11 9 (8-15) 8 12 (9-14) 8 9 (7-13)
Incubation period
1-10 15 13 (9-19) 14 14 (9-32) 7 13 (7-14)
11-20 31 13 (9-17) 11 13 (11-15) -
21 + 11 11 (7-17) 8 13 (11-21) 8 10.5 (7-16)
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Table 3.2.5. Relationship between sporozoite dose, prepatent period and incubation period in 
falciparum malaria (from Covcll ct al 1949).
Sporozoite dose 
(in thousands)
Proportion of patients in each category 
Prepatent period Incubation period
s 7 days s 7 days
< 100 
100-200 
è 200
5/11 7/11
6/9 5/9
10/10 10/10
Table 3.2.6. The effect of mosquito number on the occurrence of "chills" and the need to 
induce termination of the attack in P vivax. Pooled results of 4 strains and primary and 
reinfections (from Boyd & Stratman-Thomas 1933b).
No. mosquitos Chills Termination induced
1 15/23 (65%) 11/23 (48%)
2 7/7 (100%) 2/7 (29%)
3 7/8 (88%) 3/8 (38%)
£ 4 9/12 (75%) 3/12 (25%)
Table 3.2.7. The proportion of patients with various outcomes by grade of infection of the 
mosquito lots used. Pooled results from more than one strain o f P vivax and primary and 
subsequent inoculations (from Boyd & Stratman-Thomas 1933b).
Grade Chills Requiring
termination
Tertian
fever
Renewed
activity
Poor 5/10 (50%) 1/10 (10%) 6/10 (60%) 3/10 (30%)
Fair 8/11 (73%) 4/11 (36%) 5/11 (45%) 6/11 (55%)
Good 25/29 (86%) 14/29 (48%) 7/29 (24%) 16/29 (55%)
X* trend 5.23 4.37 4.57 1.5
P 0.02 0.04 0.03 0.2
3.2 Malaria - Literature review ot induced malaria. Tables 116
Table 3.2.8. Outcome in 65 patients inoculated with vivax malaria in relation to compatibility 
of the blood inoculated (from Wethmar 1927).
Intravenous inoculation Intracutaneous inoculation
Compatible Incompatible Compatible Incompatible
Mean incubation
period (days) 4.5 8.2 9.8 15.1
% with each type 
of fever:
Quotidian 46% 6% 13%
GO
Tertian 27% 82% 67% 92%
Mixed 27% 12% 20% 0%
Table 3.3.9. Relationship between inoculum size and type of fever in trophozoite-induced 
vivax malaria (from Kaplan et al 1946b).
Inoculum (parasite n Tertian cycles Days of remittent fever
nos in millions) Mean (95% Cl)
1 28 12/28 (43%) 1.64 (1.00-2.28)
2 - 5 28 9/28 (32%) 2.50 (1.90-3.10)
6 - 25 29 9/29 (31%) 2.34 (1.80-2.88)
26 - 150 36 9/36 (25%) 2.86 (2.29-3.43)
x2'trend in tertian cycles = 2.1, p = 0.1
Table 3.2.10. Relapse rates following treatment in experimental vivax malaria using the 
Chesson strain. Relapse rate is the ratio of the number who relapse to the number of 
individuals treated. (From Alving et al 1948).
No. of mosquito 
bites
Pentaquine Quinine alone Other suppressive 
+ quinine drugs
10
80’
4/43 10/11 52/57
4/4 2/2 4/4
1 or intracutaneous injection of salivary glands from 45-75 mosquitos
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Table 3.2.11. Number of patients suffering different numbers of relapses following an initial 
latent infection with vivax malaria, related to the number of mosquitos used to induce an 
infection. Pooled experience with 7 strains (from Tiburskaja et al 1968).
No. mosquitos n No.(%) suffering each number of relapses
0 1 2
1 52 36 (69%) 13 (25%) 3 (6%)
2 25 16 (64%) 7 (28%) 2 (8%)
3-10 18 6 (33%) 6 (33%) 6 (33%)
(X2 trend with increasing mosquito number comparing relapses vs 
no relapses = 11.5, p < 0.001)
Table 3.2.12. Relationship between the infective inoculum and the time to the onset of late 
parasitaemia in mosquito-induced St Elizabeth strain vivax malaria (from Coatney et al 1950a).
Inoculum n Days from mosquito bites to first day
(sum of pluses) of late parasitaemia. Mean (95% Cl)
1 - 10 6 292
1 1 -2 0 34 297
21 - 30 63 285
31 - 40 46 267
41 - 50 1 276
51 - 60 3 256’
(257-327)
(288-306)
(279-291)
(254-280)
' standard error not given
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ANALYSIS OF DATA FROM THERAPEUTIC MALARIA RECORDS
PlJiSMODIUM VIVAX
MATERIALS AND METHODS 
The raw data
Malaria therapy for neurosyphilis was carried out at the Horton hospital, Epsom, Surrey, from 
1923 to the 1960s, conducted from the laboratory which became the Malaria Reference 
Laboratory for the UK (Covell & Nicol 1951). Malaria was induced by mosquito bite, blood 
inoculation, or direct injection of sporozoites. Information regarding these infections exists in 
three sources: two sets of books compiled at Horton, and the original notes of the patients who 
received the therapy. One set of books is now stored in the library at the London School of 
Hygiene and Tropical Medicine. These books are arranged by episode of induced malaria and 
give the name of the patient, the date (or dates) of the therapy, the strain of malaria used, the 
type of malaria therapy given, a measure of dose depending on the type, the date the fever 
started, the date parasites were first found in the blood, the type of fever, the parasite counts on 
each day, and details of any treatment given. There are no temperature charts or details of the 
height of the fever, and, after the early years, no descriptions of the severity of the illness. 
Previous episodes of malaria therapy are sometimes mentioned, and the dates, treatment and 
parasite counts for any relapses are given (Figure 3.3.1).
A second set of books is held at the library of the Royal College of Physicians. These books 
arc complementary to the first, referring to the same patients and being arranged by patient 
rather than by episode of malaria therapy. A full record of any previous malaria therapy is 
therefore more easily obtained from them. The emphasis in these books is on the syphilis 
rather than the malaria, but they contain further details of the fever and subjective descriptions 
of the illness. They provide personal details such as sex, age and nationality, and details of any 
foreign travel including mention of any previous natural malaria. The date of transfer, 
discharge or death of the patient is usually given. These books stop in the 1950s, but contain 
details of around 2500 patients (Figure 3.3.2).
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The Horton hospital still exists as a mental hospital. About fifty sets of notes that referred to 
patients who had had malaria therapy were identified among those kept in the Medical Records 
department. Unfortunately this department only maintains the records of patients who were in 
the hospital within recent years. Older records, while kept, are not in any order and are 
difficult to extract. The notes that were extracted contained similar details to those obtained 
from the books at the College (Fig 3.3.3). No complete temperature charts were found. Since 
these notes did not add any information and since many of the patients were transferred to 
other hospitals, no effort was made to trace further notes.
The M adagascar strain of vivax malaria
About half of the malaria therapy carried out at Horton used this one strain of malaria. First 
isolated in 1925 (Figure 3.3.4) it was maintained by repeated passage through man and 
mosquito until the end of malaria therapy in the 1960s. In 1933 the strain was transferred to 
Holland, where it continued to be maintained in man and mosquito, while therapy was tried 
with another strain. In 1936 the strain was returned to the UK (Shute 1946b). Before 1933 
every batch o f mosquitos was infected from a mosquito-infected patient, but after 1936 a 
shortage of patients meant that some batches were infected from blood-infected patients. No 
loss in virulence was noted (Shute 1952). Between 1925-6 and 1930-2, however, gamelocyte 
production by the strain changed: gametocyies were found earlier and in larger numbers in the 
later period (James et al 1936).
Typical infections with the Madagascar strain were described by Shute (1952):
"1) Initial fever usually lasts 3-5 days and is irregular, the temperature seldom rising 
above 102°F, and it may not return to normal throughout this period.
2) Developed stage. - Fever is quotidian [in over 80% of primary cases], temperatures 
of 104°F and 105°F are usual, rigors may or may not occur, and after 5 or 6 attacks 
the patient feels rather exhausted.
3) Terminating stage. - After ten or more uninterrupted attacks of fever the tendency is 
towards spontaneous recovery, but this depends on the amount of resistance which the 
patient has built up as the result of his previous attacks. The first indication of 
spontaneous recovery may be the fever’s sudden change from quotidian to classical 
tertian; but this does not always happen, and patients who are having quotidian fever 
may recover spontaneously, although parasites may be plentiful in the blood.
4) Chronic stage. - After a spontaneous recovery, either from the primary attack or 
from a relapse, parasites may be quite numerous in the blood and may continue to be 
so for several weeks unless anti malarial drugs are given."
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Data extraction and entry
I extracted and entered all the data myself, directly on to the computer, using Epi Info.
Records from the different sources were collated using the name, the date and the strain of 
malaria. Since the data were entered directly and the process of extracting the data was time- 
consuming, double entry was not feasible. The decision to enter it in this way was taken so as 
to avoid the transcription errors which would have occurred if the data had been extracted as a 
separate step. Some internal checks were possible within the data, such as range checks, and 
consistency checks.
The data from all patients who had received malaria therapy with Madagascar strain vivax 
malaria were entered unless they had received prophylactic treatment (ie treatment in the 
period from two weeks before inoculation to the start of the fever or parasitaemia, whichever 
was first) or had received another strain or species of malaria concurrently. The books which 
referred to the episodes of malaria were regarded as the first set, and the books describing the 
patients were matched to them. Any episode appearing only in the second set would therefore 
not be included, but in practice this did not occur.
Many of the patients were infected with malaria on more than one day so a rule was made to 
define success and failure in episodes where malaria was given on several occasions some time 
apart: if patent parasitaemia or fever did not develop within 30 days of the dose the episode 
was called a failure. In some episodes further malaria was given during the illness. This was 
recorded.
Mosquito-induced malaria
The mosquitos used were almost always A maculipennis var. atroparvus. At first they were 
collected in the wild, mainly from pigsties, but from 1933 a breeding colony was established at 
Horton (Shute 1951). The mosquitos were infected by feeding on a patient who had been 
shown to have gametocytes in the blood. The mosquitos which had fed were identified by 
examination for bright red blood and were separated from the rest. A few mosquitos from the 
batch were dissected each day from the third day after feeding to ascertain the percentage 
infection o f the batch and the time at which sporozoites were first found in the glands (Fig 
3.3.5) (Shute 1951). Several of the early books refer to storage of mosquitos containing mature 
sporozoites in ice chests (Figure 3.3.6), and it seems likely that this was usually the case (as in
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the USA (Boyd & Stratman-Thomas 1934, 1936)). I have not been able to find published 
documentation of this.
The mosquitos used to bite a patient were placed in a jar covered in netting and this was 
applied to the patient's thigh (Nicol 1927). Whether the skin was cleaned first or wanned with 
a hot water bottle seems to have varied over time (Nicol 1927, Shute 1952). From the seventh 
day after infection four-hourly temperature charts were started, and temperatures were recorded 
every 15-30 minutes during attacks to ensure that the height of the peak was correctly 
measured (Nicol 1927, Shute 1952). Cold sponging was begun when the temperature reached 
105°F (Nicol 1927). Thin blood films, stained with Leishman’s stain, were examined daily; 
thick blood films were rarely used (Nicol 1927, Shute 1952). Parasite counts were recorded per 
25 high power fields, or per 100 high per fields at the beginning and end of the infection.
Nicol (1927) reports that these fields were those seen using a 1/12-inch oil immersion lens and 
a No. 2 eye-piece. The later account (Shute 1952) describes the same lens and a No. 6 
eyepiece. In this system there are about 400 red blood cells per field (Shute 1952).
The attacks were often modified in their early stages by a single or a few doses of treatment. 
Quinine 0.3g was generally given in the early years, and thiobismol 0.2g from the 1940s 
(Nicol 1927, Whelen & Shute 1943, Shute 1952). After thiobismol the fever was interrupted 
for a day, and after quinine for about 14 days (Nicol 1927, Shute 1952). A primary objective 
of the modifying treatment was to convert quotidian fever into lenian fever which was felt to 
be less exhausting for the patients (Whelan & Shute 1943). Treatment was given if the parasite 
count exceeded 1-2 per high power field (Nicol 1927, Shute 1952), or if the patient 
experienced "persistent vomiting, fainting or collapse during the paroxysm, cyanosis, seizures, 
undue restlessness ..albuminuria [or] jaundice”. In reaching a decision on whether to give 
treatment, and whether it should be full or modifying, account was taken of "the clinical 
condition of the patient, the duration of the paroxysms, the maximum temperature reached" and 
whether the fever was quotidian or tertian (Nicol 1927). Since the therapeutic effect of malaria 
was thought to be due to the fever and to the "parasite and its toxins in the patient’s system" 
the fever was allowed to run for ten or more paroxysms if possible (James 1931).
Measures o f dose (exposure variables)
For each episode the number o f mosquitos that bit the patient and the date or dates on which 
they were used were recorded. Using information from the dissections carried out on the batch, 
the proportion of infected mosquitos in the batch was found. An estimate of the number of
3.3 Malaria - Analysis of malaria therapy records. P vivax. Methods. Mosquito-induced 122
infected mosquitos was calculated by multiplying this proportion by the number of mosquitos 
used. The true number of infected mosquitos is unknown. The number of mosquitos dissected 
in each batch varied from eight to over one hundred, and the batch used was not always 
recorded, particularly in the earlier years.
The date on which sporozoites were first found in the glands of the mosquitos of the batch was 
recorded. The subsequent storage time until the mosquitos were used was calculated, since it 
had previously been shown to influence the attack rate (Boyd & Kitchen 1937b). In the 
analysis this storage time has been used as an exposure variable (as a possible maricer of the 
number of viable sporozoites) and as a possible confounder when looking for associations with 
mosquito number.
Since prepatent period (the time from inoculation to patent parasitaemia) and incubation period 
(the time from inoculation to symptoms, taken as fever in this data set) are inversely related to 
dose, they can be considered as indirect measures of dose. This relationship is explored further 
in the data. For reasons addressed in the discussion, they may provide a better marker of the 
number of viable sporozoites received - the true dose - than the other measures of exposure.
Outcome variables
From the first set of books the outcome variables available were the peak parasitaemia reached 
(pretreatment and overall), the type of fever (which was also given in the second set) and the 
treatments given. The second set of books recorded the peak temperature reached and the 
number of peaks over 103°F. When modifying treatment was given, the number of peaks 
before and after the treatment were sometimes recorded separately. The type of fever was 
usually recorded as "quotidian" or "tertian" or "irregular" or combinations of these. Again it 
was sometimes possible to distinguish the pretreatment fever type. The second set of books 
contained some descriptions of the symptoms suffered. These became less common over time. 
Although anaemia was sometimes noted, other patients were referred to as looking pale or very 
pale, and it is difficult to know how to interpret this. Only two subjective descriptions from the 
books have been used: "very ill" and "spontaneous recovery". Deaths were recorded in both 
sets of books, but the cause of death was often unclear. For this analysis, death occurring 
during the parasitaemia was used as the outcome variable.
Both sets of books recorded relapses, although the record appeared to be more complete for 
later relapses in the second set Since the books did not appear to have a strict definition of a
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relapse to distinguish it from a continuation of the same infection, a relapse was defined for 
the purposes of this study as a recurrence occurring after 20 days without patent parasitaemia. 
The time of loss to follow up was found in the second set of books and was taken as the date 
of transfer away from the Horton hospital. (The notes often continued after this point if the 
patient was in one of the adjoining hospitals, but this period was not included so that the care 
during follow up and the chance of relapses being noticed were more comparable).
The outcome variables used are listed below. Those relating to parasitaemia and fever were 
recorded both pretreatment and overall.
1) Relating to the parasitaemia:
- The peak parasitaemia, as parasites per 100 high power fields (hpf)
2) Relating to fever:
- The peak temperature reached.
- The number of peaks over 103°F.
- The number of peaks over 103°F as a proportion of the number of days between patent 
parasitacmia and treatment.
- Whether the fever included an episode or episodes of tertian fever.
- Whether the fever was predominantly tertian (ie pure tertian or tertian with some irregular
fever).
3) Based on descriptions in the second books:
- Whether the patient was said to be very ill during the malaria
- Whether the patient was noted to have made a spontaneous recovery. The published reports 
suggest that this referred to the fever and not the parasitaemia (Nicol 1927, Shute 1952).
- Whether death occurred during the period of patent parasitaemia
4) Relating to treatment:
- The time to any drug treatment
- The time to the full course of drug treatment
- The time to the first dose of modifying treatment
- Whether modifying treatment was given
- The number of doses of modifying treatment given
- Whether full treatment was given
- Whether parasitaemia ended before any treatment was given
- Whether parasitaemia ended before full treatment was given
5) Relating to relapses:
Whether any relapses occurred, and the number and timing of relapses
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Confounding variables
Some of ihe variables already mentioned were considered as possible confoundcrs in certain 
situations. For example, the use of modifying treatment might confound associations involving 
the timing of full treatment. Other possible confounders for which information was available 
were:
- The date of the malaria therapy
- The sex of the patient
- The age of the patient
- Whether the patient had had any previous malaria therapy and whether it was with the same 
strain, same type or different type o f malaria, the timing of this therapy and its outcome.
- Whether the patient had ever had natural malaria
- Whether the patient had ever travelled to a malarial area. If the patient was stated to have 
been in the army or at sea but no areas of travel were listed this was recorded as unknown.
Trophozoite-induced malaria
Trophozoite-induced infection was used throughout the period of malaria therapy and more 
frequently in the later years. Whole blood was used and the usual practice was intramuscular 
injection just below the scapula (Shute 1952). The blood was generally taken a few hours after 
an attack of malaria and, for patients infected by subinoculation at Horton, it appears that the 
blood was used immediately and was therefore not heparinised (Shute 1952). Blood grouping 
of the patients was not mentioned and no blood groups are recorded in the books or notes, so 
it seems unlikely that the blood was cross-matched. The care and subsequent treatment of the 
patient was the same as for mosquito-induced malaria.
Measures o f dose (exposure variables)
The first set of books recorded the date of injection, the amount of blood used, the name of the 
patient from whom the blood was taken, and sometimes the route of infection. From the 
donor’s record, the parasite count on that day was determined (in terms of parasites per 100 
high power fields). The "dose" is calculated as the volume multiplied by the parasite count.
This assumes that the parasite count was recorded at approximately the same time as the blood 
was taken. Since one high power field contains about 400 red blood cells (Shute 1952) and 
assuming a red blood cell count of 4 x 10*/ml, to estimate the actual number of parasites 
inoculated the calculated dose is multiplied by 100000. As in mosquito-induced infection, the 
prepatent period and incubation period have been used as alternative, indirect measures of
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dose.
Outcome and confounding variables
The same outcome and confounding variables were used as for mosquito-induced infection 
except that storage time did not need to be considered, and true relapses do not occur.
Sporozoite-induced malaria
James et al (1927) described a technique for extracting sporozoites. The salivary glands of one 
or more infected mosquitos were dissected out into human serum or Locke’s fluid. After 
confirming the presence of sporozoites a cover-glass was put over the glands and pressed with 
a needle to squeeze out the sporozoites so that they floated freely. The serum and sporozoites 
were drawn up together in a syringe for injection. Ten years later Shute (1937) described how 
the technique had been improved to determine the number of sporozoites injected. In this 
publication the medium was Locke’s fluid and the importance of sterility of the fluid and glass 
slide and cover-slip were stressed. A drop of blood was added to the fluid to aid focusing and 
help enumeration of the sporozoites. The mixture of fluid and sporozoites was made up to lml 
and a count was made on 0.01ml after staining. Shute noted that sporozoites did not live for 
more than a few hours in Locke’s fluid.
Measures o f dose (exposure variables)
For many of the patients an estimate of the number of sporozoites injected was available. As 
for mosquito-induced malaria the storage time of the mosquitos was calculated. In a few 
records in the first set of books comments about the state or treatment of the mosquitos or 
sporozoites were recorded which might have affected the outcome. These were:
Comment No. affected
Mosquitos over frozen 5
Sporozoites from oocysts or stomach 7
Sporozoites from coelomic fluid on legs 2
Sporozoites looked shrunken or dead 3
Sporozoites incubated at 37°C 4
Sporozoites centrifuged 1
Sporozoites stored 48/72 hours 2
Of these 24 inoculations only 7 (29.2%) were successful, compared with 105/114 (92.1%) of 
the others, and those that were successful had longer prepatent periods, suggesting a low 
number of viable sporozoites. This group of patients has been excluded in analyses using
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sporozoite number or storage time, but have been retained in analyses using the prepatent or 
incubation period. The route of injection was recorded for 60 patients overall, of whom all but 
one received intravenous inoculations.
Outcome and confounding variables
The same outcome and confounding variables were used as for mosquito-induced infection. 
Strategy of analysis
The analysis was carried out using Epi Info and Egret The continuous variables were inspected 
to see if they were noimally distributed or better described by another distribution such as the 
log normal distribution. For some of the analyses the continuous variables were divided into 
groups. This was done after consideration of several factors: the statistical advantage of having 
approximately equal numbers in each group; any natural discontinuities in the distribution 
(such as in the date of therapy); and the general character o f the distribution. To allow logistic 
regression to be used some of the outcome variables were redefined as binary variables using a 
cut off point. For example, a high temperature was defined as a fever of at least 106°F.
With the exposure variables grouped, the outcome variables were compared to them by 
tabulation of discrete variables and by comparing the means (or geometric means) for the 
continuous variables. Exposure and outcome of continuous variables were compared using 
scatter plots and linear regression. Confoundcrs were allowed for using multiple linear 
regression, stratification and logistic regression, as appropriate. In logistic regression, where 
several forms of a confounding variable were available (such as year as a linear variable, or 
grouped in three o r  four groups and then treated as a linear or factored variable) the form 
which explained most of the deviance of the model, allowing for differences in degrees of 
freedom, was used.
Since many statistical tests were done for each data set due to the variety of measures of both 
dose and outcome, the finding of some small p  values is to be expected due solely to chance, 
and results have to  be interpreted very conservatively.
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RESULTS
(The main results are summarised in Table 3.3.20.)
Mosquito-induced malaria
Information was available on 1298 episodes of mosquito-induced infection. Positive 
parasitaemias were recorded in 1164 and this was associated with fever in all but 7. (These 7 
had all had previous malaria therapy with the Madagascar strain and had parasitaemias of 
1/100 hpf or less.) Two episodes gave rise to latent infections with prepatent periods of 147 
and 252 days. Other prepatent periods were between 7 and 26 days except for one of 46 days. 
Full details were not available for all episodes so the numbers given in the descriptions of the 
variables do not always add up to the full total. In particular, information from the second set 
of books was only available for 1156, and on batch for 1146.
In the first few years the patients were exclusively female, males only being included from the 
end of 1931. Overall, 46% were female. The mean age was 44 years, with a minimum of 7 
and a maximum of 75. Most of the patients were treated between 1936 and 1950, with a range 
from 1925 to 1959. Previous malaria therapy had been given to 224, and in 166 it was with 
the same species of malaria. Thirty-four were known to have had previous malaria (unknown 
in 213) and 129 were known to have travelled to malarial areas (unknown in 446). Excluding 
those who had had previous malaria therapy with P vivax or were known to have had natural 
malaria leaves 1093 of whom 1039 (95%) developed fever and parasitaemia. Only those who 
developed fever and parasitaemia are considered further.
Records were only included in the subsequent analysis if information was available on the 
batch from which the mosquitos came and on the percent of infection of the batch. Records 
were excluded if the prepatent period was equal to or more then 30 days, if the patient had had 
previous malaria therapy with the same species of malaria (including unsuccessful 
inoculations), or had had previous natural malaria. Episodes with longer prepatent periods were 
excluded because of the rules made when entering the data to define success and failure in 
episodes where mosquitos were given on several occasions some time apart.
The initial analysis was carried out on a subset of the data relating to successful infections in 
which mosquitos had been used on only one day. (Five additional patients who received further
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doses after the malaria had started were included in the analysis of the association of dose with 
prepatent and incubation periods.) There were 540 records which fulfilled the above criteria.
For all of the analyses except those relating dose to prepatent and incubation periods, only 
episodes where no drugs were given within the first five days of patent parasitaemia were 
included (leaving 289 records). The cut-off at five days was chosen following comparison of 
the time to treatment with various other outcome measures in the whole data set for mosquito- 
induced malaria. Those treated within the first five days had mean peak parasitaemias which 
were lower than those treated later, whereas by 6 or 7 days the mean was in the same range as 
the rest. The mean peak fever reached full height within the first five days.
The number of mosquitos, the number of infected mosquitos, the prepatent period, the 
incubation period and the storage time were all approximately log normally distributed. The 
peak parasitaemia approximated to a log normal distribution, and the peak temperature, the 
number of peaks over 103°F, and the number of peaks over 103°F as a proportion of time to 
treatment approximated to normal distributions. Age and the year of therapy were also 
approximately normally distributed.
The relationship between mosquito number, storage time and prepatent and incubation periods 
The prepatent period was inversely related to the number of infected mosquitos used. Linear 
regression, using the logs of both variables, gave: 
r = -0.26 (-0.33 to -0.18) 
b = -0.0739 (-0.0975 to -0.0504) 
a = 1.175, F = 37.88
Using multiple linear regression, this association was found to be independent of storage time, 
the year of the inoculation, and the age and sex of the patient. Longer storage times were 
associated with longer prepatent periods. Prepatent periods were shorter in the more recent 
years, and increased slightly with age and were slightly longer in men than in women.
The relationships with incubation period were similar: an inverse correlation with the number 
of infected mosquitos which was independent o f the relationships with the other variables; 
positive correlations with storage time and age, a negative correlation with the year of the 
inoculation, and longer incubation periods in men.
Using the total number of mosquitos the results were very similar for both prepatent period and 
incubation period. Both sets of results are summarised in Tables 3.3.1 and 3.3.2 , and the
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relationships with the number of infected mosquitos and the storage time are shown in Figures
3.3.7 and 3.3.8.
Results relating to parasitaemia
Peak parasitaemia before treatment and overall was compared with the various measures of 
exposure by examining scatter plots, comparing the geometric means of the peak parasitaemia 
for different groups of the exposure variables, and using linear regression.
There were no associations found between the peak parasitaemia, before treatment or overall, 
and any of the measures of dose - number of mosquitos, number of infected mosquitos, storage 
time, prepatent period or incubation period (Figure 3.3.9, Tables 3.3.3-4). No relationships 
were found after allowing for possible confounders (age, sex, year of inoculation, and time to 
treatment). A high parasitaemia was defined as a parasitaemia of at least 100 per 100 high 
power fields. This occurred in 60 (20.8%) patients before treatment and 71 (24.6%) overall. 
High parasitaemia was not associated with any of the exposure variables, before or after 
allowing for confounding. The peak parasitaemia before treatment and overall was higher in 
the earlier years and older age groups. There were no differences between the sexes.
Results relating to temperature
The peak temperatures reached before treatment and overall were compared with the exposure 
variables by calculating the means for the grouped exposure variables and by using linear 
regression. No relationships were found between the peak temperature pretreatment or overall 
and the number of mosquitos, the number of infected mosquitos, the prepatent period or the 
incubation period (Figure 3.3.10, Tables 3.3.3-4). No relationships were found after allowing 
for the possible confounders. The storage time was negatively associated with the pretreatment 
peak but not with the overall peak. This association persisted after adjusting for confounders in 
a multiple regression model. A high temperature was defined as a peak of at least 106°F. This 
was reached by 28/257 (10.9%) of patients overall and 12/160 (7.5%) before treatment. No 
associations were found with high temperatures occurring overall or pretreatment and any of 
the exposure variables. The peak temperature overall and before treatment was higher in the 
earlier years and in women, though this was mainly due to confounding by year. There were 
no associations with age.
The number of peaks over 103°F before treatment and overall were both highly dependent on 
the time elapsing before treatment. Time to treatment was allowed for by including a term in
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the multiple regression model, by considering results in separate strata, and by creating new 
variables by dividing the number of peaks by the number of days elapsing before treatment.
No associations were found between the number of peaks pretreatment or overall and the 
number of mosquitos, the number of infected mosquitos, the prepatent period or the incubation 
period, with or without adjusting for the time to treatment or other possible confounders 
(Figures 3.3.11-12, Tables 3.3.3-4). The storage time was negatively associated with the 
number of peaks occurring pretreatment, but not after adjusting for the time to treatment. The 
year of the inoculation was negatively associated with the total number of peaks, both before 
and after adjusting for the time to treatment, but not with the number of pretreatment peaks.
The age and sex of the patients were not associated with the number of peaks.
Episodes of tertian fever occurred in 155/283 (54.8%) of the patients overall, and in 41/226 
(18.1%) before treatment. Predominantly tertian fever (after the initial phase) occurred in 
13/226 (5.8%) before treatment, and in 15/283 (5.3%) overall. Neither the number of 
mosquitos nor the number of infected mosquitos were related to the occurrence of tertian fever 
at any time (Table 3.3.5). The prepatent period and the incubation period were not associated 
with the occurrence of tertian fever overall, but were strongly associated with the occurrence of 
tertian fever before treatment, and also with the occurrence of predominantly tertian fever 
before treatment and, for prepatent period, with predominantly tertian fever overall (Table 
3.3.6). Longer storage times were associated with a higher proportion of patients with tertian 
fever overall, but not with the other measurements of tertian fever.
Confounding was looked for by stratification and in logistic regression models, using the 
grouped exposure variables as linear variables. The year of the inoculation was positively 
associated with the occurrence of tertian fever but not with the other measures, and the time to 
treatment was associated with tertian fever before treatment, but not with the others. There 
were no associations between sex or age and tertian fever. There was no evidence of 
confounding in any of the associations with tertian fever, but there was an interaction with sex: 
the strong positive association of prepatent period and incubation period with tertian fever 
occurring before treatment was seen only among the men. However, for predominantly tertian 
fever occurring before treatment, the associations with prepatent and incubation periods were 
seen among the women and not the men.
Results based on descriptions
Nineteen patients were described as "very ill" and 43 were said to have made a spontaneous
3.3 Malaria - Analysis ol malaria therapy records. P vivax. Results. Mosquito-induced 131
recovery. There were only six deaths during malaria in this data set and they showed no 
particular association with any of the exposure variables. A higher proportion of patients were 
described as "very ill" during the earlier period, when descriptions tended to be fuller. 
Spontaneous recovery was noted almost entirely during the middle period of 193S to 1945.
One patient was noted to have been very ill and to have had a spontaneous recovery.
There were no associations between the number of mosquitos or the number of infected 
mosquitos and whether the patient was described as being very ill or having had a spontaneous 
recovery (Table 3.3.5). Spontaneous recovery was strongly positively associated with prepatent 
period and incubation period (Table 3.3.6). There was no evidence of confounding, but the 
trend was only seen for men, among whom 30 o f the 43 cases of spontaneous recovery 
occurred. Longer storage times were also associated with an increased proportion undergoing 
spontaneous recovery, and again this was only apparent among men. The association with 
prcpalent period was unaltered by adjusting for storage time.
Prepatent period, and to a lesser extent incubation period, were weakly, positively associated 
with being very ill (Table 3.3.6).
Results relating to treatment
Full treatment was given in all but 6 patients. There were no associations between receiving 
full treatment and any of the measures of dose. Modifying treatment was given in 186 
episodes. To measure spontaneous recovery in relation to the parasitacmia, rather than in terms 
of fever as used in the descriptions in the notes, two new variables were defined, one which 
was positive if the parasitacmia ended before full treatment was given, and the other which 
was positive if the parasitaemia ended before any treatment. Twenty-six cases fulfilled the first 
criterion and nine the second. They were related to the description of spontaneous recovery as 
shown in Table 3.3.7.
There were no associations between the proportion of people for whom the parasitaemia ended 
before full treatment was started and any of the exposure variables. The parasitaemia was more 
likely to end before any treatment following longer prepatent and incubation periods. There 
was no relationship between this outcome and the other exposure variables (Tables 3.3.S-6).
Modifying treatment was given to a higher proportion of people in more recent years and they 
tended to get more doses and to get treated earlier. People with longer prepatent or incubation
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periods were less likely to receive modifying treatment. People who were bitten by more 
mosquitos or, to a lesser extent, more infected mosquitos were more likely to receive 
modifying treatment, and these trends were more marked after allowing for the year of 
inoculation (Table 3.3.8). There was no relationship between the storage time and any 
measures of treatment.
The number of doses of modifying treatment showed a similar relationship with the exposure 
variables (Table 3.3.S.6 & 8). Receiving at least two doses was negatively associated with 
prepatent and incubation period (though this relationship was less strong after adjusting for 
year) and positively associated with the number of mosquitos and the number of infected 
mosquitos (and these trends were more marked after adjusting for year). Receiving at least 
three doses was not associated with incubation period, nor prepatent period after adjusting for 
year. It was positively related to the number of mosquitos, and to the total number of infected 
mosquitos after adjusting for year.
There were no associations between the timing of treatment - full, modifying or any - and the 
prepatent period, incubation period, number of infected mosquitos used or the storage time, at 
least after allowing for the year of inoculation. Patients bitten by mote mosquitos tended to 
receive earlier treatment, but this depended on whether modifying treatment was given, and 
there was no trend in the timing of modifying treatment (Figure 3.3.13).
Results relating to relapses
The length of follow up was very variable and often brief, so assessment of relapse rates has to 
take this into account. (The wards appear to have been cleared at the outbreak of the war by 
transferring patients to other hospitals, and during the war, although malaria therapy continued, 
patients were often admitted only for the duration of the therapy.) Kaplan-Meier survival 
estimates were plotted and Cox's proportional hazard ratios were calculated. No associations 
with any of the exposure variables were noted but the confidence intervals were very wide.
Results when mosquitos were used on more than one day
Episodes where mosquitos were given over 2 or 3 days were analysed separately. The same 
exclusion criteria were used as before. The mosquito number was taken as the total number 
used over the three days, and the prepatent and incubation periods were calculated from the 
first day when mosquitos were used. 231 episodes fulfilled the criteria, o f which 110 did not 
receive treatment within the first five days of patent parasitaemia.
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Mosquito number was inversely related to prepatent and incubation periods. Longer storage 
times led to longer prepatent and incubation periods, and these two effects were independent.
The pretreatment peak parasitacmia was weakly correlated with the number of infected 
mosquitos and the total number of mosquitos used, but these associations were reduced after 
adjusting for year of treatment. There were no associations between prepatent period, 
incubation period or storage time and pretreatment peak parasitaemia. The results using overall 
peak parasitacmia were similar, although the effects of adjusting for year were less marked.
No associations were found between any of the measures of dose and the peak temperature 
before treatment or overall, either in the crude analysis or after adjusting for confounders.
There were no associations between measures of dose and the number of paroxysms over 
103°F pretreatment. Using the overall number of paroxysms, after adjusting for time to 
treatment, weak negative correlations with prepatent and incubation period were found, but 
these were lost after adjusting for the other confounders.
Episodes of tertian fever overall were more common in those bitten by fewer mosquitos and 
fewer infected mosquitos and in those where the mosquitos were stored for longer than 20 days 
(13/18 of those stored S 20 days compared with 38/90 stored < 20 days). After adjusting for 
confounders the associations with the number of mosquitos were lost but the association with 
storage time became more marked. There were no associations with prepatent or incubation 
period.
Episodes of tertian fever p re treatment were also more common when mosquitos were stored for 
more than 20 days (7/14 compared with 10/75). This persisted after adjusting for confounders. 
No associations were found between this outcome and any of the other measures of dose in 
either crude or multivariate analyses. Pure tertian fever p re treatment and overall was only 
found in three patients.
Spontaneous recovery was recorded for 13 patients and "very ill" for 7. There were no 
associations between either o f  these outcomes and any of the measures of dose in crude or 
multivariate analyses. Only two of the patients died.
Modifying treatment was given to S3 patients. Those bitten by more mosquitos or more 
infected mosquitos were less likely to receive modifying treatment. After adjusting for year
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these relationships persisted, but using the number of infected mosquitos the association was of 
borderline significance. Modifying treatment was given less frequently after longer prepatent 
and incubation periods and was not associated with storage time (Table 3.3.9).
There were no associations between the measures of dose and the number of doses of 
modifying treatment. Nor were there any associations with the time elapsing before treatment 
which were independent o f whether modifying treatment was given. In five patients the 
parasitaemia ended before full treatment was given. This outcome was not significantly 
associated with any of the measures of dose. In only two did the parasitaemia end before any 
treatment was given.
Results obtained by using both mosquito number and storage time to determine dose groups 
Patients bitten on only one day, selected using the criteria given above, were divided into 
groups according to the estimated number of infected mosquitos used and the storage times. 
Those bitten by at least five mosquitos which had been stored for less than 10 days were 
regarded as the high dose group (n = 91). Those bitten by less than five mosquitos which had 
been stored for at least 10 days were regarded as the low dose group (n = 49). The rest of the 
patients were excluded from this analysis.
Patients in the high dose group had much shorter prepatent and incubation periods (Table 
3.3.10). For continuous outcome variables the means (or geometric means) were compared 
between the two groups. For binary outcome variables results were assessed using two-by-two 
tables. Few differences were found in the distributions of the outcome variables between the 
two groups. The pretreatment peak temperature was slightly higher in the high dose group. The 
proportion of days pretreatment with peaks over 103°F was also higher in the high dose group, 
but there was no difference in the crude number of peaks before treatment.
Trophozoite-induced malaria
Information was available for 241 trophozoite inoculations of which 217 had further 
information available from the second set of books or notes. 230 (95.4%) of the inoculations 
led to parasitaemia and fever. (One additional patient had low grade parasitaemia alone and 
died of bronchopneumonia within 4 days. He was not included in the analysis.)
For the analysis the same exclusion criteria were applied as previously: patients were excluded
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if they had had previous malaria therapy with the same type of malaria (including unsuccessful 
inoculations), if they were known to have had natural malaria in the past, if the prepatent 
period was equal to or greater than 30 days, or if inoculations were given on more than one 
day. This left 166 patients. For all of the analyses except the comparison of dose with 
prcpatcni and incubation periods, patients receiving treatment within the first five days were 
excluded (leaving 107 patients).
Dose, prepatent period and incubation period were all approximately log-normally distributed. 
The route of infection was only known for 47 patients, of whom 44 received intramuscular 
injections and 3 intravenous. The distribution of incubation and prepatent period curves overall 
and for those receiving known intramuscular injection were very similar (Fig 3.3.14), 
suggesting that the vast majority of the injections were intramuscular. After excluding patients 
who were treated in the first five days, none were known to have had intravenous inoculations. 
The mean estimated number of parasites inoculated was approximately 3 x 10’ and the median
1.7 x 10’, with a range of 2.5 x 10’ to 48 x 107. Almost all of the patients were inoculated 
between 1936 and 1950. Their mean age was 45 (range 7 to 69), and 65% were male.
The relationship between dose and prepatent and incubation periods 
Log prepatent period was weakly, negatively correlated with log dose: 
r  = -0.24 (95% Cl -0.38 to -0.08) 
b  = - 0.063 (-0.10 to -0.022) 
a = 1.4!, F = 9.01
A similar relationship was seen for incubation period, and neither was altered by adjusting for 
sex, age or year (Table 3.3.11).
Results relating to paras itaemia
There were no associations between any of the measures of exposure and the peak paras itaemia 
reached before treatment or overall (Tables 3.3.12-13). The peak parasitaemia increased slightly 
with age but was not associated with sex or year. No associations with the exposure variables 
were found after adjusting for the possible confounders.
Results relating to temperature
The peak temperature overall, but not the peak temperature occurring before treatment, 
decreased with increasing dose (Table 3.3.12). This persisted after adjusting for the possible 
confounders. No associations were found between peak temperature and either prepatent period
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or incubation period, before or after adjusting for confounders (Table 3.3.13). The peak 
temperature before treatment and overall decreased with age, but did not vary with sex or the 
year of treatment.
The number of paroxysms over 103°F before treatment and overall were strongly related to the 
time between patent parasitaemia and treatment. The overall number o f paroxysms decreased 
with age. There were no associations between any of the exposure measures and the number of 
paroxysms before treatment or overall, with or without adjusting for the time to treatment or 
other possible confounders (Tables 3.3.12-13).
No associations were found between dose and the occurrence of episodes of tertian fever or 
predominantly tertian fever overall or before treatment (Table 3.3.14). Episodes of tertian fever 
both before treatment and overall were more frequent following longer prepatent and 
incubation periods (Table 3.3.IS). The trend overall was not affected by adjusting for the 
confounders, but was seen predominantly before 1940. The trend before treatment was more 
marked after adjusting for the time to treatment, and was seen mainly among the women.
Predominantly tertian fever before treatment and overall also occurred more frequently 
following longer prepatent and incubation periods. After adjusting for year the association 
between prepatent period and predominantly tertian fever overall remained of borderline 
significance, but the other associations were lost. Predominantly tertian fever was recorded 
more commonly before 1940. There were no associations between age or sex and any of the 
measures of tertian fever.
Results based on descriptions
Only three deaths during patent parasitaemia were recorded. Seven patients were recorded as 
being "very ill". There were no associations between being very ill and any of the measures of 
exposure, before or alter adjusting for possible confounders.
Thirteen patients were reported to have made a spontaneous recovery. This was more likely to 
occur following smaller doses, but was not associated with prepatent or incubation period 
(Tables 3.3.14-15). Spontaneous recovery was more likely at younger ages and in earlier years; 
the results were not changed by adjusting for possible confounders.
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Results relating to treatment
Full treatment was given to all but 3 patients. Modifying treatment was given to 47 (43.9%), at 
least two doses to 12 and at least three to 7. More modifying treatment was given in the later 
years and slightly more at older ages. The parasitaemia ended before full treatment was given 
in 13 cases and before any treatment in 6. No associations were found between these outcomes 
and any of the measures of exposure (Tables 3.3.14-15).
The time between patent parasitaemia and the first treatment was not associated with any of 
the exposure variables. The time between patent parasitaemia and starting full treatment 
decreased with increasing dose and increased with increasing incubation periods. It increased 
slightly with increasing prepatent period but this was less marked. These associations persisted 
after adjusting for possible confounders, including whether modifying treatment was givea
Whether modifying treatment was given, the number of doses of modifying treatment, and the 
time between patent parasitaemia and the first modifying treatment were not associated with 
prcpatent or incubation period. Modifying treatment was not associated with dose in the crude 
analysis, but, after adjusting for year, modifying treatment was found to be given slightly less 
often following higher doses. The timing of modifying treatment was not associated with dose 
(Tables 3.3.14-15).
Sporozoite-induced malaria
138 patients received sporozoite inoculations of whom 111 developed fever and parasitaemia. 
One further patient, who had had previous malaria therapy with P vivax had parasitaemia 
alone. After excluding the 24 patients where the treatment of the mosquitos or sporozoites was 
unusual (see methods) and patients who had had previous malaria therapy with vivax or natural 
malaria, the attack rate was 92.7% (89/96). For the analysis the same exclusion criteria were 
applied as previously: patients were excluded if they had had previous malaria therapy with 
vivax malaria, previous natural malaria, prepatent periods over 29 days, or inoculations on 
more than one day. This left only 83 successful inoculations of which the batch of mosquitos 
was known in 73, and information from the second set of books was available for 79. An 
estimate of the number of sporozoites was available for 60 of the successful inoculations. As 
before, for all of the analyses except the comparison of dose with prepatent and incubation 
periods, patients receiving treatment within the first five days o f patent parasitaemia were 
excluded, leaving 57 patients among whom an estimate of sporozoite numbers was available
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for 42.
The estimated number of sporozoites was approximately log normally distributed with a 
median of about 40,000, minimum of 800 and maximum of 440,000. One value of 8,400,000 
was excluded in the calculations involving number because the sporozoites came from oocysts 
(see methods). The prépaient and incubation periods approximated to normal distributions with 
means of 12.7 and 10.8 respectively. Two thirds o f  the patients were male and half were over 
45. The date of the inoculation ranged from 1927 to  1959 with the majority being carried out 
in the two years 1937 and 1945.
The relationship between dose, storage time and prepatent and incubation periods 
The prcpatent period was inversely related to the number of sporozoites and was longer with 
longer storage times (Figure 3.3.15). The incubation period showed little relationship with the 
number of sporozoites but was also longer with longer storage times (Figure 3.3.16).
Results relating to measures o f severity
The relationships between sporozoite numbers and prepatent period with various outcome 
measures are shown in Tables 3.3.16-19. No strong associations between the exposure and 
outcome variables were found. The occurrence of tertian fever before treatment increased with 
longer prepatent periods, but this association was reduced after adjusting for confounding by 
age. The time to first drug treatment increased with prepatent period, but no associations with 
other measures of treatment were found. The numbers are small in many of the groups and no 
results were possible for some of the outcome variables used in the other types of malaria 
therapy (see tables).
DISCUSSION
For all three types of induced malaria the inverse relationship between dose and prepatent and 
incubation periods was confirmed. With some notable exceptions, there was little correlation 
between the estimates of dose and any of the measures of severity (Table 3.3.20). Some of the 
problems relating to the measurements of dose were discussed in the review of the literature. In 
mosquito-induced infections the number of mosquitos used is likely to correlate only poorly 
with the number o f  viable sporozoites injected: not all the mosquitos in a batch are always 
infected; the storage time appears to affect the viability of the sporozoites; and the number of
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sporozoites transmitted by individual mosquitos is highly variable. While it was possible to 
adjust for the probable proportion of infected mosquitos and for the storage time, the number 
of sporozoites transmitted remains unknown.
For sporozoite-induced malaria the handling of the sporozoites may have affected their 
viability. The attack rate was similar in non-immunes bitten by mosquitos and those given 
direct sporozoite injection. However, since the number of sporozoites given directly was very 
much larger than that likely to have come from bites, a large fall off in viability could occur 
without affecting the attack rate. The geometric mean prepatent period for sporozoite-induced 
infection was less than a day shorter than that for mosquito-induced infection (12.02 days, 95% 
Cl 11.48-12.60, compared to 12.88, 95% Cl 12.66-13.11, Figure 3.3.17). This suggests a 
considerable loss in numbers of viable sporozoites. It is likely that the proportion of 
sporozoites remaining viable varied from inoculation to inoculation. It has been suggested that 
the counts were not very accurate, perhaps because sporozoites tend to adhere to glass vessels 
(Roy 1938). The storage of the mosquitos before the glands were dissected could also affect 
the outcome but could be adjusted for.
For trophozoite-induced infections it was assumed that the blood was taken from the donor 
patient at the same time as the parasite count was done. It is known that when compatible 
blood is used the incubation period is much shorter than when incompatible blood is used 
(Polayes & Derby 1934), presumably indicating that a higher proportion of the injected 
trophozoites survive. However in this data set no blood groups were available. For both 
sporozoite- and trophozoite-induced infections all the injections were assumed to be by the 
same route (intravenous and intramuscular respectively); it was known from the larger data set 
that the majority but not all of the infections were by these routes.
Since the measures of dose correlated as expected with the prepatent and incubation periods 
they must also correlate to some extent with the "true" dose. It is possible that the prepatent 
and incubation period provide better measures of the true dose because they can be expected to 
vary with some of the factors which affect the true dose but are unrecorded, such as the 
number of sporozoites in mosquito-induced infection, the viability o f the sporozoites or the 
blood compatibility. Another advantage of using the prepatent or incubation period rather than 
the number of mosquitos in mosquito-induced malaria is that it was possible to split the 
exposure variable into more groups reflecting a wider range of dosages: in the selected data set 
of those bitten on one day, around 80% of patients were bitten by between 5 and 15
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mosquitos, or between 3 and 10 infected mosquitos. The disadvantage is that variations in 
patient immunity and susceptibility could confound any relationship between dose and severity 
which uses the prepatent or incubation period as measures of dose since they would be 
expected to influence both the prepatent or incubation period and the outcome. In this data set 
none of the patients were immune (patients who were known to have had previous natural 
malaria or previous malaria therapy with the same species were excluded). This lack of 
immunity is reflected in attack rates of over 90%. Variations in susceptibility due to age and 
sex were controlled for in the analysis. All the patients were white, and most were English.
"Low" and "high" dose groups were defined on the basis of both numbers and storage time as 
a response to the marked effect o f  both of these variables on prepatent and incubation period, 
and as an attempt to create two distinct groups for comparison. However, as the mosquito 
numbers used for most patients came from a small range, the groups could not be very distinct. 
Thus 34/48 in the low dose group were bitten by at least 3 mosquitos, and 45/90 in the high 
dose group were bitten by fewer than 7. The failure to find associations between these groups 
and most of the outcome measures may reflect this concentration of the distribution. But, since 
these dose groups were highly predictive of prepatent and incubation period, it does also 
suggest that the correlations found with outcome measures when using prepatent and 
incubation period in the other parts of the analysis could be due to confounding by 
susceptibility.
In this data set the recorded prepatent period is longer than the incubation period, which is the 
reverse of the usual pattern. The restriction of examinations to thin films will have delayed the 
first recording of patent parasitaemia, and the use of regular temperature charts before the first 
clinical signs of fever will have led to earlier recordings of the fever. The prepatent and 
incubation periods were highly correlated, with only rarely more than three days between them 
for any individual patient and the results obtained using them as measures of dose were very 
similar.
For both mosquito-induced and trophozoite-induced infections, longer prepatent and incubation 
periods were associated with increased proportions of patients showing tertian fever. (For 
sporozoite-induced infections the numbers were very small.) No associations between the more 
direct measures of dose and tertian fever were found in this study.
Apan from the occurrence of tertian fever, the only outcome measures which were strongly
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correlated with exposure variables were those which relied on a clinical assessment of the 
patient: spontaneous recovery and whether modifying treatment was given. In mosquito- 
induced malaria where mosquitos were used on only one day, the proportion of patients 
undergoing spontaneous recovery approximately doubled with every two day increase in 
prcpatent period (Table 3.3.6). Modifying treatment was more likely to be given to patients 
bitten by more mosquitos and with longer prepatent or incubation periods (Table 3.3.8). 
However, the results found when mosquitos were given on two or three days contradicted the 
results relating modifying treatment to mosquito number a surprising negative correlation 
between mosquito number and giving modifiying treatment was found, although the results 
with prepatent and incubation period confirmed the previous findings.
According to the published reports (Nicol 1927, Shute 1952), spontaneous recovery was used 
to describe recovery from fever, often despite persistent parasitacmia. What it meant in practice 
is difficult to assess. Half (22/43) of the patients said to have had a spontaneous recovery in 
mosquito-induced malaria received modifying treatment (compared to two thirds, 140/215, of 
the others). And two patients who were not recorded as having had a spontaneous recovery 
stopped having patent parasitaemia before any treatment was given (Table 3.3.7).
The published reports suggest that modifying treatment was given in response to severe 
symptoms or high parasitaemias (Nicol 1927, Shute 1952). If this were always the case it 
would make an excellent overall marker for severe disease but it was often given so early that 
there must be some doubt. The analyses excluded patients treated within the first five days of 
patent parasitacmia; within the resulting subset of patients the use of modifying treatment may 
have been more closely related to severity of disease. For occasional patients the reason for 
giving the modifying treatment was stated. The reason usually related to symptoms but was 
occasionally administrative (such as for Christmas). Modifying treatment was also given when 
the patient's overall state of health was poor, which depended on the neurosyphilis as well as 
the malaria. Modifying treatment was given much more frequently and earlier in more recent 
years. This was adjusted for in the analysis, but suggests that the criteria for giving treatment 
changed.
A few other correlations between exposure and outcome variables were found which 
approached or reached statistical significance at the 5% level. Some were in the direction to 
support a dose-severity relationship, others not. They are all mentioned in the results sections. 
Their true significance is dubious. Any analysis which makes as many comparisons as this can
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be expected to produce some "significant" results by chance and none of these results were 
consistent between related outcome variables or related exposure variables. Surprising 
correlations were found between prepatent and incubation periods and the outcome "very ill" 
(Table 3.3.6), but it was difficult to tell when entering the data whether the comments referred 
to the underlying state of the patient from their neurosyphilis or to the malarial illness.
The lack of association of the exposure variables with the more objective outcome measures - 
parasitacmia, peak fever, the number of peaks over 103°F, and death - is striking. So how 
accurate are these outcomes?
As mentioned in the methods, there is a discrepancy in the two published accounts regarding 
the eye-piece used on the microscope when parasite counts were done, suggesting a change in 
practice some time between 1927 and 1952 (Nicol 1927, Shute 1952). When this change 
occurred is unknown, but, if it represents a real change and not a typographical error, it means 
that the recorded number of parasites per high power field will have had a different 
interpretation in terms of percentage parasitaemia at one time from another. For the analysis a 
consistent interpretation has been assumed. Controlling for the year of the malaria therapy will 
not have effectively adjusted for the change, as year was treated as a linear variable or in a few 
groups, and the change occurred once at an unknown time. Even without these problems the 
parasite counts recorded may not accurately represent the true peak counts as they were done 
only once a day. Neither the actual timing of the blood sample, nor the timing in relation to 
symptoms were recorded.
The temperature was recorded to the nearest 0.2°F. Nicol (1927) noted that attempts were 
made to lower the fever when it reached 105°F so some potentially higher fevers would have 
been lowered. There is an excess of peak fevers of 104.8°F (Fig 3.3.18) suggesting that peaks 
may have been under-recorded to avoid cold sponging. The measurement of the number of 
peaks over 103°F avoids these problems but is obviously very dependent on the time elapsing 
before treatment. In the analysis this was controlled for in several ways; in none of the data 
sets was the number of peaks over 103°F before treatment or overall, associated with the direct 
measures of dose, nor with the other exposure variables after allowing for confounding.
Death, while an objective endpoint in itself, was not necessarily due to the malaria. Indeed a 
few patients, who were not included in the analysis, died during the incubation period, 
indicating the severity of the neurosyphilis and its associated complications in some cases.
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Given the inaccuracies of measurement of both dose and outcome which lead to non­
differential misclassification and therefore underestimation of any associations, it is difficult to 
reach conclusions of no effect from the data. However, the finding of the expected associations 
between dose and prepatent and incubation periods is evidence that the measures of dose 
reflect the true dose to some degree. Only the relationships between prepatent and incubation 
period and the occurrence of tertian fever and the use of modifying treatment were found in 
more than one of the data sets, and no consistent relationships were found with the more direct 
measures of dose.
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PLASMODIUM OVALE 
BACKGROUND
Although other types of malaria were used at the Horton, the experience with other individual 
strains transmitted by a single route was very limited. Considering only those patients with 
successful inoculations who had not had previous malaria therapy with the same strain and 
who were not treated within the first 5 days, only one other strain was given to sufficient 
patients to make analysis worthwhile. (Other strains were given to a maximum of SO patients.) 
This was a strain of P ovale first isolated from a patient who had come from the Gold Coast in 
1939, referred to as West African strain V. It was maintained mostly by person-to-person 
transmission until 1943 when it became mixed with vivax (presumably due to an accidental 
infection or a relapse).
METHODS
Data was only entered on patients who had had no previous malaria therapy with P ovale, 
received blood inoculation on one day only, had had no prophylactic treatment, and were not 
treated within the first five days of patent parasitaemia. The calculation of dose and the 
methods of analysis were the same as for the Madagascar strain of vivax malaria.
RESULTS
81 patients fulfilled the above criteria. One was excluded as he had had previous natural 
malaria. The route of injection was not recorded on any of the patients. Dose, prepatent period, 
incubation period, and peak parasitaemia approximated to log normal distributions, the other 
continuous variables approximated to normal distributions. All analyses were repeated adjusting 
for possible confounders: age, sex, year of treatment, and time of treatment.
No relationship was demonstrated between dose and either prepatent or incubation period.
In contrast to vivax malaria, the majority of patients treated with this strain appeared to be
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recovering before any treatment was given. 57/80 had spontaneous recovery recorded in their 
notes, and 45/77 had parasilacmias of S 1 per 100 high power fields when treatment was 
begun. Modifying treatment was only given to one patient, and there were no differences in the 
outcome measures (peak parasilaemia, peak fever, type of fever or number of peaks over 
103°F) whether they were recorded pretreatment or overall.
No associations were found between the peak parasitaemia and the calculated dose, the 
prepatent period or the incubation period. The peak temperature was not associated with the 
dose or the incubation period, but there was a weak inverse relationship between peak 
temperature and log prepatent period: r = -0.22 (95%CI -0.42 to 0.00), b = -1.55 (95% Cl 
-3.08 to -0.022). The regression coefficient was closer to zero after adjusting for time lapsing 
before treatment, but the association persisted in those who had a spontaneous recovery.
There was an inverse correlation between both prepatent period and incubation period and the 
number of peaks over 103°F. The correlations were less strong but were still seen after 
adjusting for time to treatment. In both cases the relationships were marked among those who 
had made a spontaneous recovery (Table 3.3.21). Using log prepatent period the following 
relationships were found: overall, r = -0.34 (95% Cl -0.52 to -0.13), b = -9.50 (95% Cl -15.23 
to -3.68); in those with spontaneous recovery, r = -0.44 (95% Cl -0.63 to -0.20), b = -12.82 
(95% Cl -19.80 to -5.83). No relationships were found between the number of peaks over 
103°F and the dose.
Tertian fever occurred in over half of the patients, and predominantly tertian fever in a quarter. 
No relationships were found between the dose or the prepatent or incubation period and the 
occurrence of episodes of tertian fever, or predominantly tertian fever.
Neither the dose nor the prepatent or incubation period predicted whether spontaneous recovery 
was recorded. Full treatment was given to all but 8 patients. It appeared that it was given early 
either because the clinical infection was nearly over anyway or because the infection was 
severe. The time to treatment overall was therefore not a useful measure o f severity. For those 
who were recorded as making a spontaneous recovery, the time to treatment or to the end of 
the patent parasitaemia if earlier was calculated as a measure of the duration of infection. The 
duration was not related to dose, but was inversely correlated with both prepatent period and 
incubation period (Table 3.3.22). Using log prepatent period and log duration: r = -0.38 (95% 
Cl -0.58 to -0.13), b = -0.58 (95% Cl -0.95 to -0.20).
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DISCUSSION
In this data set no associations were found between dose and the prcpaicnt period or incubation 
period or any of the outcome variables. The lack of association with prepatent and incubation 
period is surprising in light of the results with vivax malaria. I have found no information 
relating dose and outcome in induced ovale malaria in the published literature. As with vivax 
malaria, it was assumed in calculating the dose that the parasite count recorded for the donor 
on the day blood was taken was the same as that in the donated blood, although the two 
procedures may not have occurred at the same time. The date of the change in microscope eye­
pieces is unknown, but it would be unlucky for it to have occurred in the four year period 
covered by this data. These problems and the lack of information on blood groups (meaning 
that some inoculations are compatible and others incompatible) may provide the explanation 
for this lack of association.
Similar relationships with the outcome measures were found using prepatent and incubation 
periods. The incubation periods were missing in some cases, usually because an early fever 
was attributed to blood inoculation. The prepatent periods are probably more reliable. No 
relationship was found between prepatent period and spontaneous recovery. The recording of 
spontaneous recovery in the notes is taken to refer to the fever, but from the parasitaemia 
records it appeared that almost all patients were beginning to recover before treatment was 
staned, so it may not distinguish mild infections as well as for vivax.
Tertian fever before treatment was commoner than in vivax malaria, and in contrast to vivax 
malaria, it was not associated with prepatent period.
Because the majority of infections recovered spontaneously, both the number of peaks over 
103°F and the duration of infection were useful measures of severity. Both were inversely 
associated with prepatent period.
Overall, in this data set, there is some evidence of a relationship between prepatent period and 
severity, but none of a relationship between dose and prepatent period or dose and severity.
The lack of association with dose may be due to the problems in measuring dose in un- 
crossmatched patients, but the associations found with prepatent period may be due to 
confounding by susceptibility.
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PUiSM ODW M  FALCIPARUM : AMERICAN DATA 
MATERIALS AND METHODS
For falciparum malaria few patients were treated with any one strain at Horton, and most were 
treated early. A small malaria therapy data set was available from the USA, from neurosyphilis 
patients treated in mental hospitals in South Carolina and Georgia in the 1940s and SOs. No 
infoimation was available on the handling or storage of the mosquitos. The practice of the 
South Carolina Hospital was to "allow up to 20 paroxysms if we think the patient can 
withstand this amount of treatment. As many as 25 or 30 paroxysms are allowed for Negroes." 
(Mayne & Young 1941).
The records of 108 patients were available. As far as was known, none of the patients had had 
previous malaria, although a few had had failed attempts to induce malaria using other strains. 
Three different strains of falciparum malaria were used: El Limon (EL) McLendon (ML) and 
Santee Cooper (SC). Personal details were usually lacking: all 41 of the patients for whom 
details were recorded were male and Black.
The data was analysed to look for an association between dose and severity of outcome.
Almost all of the infections in the data set were induced using mosquito bites: the few where 
direct inoculation of sporozoites was used were excluded from the analysis.
The measures of dose available were the number of mosquitos used and the sum of the number 
of pluses, based on a scoring system from the number of sporozoites seen in the gland of 
dissected mosquitos. Summing the pluses in this way makes the assumption that being bitten 
by one mosquito scoring 4+ (equivalent to  >1000 sporozoites in the glands) is equivalent to 
being bitten by four mosquitos scoring 1-«- each (equivalent to 1 - 10 sporozoites in the glands). 
Since there is no basis for this assumption (the number of sporozoites ejected correlates poorly 
with the gland load, as discussed above), since the number of pluses was not recorded on all 
the patients, and since, in practice, the number of pluses was highly correlated with the number 
of mosquitos, this measure was not used. The prepatent period was also investigated as a 
possible indirect measure of infective dose, as before.
Several measures of severity were available. The most general was whether the patient received
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any treatment during the acute phases of the infection (taken as the first twenty days of patent 
parasilacmia). Daily counts and any fevers over 101°F during this twenty day period were 
recorded, together with the total duration of the parasitacmia and whether any later treatment 
was given. Patients were treated with cool sponging and cold drinks during febrile episodes 
(Mayne & Young 1941).
RESULTS
Eight patients were excluded because they had received direct inoculations of sporozoites 
instead of or as well as mosquito bites. Fifty patients received EL, 39 ML and 10 SC. There 
were differences between the strains in the number of mosquitos used, the prepatent period and 
the outcome, so any analyses have to take account of this (see Table 3.3.23)
The number of mosquitos used, the prepatent periods, the parasite counts and the duration of 
parasitaemia all approximated more closely to lognormal distributions than normal 
distributions, so log values were used for the analyses. There was a weak inverse correlation 
between the number of mosquitos used and the prepatent period but this was lost after 
adjusting for strain.
Four different types of mosquito were used: An quadrimaculatus, An albimanus. An crucians 
and An freeborni. The first two were used for the vast majority o f the infections, mainly An 
albimanus for strain EL and An quadrimaculatus for strain ML. Since it is possible that 
different mosquito species transmit different numbers of sporozoites, when the strains were 
considered separately using mosquito number as the measure of dose, analyses were repeated 
using just the predominant mosquito species (Table 3.3.24). This had little effect on the results.
No information describing the criteria for giving treatment was available. It is possible that, as 
in the Horton data, treatment given very early was unlikely to be a response to the severity of 
the malaria. Comparing the mean pretreatment peak parasitaemias in those treated on different 
days, it appeared that those treated after about day five had peak parasitaemias as high as the 
rest whereas those treated earlier had lower peaks. Those treated within the first five days were 
therefore excluded from the analysis, leaving 82 patients.
There was no relationship between the number of mosquitos used and whether early treatment
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(ic treatment between 6 and 20 days) was given. Of those bitten by fewer than 15 mosquitos, 
19/35 (54.3%) received early treatment, compared with 26/46 (56.5%) of those bitten by 15 or 
more. The relative risk was unchanged after stratifiealion by strain. There were no associations 
found between number of mosquitos and early treatment when strains EL and ML were 
analysed separately.
To assess whether the prepatent period was related to the need for early treatment the strains 
were only considered separately because of the different ranges of prcpatcnt period. For EL, 
19/26 (73.1%) of those with prepatent periods of 10 days or less received early treatment, 
compared with 19/24 (79.2%) of those with longer prepatent periods.
For ML, 11/15 (73.3%) of those with prepatent periods of 12 days or less received early 
treatment, compared w ith only 7/19 (36.8%) of those with longer prepatent periods. The 
relative risk of early treatment following a short prepatent period was 1.99 (95% Cl 1.03 - 
3.86). There was no association using ML or EL between prepatent period and the time of the 
early treatment.
For strains EL and ML the two measures of dose - mosquito number and prepatent period - 
were compared with pretreatment peak parasitaemia, pretreatment peak fever, and the 
proportion of days occurring pretreatment, or in the first 20 days, on which fevers of over 
103°F and over 101°F occurred. No associations were found with any of these measures using 
cither strain, cither in the crude analysis or after controlling for early treatment and/or the 
timing of the treatment.
The remaining analyses considered only those who had received no early treatment. They were 
carried out for the three strains together, controlling for strain by multiple regression, and for 
strains EL and ML separately.
No associations were found between the number of mosquitos employed and the peak 
parasitaemia, the geometric mean parasitaemia over the first twenty days, the peak fever 
reached, the number o f  days of fever over 101°F or over 103°F in the first twenty days, or the 
total duration of parasitaemia (in those who received either no treatment or treatment 
commencing at least 30 days after the last parasitaemia).
No associations were found between the prepatent period and any of the measures of severity
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except the number of days of fever over 103°F, and this was lost after controlling for strain.
DISCUSSION
The data set is small but provides rare information on patients with untreated falciparum 
malaria biuen by a known number of mosquitos.
No associations were found between the number of mosquitos employed and any of the 
measures of severity. However there were several problems with the data, in particular the lack 
of personal information about the patients and the lack of information about the storage time of 
the mosquitos, which may affect the infectivity of the sporozoites.
As the transmission of sporozoites by mosquitos is very variable, the prepatent period was 
considered as an alternative measure of dose. For the ML strain, patients with shorter prepatent 
periods were more likely to receive treatment within the first 20 days. This was not found for 
the EL strain, and no other evidence of an association between dose and severity was found.
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Table 3.3.1. P vivax. The relationship between the number of mosquitos used and the prepatent
period
Prepatent period
n Geometric 95% Cl
mean
Number of < 5 151 13.55 13.16-13.96
infected
mosquitos 5 - 9 270 13.06 12.76-13.37
10 -1 9 86 12.59 11.44-13.15
2 20 31 10.76 10.15-11.42
Total number of < 5 49 13.77 12.97-14.63
mosquitos used 5 - 9 251 13.18 12.88-13.49
10 - 19 189 13.00 12.64-13.37
2 20 49 11.25 10.65-11.87
Table 3.3.2. P  vivax. The relationship between the number of mosquitos used and the
incubation period
Incubation period
n Geometric 95% Cl
mean
Number of < 5 151 12.19 11.81-12.58
infected
mosquitos 5 - 9 269 11.48 11.20-11.77
10 -1 9 86 11.17 10.69-11.67
2 20 31 9.64 8.93-10.40
Total number of < 5 49 12.30 11.59-13.06
mosquitos used 5 - 9 251 11.75 11.47-12.04
10 - 19 188 11.38 11.03-11.73
2 20 49 10.05 9.48-10.65
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Table 3.33 . P vivax. The relationship between the estimated number of infected mosquitos 
used and various measures of severity (unadjusted for any confounders).
Number of infected mosquitos
< 5 5 - 9 ¿10
Peak n 70 167 50
parasitaemia 
(per 100 high Geometric 57.02 60.81 57.02
power fields) mean
95% Cl 48.37-67.21 55.42-66.73 47.90-67.87
Pretreatment n 70 167 50
peak
parasitaemia Geometric 47.42 53.95 50.82
(per 100 high mean
power fields) 95% Cl 39.82-56.48 48.36-60.18 40.41-63.90
Peak n 61 153 41
temperature (°F)
Mean 105.1 105.2 105.2
95% Cl 105.0-105.3 105.1-105.3 105.0-105.3
Pretreatment n 33 98 27
peak
temperature (°F) Mean 105.0 105.1 105.1
95% Cl 104.9-105.2 105.0-105.2 104.8-105.3
No. of peaks 
over103°F
n 61
10.31
153
10.52
41
9.49Mean
95% Cl 9.65-10.97 10.07-10.96 8.51-10.46
No. of peaks 
over 103°F 
pretreatment
n
Mean
33
9.52
95
8.76
27
8.19
95% Cl 8.34-10.69 8.10-9.42 6.78-9.59
No. of peaks 
over103°F
n 61 153 41
1.04divided by time Mean 1.08 1.14
to treatment 95% Cl 0.96-1.20 1.07-1.21 0.92-1.15
No. of peaks 
over 103°F
n 33 95 27
pretreatment 
divided by time
Mean 0.70 0.81 0.80
to treatment 95% Cl 0.62-0.79 0.76-0.86 0.70-0.90
Days between n 69 166 49
patent
parasitaemia Mean 10.90 10.11 9.71
and treatment 95% Cl 9.77-12.03 9.47-10.75 8.68-10.75
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Table 3.3.4. P vivax. The relationship between prepatent period and various measures of 
severity in mosquito-induced infections (unadjusted for any confounders).
Prepatent period (days)
< 12 12-13 14-15 16-17 2  18
Peak n 56 92 74 43 23
parasitaetnia 
(per 100 high 
power fields)
Geometric
mean
55.6 56.8 64.3 63.1 53.2
95% Cl 46.4-66.6 49.5-65.1 56.3-73.3 52.3-76.1 40.8-69.4
Pretreatment n 56 92 74 43 23
peak
parasitaemia Geometric 45.6 50.2 54.8 60.4 46.8
(per 100 high mean
power fields) 95% Cl 36.2-57.5 43.2-58.5 46.3-65.0 50.2-72.7 35.5-61.6
Peak n 50 79 68 38 21
temperature (°F)
Mean 105.2 105.2 105.1 105.0 105.2
95% Cl 105.0-105.3 105.1-105.3 105.0-105.3 104.9-105.2 104.9-105.5
Pretreatment n 17 49 46 29 18
peak
temperature (°F) Mean 105.0 105.2 105.0 105.0
105.2
95% Cl 104.7-105.2 105.0-105.3 104.9-105.2 104.8-105.2 104.9-105.5
No. of peaks n 50 79 68 38 21
over103°F
Mean 10.14 10.46 10.78 9.84 9.38
95% Cl 9.29-10.99 9.88-11.03 10.08-11.48 9.06-10.62 8.00-10.76
No. of peaks n 17 47 45 29 18
over103°F 
pretreatment Mean 9.24 8.81 9.02 8.55 8.17
95% Cl 7.43-11.04 7.80-9.82 8.01-10.03 7.36-9.74 6.48-9.86
No. of peaks n 50 79 68 38 21
over 103°F 
divided by time Mean 1.09 1.18 1.14 1.04 0.93
to treatment 95% Cl 0.98-1.20 1.07-1.29 1.04-1.24 0.89-1.18 0.72-1.14
No. of peaks n 17 47 45 29 18
over 103°F 
pretreatment Mean 0.77 0.81 0.82 0.77 0.71
divided by time 
to treatment 95% Cl 0.65-0.89 0.73-0.87 0.75-0.88 0.67-0.88 0.57-0.84
Days between n 56 91 74 43 21
patent
parasitaemia Mean 9.82 9.85 10.14 11.14 11.43
and treatment 95% Cl 8.89-10.76 8.96-10.73 9.26-11.01 9.58-12.70 9.04-13.81
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Table 3.3.5. P vivax. The relationship between the estimated number of infected mosquitos 
used and various measures of severity (unadjusted for any confoundcrs).
Number of infected mosquitos x 2
linear
Episodes of tertian n
< 5 
36/68
5 - 9
87/166
2 10 
30/47
fever
% 52.9 52.4 63.8
Episodes of tertian n 11/54 22/137 7/33
fever pretreatment
% 20.4 16.1 21.2
Predominantly n 2/68 8/166 5/47
tertian fever
% 2.9 4.8 10.6
Predominantly n 1/54 8/137 4/33
tertian fever 
pretreatment % 1.9 5.8 12.1
Spontaneous n 8/61 24/154 9/41
recovery
% 13.1 15.6 22.0
'Very ill’ n 6/61 10/154 3/41
% 9.8 6.5 7.3
Death during n 1/70 4/167 1/50
parasitaemia
% 1.4 2.4 2.0
End parasitaemia n 4/69 17/166 5/49
before full 
treatment % 5.8 10.2 10.2
End parasitaemia n 2/70 5/166 2/50
before any 
treatment % 2.9 3.0 4.0
Modifying n 40/70 111/167 33/50
treatment given
% 57.1 66.5 66.0
At least 2 doses n 15/70 32/167 16/50
modifying 
treatment given % 21.4 19.2 32.0
At least 3 doses of n 6/70 6/167 7/50
modifying 
treatment given % 8.6 3.6 14.0
Full treatment n 68/69 164/167 48/50
given
% 98.6 98.2 96.0
P
0.1
0.09
0.3
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Table 3.3.6. P vivax. The relationship between prepatent period and various measures of 
severity in mosquito-induced infections (unadjusted for any confounders).
Prépaient period
Episodes ol tertian 
lever
Episodes of tertian 
lever pretreatment
Predominantly 
tertian lever
Predominantly 
tertian fever 
pretreatment
Spontaneous
recovery
"Very ill"
Death during 
parasitaemia
End parasitaemia 
before full 
treatment
End parasitaemia 
before any 
treatment
Modifying 
treatment given
At least 2 doses 
modifying 
treatment given
At least 3 doses of 
modifying 
treatment given
Full treatment 
given
< 12
n 34/55
% 61.8
n 4/39
% 10.3
n 1/55
% 1.8
n 0/39
% 0.0
n 2/50
% 4.0
n 0/50
% 0.0
n 2/56
% 3.6
n 6/56
% 10.7
n 0/56
% 0.0
n 43/56
% 76.8
n 19/56
% 33.9
n 8/56
% 14.3
n 55/56
% 98.2
12-13 14-15
45/88 38/73
51.1 52.1
7/72 10/61
9.7 16.4
4/88 3/73
4.5 4.1
2/72 3/61
2.8 4.9
7/78 11/68
9.0 16.2
5/78 6/68
6.4 8.8
1/92 1/74
1.1 1.4
8/92 2/71
8.7 2.8
1/92 0/73
1.1 0.0
63/92 48/74
68.5 64.9
24/92 13/74
26.1 17.6
7/92 3/74
7.6 4.1
91/92 72/73
98.9 98.6
16- 17 à  18
23/43 15/23
53.5 65.2
11/34 9/19
32.4 47.4
2/43 5/23
4.7 21.7
4/34 3/19
11.8 21.1
12/39 11/22
30.8 50.0
5/39 2/22
12.8 9.1
2/43 0/23
4.7 0.0
5/43 5/23
11.6 21.7
4/43 4/23
9.3 17.4
23/43 9/23
53.5 39.1
6/43 1/23
14.0 4.3
1/43 0/23
2.3 0.0
42/43 21/23
97.7 91.3
X2 P
linear 
trend
16.5 < 0.001
6.3 0.01
11.5 <0.001
28.5 < 0.001
4.3 0.04
16.1 <0.001
11.9 <0.001
11.6 < 0.001
7.7 0.005
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Table 3.3.7. P vivax. The relationship between parasitacmia, treatment and "spontaneous 
recovery” in mosquito-induced malaria.
End parasitaemia before full treatment
No Yes All
'Spontaneous No 197 15 (7.1%) 212
recovery” Yes 35 8 (18.6%) 43
All 232 23 255
End parasitaemia before any treatment
No Yes All
'Spontaneous No 211 3 (1.4%) 214
recovery” Yes 37 6 (14.0%) 43
All 248 9 257
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Table 3.3.8. P vivax. Relationships between four measures of dose and the modifying 
treatment given in infections induced by mosquito bites on only one day.
Outcome: modifying treatment given 
Unadjusted Adjusted for year of treatment
OR (95% Cl) LRS
Number of
infected
mosquitos
1.29
(0.92-1.80)
2.3
Total number 
of mosquitos
1.41
(0.99-2.00)
3.8
Prepatent
period
0.69
(0.56-0.85)
12.3
Incubation
period
0.76
(0.63-0.93)
7.2
P OR (95% Cl) LRS P
0.1 1.57 5.8 0.02
(1.08-2.28)
0.05 1.50
(1.03-2.19)
4.7 0.03
<0.001 0.77
(0.62-0.96)
5.5 0.02
0.007 0.77
(0.62-0.94)
6.5 0.01
Outcome: at least two doses of modifying treatment given 
Unadjusted Adjusted for year of treatment
OR (95% Cl) LRS P OR (95% Cl) LRS P
Number of
infected
mosquitos
1.55
(1.08-2.22)
5.6 0.02 2.08
(1.34-3.24)
11.7 <0.001
Total number 
of mosquitos
1.99
(1.35-2.93)
12.6 <0.001 2.48
(1.55-3.96)
16.0 <0.001
Pre patent 
period
0.63
(0.48-0.82)
12.8 <0.001 0.74
(0.55-0.98)
4.6 0.03
Incubation
period
0.73
(0.57-0.93)
7.1 0.008 0.74
(0.57-0.96)
5.6 0.02
The results were calculated using logistic regression with each exposure variable being categorised in five groups 
and treated as a linear variable. The groups used were, for number of infected mosquitos and total number of 
mosquitos: < 5, 5-9,10-19, 20-39, ^  40; for prepatent period (in days): < 12,12-13, H -1 5 ,16-17, 2: 18; for 
incubation period (in days): < 10,10-11,12-13,14-15,2 16. Each line of the table refers to a separate model.
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Table 3.3.9. P  vivax. Relationships between four measures of dose and whether modifying 
treatment was given in infections induced by mosquito bites over 2 or 3 days.
Outcome: modifying treatment given
Unadjusted
OR (95% Cl) LRS
Number of
infected
mosquitos
0.49
(0.28-0.86)
6.7
Total number 
of mosquitos
0.54
(0.32-0.92)
5.5
Prepatent
period
0.53
(0.32-0.88)
6.4
Incubation
period
0.66
(0.41-1.06)
3.1
Adjusted for year of treatment
P OR (95% Cl) LRS P
0.01 0.55
(0.30-1.00)
4.1 0.04
0.02 0.49
(0.27-0.89)
5.9 0.02
0.01 0.57
(0.33-0.97)
4.4 0.04
0.08 0.60
(0.36-0.99)
4.1 0.04
The results were calculated using logistic regression with each exposure variable being 
categorised in three groups and treated as a linear variable. The groups used were, lor number 
of infected mosquitos: < 9, 9-13, 2 13; for total number of mosquitos: <11,  11-15, 15; for
prepatent period (in days): s 12, 13-14, > 14; for incubation period (in days): s 10. 11-12, > 12. 
Each line of the table refers to a separate model.
Table 3.3.10. P  vivax. The relationship between dose groups (see text) and prepatent and 
incubation periods.
Prepatent period (days) Incubation period (days)
n Geometric
mean
95% Cl n Geometric
mean
95% Cl
Dose Low 49 14.3 13.5-15.2 49 12.7 12.0-13.3
group High 90 11.9 11.5-12.3 90 10.5 10.1-10.9
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Table 3.3.11. P vivox. The relationship between dose and prepatent and incubation periods for 
trophozoite-induced infections.
Prepatent period
n Geometric 95% Cl
mean
No. of parasites £ 80 42 10.23 9.13-11.47
inoculated 
x 100000 > 80 - 5 160 34 9.35 8.57-10.21
> 1 6 0 -5  320 38 8.55 7.60-9.62
> 320 - 5  640 26 9.40 8.30-10.64
> 640 14 8.07 6.82-9.56
Incubation period
N Geometric 95% Cl
mean
No. of parasites 5  80 42 8.39 7.32-9.63
inoculated 
x 100000 > 80 - 5 160 33 7.46 6.87-8.11
> 1 6 0 -5  320 37 7.19 6.32-8.19
>320 - 5  640 24 8.02 6.70-9.60
> 640 13 6.19 5.25-7.31
3.3 Malaria - Analysis ot malaria therapy records. Tables 160
Table 3.3.12. P vivax. The relationship between the estimated number of parasites inoculated 
and and various measures of severity in tropho/.oitc-induccd infections (unadjusted for any 
confounders).
Estimated number of parasites x 10(000
£80 >80 -£160 >160 - £320 >320 £640 >640
Peak n 26 21 25 19 10
parasitaemia 
(per 100 high Geometric 56.8 69.7 55.5 71.3 64.6
power fields) mean
95% Cl 41.6-77.4 46.9-103.5 38.9-79.1 45.6111.5 22.1-188.7
Pretreatment n 26 21 25 19 10
peak
parasitaemia Geometric 51.5 68.9 53.5 63.1 64.6
(per 100 high mean
power fields) 95% Cl 37.0-71.7 46.4-102.2 37.3-76.6 40.4-98.5 22.1-188.7
Peak n 24 20 23 18 6
temperature (°F)
Mean 105.1 104.9 105.1 104.7 104.8
95% Cl 105.0-105.3 104.6-105.2 104.9-105.3 104.5-104.9 103.9-105.6
Pre treatment n 16 14 18 12 5
peak
temperature (°F) Mean 105.0 104.8 105.0 104.7 104.8
95% Cl 104.8-105.2 104.4-105.3 104.7-105.3 104.5-105.0 103.7-105.8
No. of peaks 
over103°F
n 24 20
9.75
23
10.35
18 6
8.50Mean 9.38 9.28
95% Cl 8.39-10.37 8.08-11.42 9.25-11.45 7.55-11.01 4.94-12.06
No. of peaks 
over103°F
n 16 14 18 12 5
pretreatment Mean 8.56 9.57 9.89 9.17 8.00
95% Cl 7.00-10.12 7.21-11.93 8.43-11.35 6.94-11.40 3.61-12.39
No. of peaks n 24 20 23 18 6
over 103°F 
divided by time Mean 0.93 0.90 0.93 0.99 0.92
to treatment 95% Cl 0.79-1.07 0.71-1.09 0.74-1.12 0.74-1.12 0.78-1.21
No. of peaks 
over 103°F
n 16 14 18 12 5
pretreatment 
divided by time
Mean 0.77 0.75 0.73 0.83 0.86
to treatment 95% Cl 0.64-0.90 0.57-0.93 0.61-0.85 0.661.01 0.19-153
Days between n 26 20 25 19 10
patent
parasitaemia Mean 11.50 11.45 12.72 9.95 11.00
and treatment 95% Cl 9.39-13.61 9.76-13.14 10.66-14.78 7.79-12.11 9.25-12.75
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Table 3.3.13. P vivax. The relationship between prepatent period and various measures of 
severity in trophozoite-induced infections (unadjusted for any confoundcrs).
Prepatent period (days)
< B 8-9 10-11 12-13 «► 14
Peak n 9 30 30 20 18
parasi taemia 
(per 100 high 
power fields)
Geometric
mean
87.9 52.1 75.3 45.2 73.6
95% Cl 47.3-163.3 37.5-72.4 55.6-102.1 28.6-71.3 54.0-100.3
Pretreatment n 9 30 30 20 18
peak
parasitaemia Geometric 83.6 52.1 69.2 40.7 69.8
(per 100 high mean
power fields) 95% Cl 44.2-158.0 37.5-72.4 49.9-96.0 23.8-69.6 50.2-97.2
Peak n 8 26 28 18 17
temperature (°F)
Mean 105.0 105.0 104.9 105.1 105.0
95% Cl 104.3-105.6 104.7-105.3 104.7-105.1 104.9-105.4 104.7-105.2
Pretreatment n 7 21 20 11 9
peak
temperature (°F) Mean 105.0 104.9 104.8 105.0 105.0
95% Cl 104.2-105.8 104.6-105.3 104.6-105.0 104.7-105.3 104.6-105.4
No. of peaks n 8 26 28 18 17
over103°F
Mean 9.50 9.85 9.86 10.06 8.35
95% Cl 6.74-12.26 8.51-11.19 8.77-10.95 8.60-11.52 7.06-9.64
No. of peaks n 7 21 20 11 9
over103°F 
pretreatment Mean 9.43 9.48 8.95 9.18 8.11
95% Cl 6.15-12.71 7.87-11.08 7.34-10.56 6.78-11.58 6.25-9.97
No. of peaks n 8 26 28 18 17
over103°F 
divided by time Mean 0.73 0.90 1.05 1.06 0.81
to treatment 95% Cl 0.46-0.99 0.73-1.00 0.91-1.19 0.83-1.29 0.62-1.00
No. of peaks n 7 21 20 11 9
over103°F 
pretreatment Mean 0.67 0.80 0.85 0.82 0.61
divided by time 
to treatment 95% Cl 0.40-0.95 0.65-0.94 0.75-0.95 0.55-1.08 0.51-0.71
Days between n 9 29 30 20 18
patent
parasitaemia Mean 13.44 12.59 10.03 10.55 11.67
and treatment 95% Cl 8.75-18.14 10.99-14.18 8.48-11.50 8.69-12.41 9.22-14.11
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Table 3.3.14. P vivax. The relationship between estimated number of parasites inoculated and 
various measures of severity in trophozoite-induced infections (unadjusted for any 
confoundcrs).
Estimated number ot parasites x 100000 p
linear
<80 >80 -<160 >160 - ¿320 >320 <640 >640 trend
Episodes of tertian n 16/26 9/21 11/25 10/19 3/10
(ever
% 61.5 42.9 44.0 52.6 30.0 1.5 0.2
Episodes of tertian n 7/19 5/17 5/23 4/13 1/5
fever pretreatment
% 36.8 29.4 21.7 30.8 20.0
Predominantly n 5/26 3/21 3/25 1/19 1/10
tertian fever
% 19.2 14.3 12.0 5.3 10.0 1.3 0.2
Predominantly n 4/19 3/17 2/23 1/13 0/5
tertian fever 
pretreatment % 21.1 17.6 8.7 7.7 0.0 2.2 0.1
Spontaneous n 7/24 2/20 2/23 2/18 0/6
recovery
% 29.2 10.0 8.7 11.1 0.0 3.7 0.05
■Very ill' n 2/24 1/20 1/23 1/18 2/6
% 8.3 5.0 4.3 5.6 33.3
End parasitaemia n 4/26 2/20 1/25 0/19 3/10
before full 
treatment % 15.4 10.0 4.0 0.0 30.0
End parasitaemia n 1/26 2/21 1/25 0/19 2/10
before any 
treatment % 3.8 9.5 4.0 0.0 20.0
Modifying n 13/26 9/21 10/25 10/19 1/10
treatment given
% 50.0 42.9 40.0 52.6 10.0 1.5 0.2
At least 2 doses n 4/26 0/21 2126 3/19 0/10
modifying 
treatment given % 15.4 0.0 8.0 15.8 0.0
At least 3 doses of n 2/26 0/21 2/25 2/19 0/10
modifying 
treatment given % 7.7 0.0 8.0 10.5 0.0
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Table 3.3.15. P  vivax. The relationship between prepatent period and various measures of 
severity in trophozoite-induced infections (unadjusted for any confoundcrs).
Prepatent period x ’  P
linear
< 8 8 - 9 10-11 12-13 ¿14 trend
Episodes of tertian n 5« 9/30 13/30 11/20 15/18
fever
% 55.6 30.0 43.3 55.0 83.3 7.7 0.005
Episodes ol tertian n 2/6 5/24 3/23 5/16 9/13
fever pretreatment
% 33.3 20.8 13.0 31.3 69.2 5.7 0.02
Predominantly n 1/9 3/30 1/30 3/20 6/18
tertian fever
% 11.1 10.0 3.3 15.0 33.3 4.0 0.05
Predominantly n 1/6 2/24 1/23 2/16 5/13
tertian fever 
pretreatment % 16.7 8.3 4.3 12.5 38.5 3.3 0.07
Spontaneous n 0/8 7/26 2/28 2/18 3/17
recovery
% 0.0 26.9 7.1 11.1 17.6
’ Very ill" n 1/8 3/26 1/28 0/18 2/17
% 12.5 11.5 3.6 0.0 11.8
End parasitaemia n 0/9 6/29 1/30 2/20 4/18
before full 
treatment % 0.0 20.7 3.3 10.0 22.2
End parasitaemia n 0/9 4/30 0/30 1/20 1/18
before any 
treatment % 0.0 13.3 0.0 5.0 5.6
Modifying n 3/9 12/30 13/30 10/20 9/18
treatment given
% 33.3 40.0 43.3 50.0 50.0 0.9 0.3
At least 2 doses n 2ft 0/30 4/30 2/20 4/18
modifying 
treatment given % 22.2 0.0 13.3 10.0 22.2
At least 3 doses of n 1/9 0/30 3/30 2/20 1/18
modifying 
treatment given % 11.1 0.0 10.0 10.0 5.6
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Table 3.3.16. P vivax. The relationship between the number of sporozoites injected and various 
measures of severity (unadjusted for any confounders).
Number of sporozoites x 1000
<30 3 0 -< 1 2 0 £ 120
Peak n 13 15 11
parasitaemia 
(per 100 high Geometric 55.7 53.3 59.3
power fields) mean
95% Cl 35.4-87.7 38.3-74.3 40.6-86.6
Pretreatment n 13 15 11
peak
parasitaemia Geometric 50.1 47.1 56.9
(per 100 high mean
power fields) 95% Cl 26.2-96.0 31.4-70.6 40.2-80.6
Peak n 13 15 9
temperature (°F)
Mean 104.9 105.2 105.3
95% Cl 104.7-105.1 104.8-105.6 104.9-105.8
Pre treatment n 6 8 4
peak
temperature (°F) Mean 104.7 105.2 105.2
95% Cl 104.6-104.8 104.7-105.8 104.4-105.9
No. of peaks 
over103°F
n 13 15
9.53
9
10.33Mean 9.23
95% Cl 7.69-10.77 7.75-11.32 9.06-11.61
No. of peaks 
over 103°F
n 6 8 4
9.25pretreatment Mean 7.00 8.63
95% Cl 4.61-9.39 6.58-10.67 3.99-14.51
No. of peaks 
over103°F 
divided by time
n
Mean
13
0.87
15
1.19
9
1.14
to treatment 95% Cl 0.62-1.12 0.87-1.51 0.80-1.49
No. of peaks 
over 103°F
n 6 8 4
pretreatment 
divided by time
Mean 0.53 0.90 0.73
to treatment 95% Cl 0.32-0.75 0.69-1.11 0.52-0.93
Days between n 13 15 11
patent
parasitaemia Mean 12.31 9.27 10.09
and treatment 95% Cl 8.49-16.13 8.49-11.89 7.81-12.37
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Table 3.3.17. P vivax. The relationship between the prepatent period and various measures of 
severity in sporozoite-induced infections (unadjusted for any confoundcrs).
Prepatent period (days)
< 12 12-13 i  14
Peak n 17 21 19
parasitaemia 
(per 100 high Geometric 57.4 51.8 73.0
power fields) mean
95% Cl 36.3-90.8 40.0-67.0 53.2-100.1
Pretreatment n 17 21 19
peak
parasitaemia Geometric 46.9 50.1 61.5
(per 100 high mean
power fields) 95% Cl 27.1-81.0 38.8-64.7 47.1-80.3
Peak n 15 21 18
temperature (°F)
Mean 105.1 105.2 105.1
95% Cl 104.8-105.6 104.9-105.5 104.9-105.4
Pretreatment n 6 12 13
peak
temperature (°F) Mean 104.8 105.2 105.1
95% Cl 104.6-105.0 104.8-105.6 104.9-105.4
No. of peaks 
over 103°F
n 15
9.87
20
9.20
18
10.39Mean
95% Cl 8.50-11.24 7.85-10.55 9.02-11.76
No. of peaks 
over 103°F
n 6
8.50
12 13
8.77pretreatment Mean 8.33
95% Cl 4.48-12.52 6.92-9.75 7.21-10.33
No. of peaks n 15 20 18
over 103°F 
divided by time Mean 1.16 1.00 1.06
to treatment 95% Cl 0.88-1.44 0.80-1.20 0.79-1.32
No. of peaks 
over 103°F
n 6 12 13
pretreatment 
divided by time
Mean 0.73 0.79 0.83
to treatment 95% Cl 0.45-1.01 0.66-0.93 0.66-1.01
Days between n 17 21 19
patent
parasitaemia Mean 9.41 10.10 12.00
and treatment 95% Cl 8.04-10.79 8.03-12.16 9.24-14.76
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Table 3.3.18. The relationship between the estimated number of sporozoites injected and 
various measures of severity (unadjusted for any confoundcrs).
Number of sporozoites x 1000
<30 3 0 -<  120 2 120
Episodes of tertian n 5/13 6/15 6/11
fever
% 38.5 40.0 54.5
Episodes of tertian n 2/11 1/14 1/8
fever pretreatment
% 18.2 7.1 12.5
Spontaneous n 2/11 1/15 1/9
recovery
% 15.4 6.7 11.1
Modifying n 8/13 11/15 7/11
treatment given
% 61.5 73.3 63.6
At least 2 doses n 2/13 5/15 2/11
modifying 
treatment given % 15.4 33.3 18.2
Table 3.3.19. P vivax. The relationship between the prepatent period and various measures of 
severity in sporozoite-induced infection (unadjusted for any confounders).
Prepatent period (days) 
<12 12-13
i
it 14
x ’
linear
trend
Episodes of tertian n 7/17 10/21 6/19
fever
% 41.2 47.6 31.6
Episodes of tertian n 0/12 4/21 3/16
fever pretreatment
% 0.0 19.0 18.8 1.7
Spontaneous n 2/15 4/21 2/18
recovery
% 13.3 19.0 11.1
Modifying n 10/17 16/21 10/19
treatment given
% 58.8 76.2 52.6
At least 2 doses n 2/17 6/21 3/19
modifying 
treatment given % 11.8 28.6 15.8
Table 3.3.20. Summary of relationships of dose and prcpatent period with major outcome measures from the analyses of induced malaria. 
All the results are from non-immune patients not treated within the first 5 days of patent parasitacmia.
0 = No relationship
+ = positive association (or outcome more common after higher doses or longer prepatent periods)
+ = p < 0.05, ++ = p < 0.001
- = negative association (or outcome less common after higher doses or longer prepatent periods)
- = p < 0.05, -  = p < 0.001
P  vivax
Mosquitos one day 
(n = 289)
P  vivax
Mosquitos 2-3 days 
(n = 110)
P vivax 
Trophozoites 
(n = 107)
P  vivax 
Sporozoites 
(n = 57)
P  ovale 
Trophozoites 
(n * 80)
P falciparum 
Mosquitos 
(n .  82)
Dose' Prepatent
period
Dose' Prepatent 
period
Dose Prepatent
period
Dose Prepatent 
period
Dose Prepatent
period
Dose Prepatent 
period
Pretreatment peak parasitaemia 0 0 + 0 0 0 0 0 0 0 0 0
Pretreatment peak temperature 0 0 0 0 0 0 0 0 0 - (0)2 0 0
Peaks over 103°F pretreatment 0 0 0 0 0 0 0 0 0 - 0 0
Modifying treatment 0(+) “ (-) - - O(-) 0 0 0 0 - /  o3
Spontaneous recovery 0 ++ 0 0 - 0 0 0 0 0
Tertian fever pretreatment 0 ++ 0 0 0 + 0 +(0) 0 0
1 Estimated number ot infected mosquitos
* Result after adjusting tor confounding (given only if it differs from crude result) 
’ Two different strains. The results refer to early treatment in this data set
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Table 3.3.21. P ovale. The relationship between the prepatent period and the number of peaks 
over 103°F in trophozoite-induced ovale malaria
Overall
n mean
Prepatent £  10 25 7.28
period
(days) 10-13 27 4.63
> 13 27 4.85
No. of peaks over 103°F
Spontaneous recovery
95% Cl n mean 95% Cl
6.09-8.47 20 7.45 6.01-8.89
3.63-5.64 18 4.83 3.49-6.18
3.45-6.16 18 4.94 3.41-6.47
Table 3.3.22. P ovale. The relationship between prepatent period and the duration of infection 
among patients with spontaneous recovery following trophozoite inoculation.
Duration of infection (days)
n Geometric 95% Cl
mean
Prepatent 5 10 20 20.0 16.8-23.7
period
(days) 10-13 19 18.2 15.7-21.2
> 13 18 13.7 11.4-16.4
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Table 3.3.23. P falciparum. Variation between the strains of falciparum malaria used.
Strain Number of mosquitos
Geometric mean
n Mean 95%CI n
EL 50 23.5 16.0-34.5 50
ML 38 10.4 8.0-13.5 39
SC 10 20.6 8.7-48.5 10
Prepatent period Geometric mean count over
Geometric mean first 20 days
Mean 95%CI n Mean 95%CI
10.4 9.8-10.9 12 2250 965-5291
12.9 12.0-14.0 16 549 260-1161
9.7 8.2-11.5 9 1205 344-4224
T able 3.3.24. P falciparum. Types of mosquitos used in induced falciparum malaria
Mosquito Strain
species
EL ML SC
Early treatment Early treatment Early treatment
No Yes No Yes No Yes
An albimanus 12 29 2 1 1 -
An quadrimaculatus - 4 13 21 8 1
An crucians - - 1 - - -
An freeborni - 3 - - - -
mixed . 2 - - - -
5>
3 .3  Malaria - Analysis o l malaria therapy records. Figures 170
Figure 3 .3 .1 . Example o f malaria therapy entry from first set o f books
liu
i^l
 
'i-
' V
" <
?( 
¿
f
33  Malaria ■ Analysis o l malaria therapy records. Figures 171
Figure 3.3.2. Example of an entry from the second set o f books.
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Figure 3 3 3 . Example o f  description of malaria therapy in a patient’s medical notes.
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Figure 3.3.4. Decription of the origin of the Madagascar strain. From first set of books.
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Figure 33.5. Description of a batch of mosquitos used for malaria therapy. From first set of 
books.
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Figure 3 J i .  An entry mentioning the use of an ice chest for storing mosquitos. (It describes 
the accidental infection of PG Shute.)
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N o . o f  in fe c t iv e  m o s q u ito s
Figure 3.3.7. P vivax. Geometric mean prepatent periods (with 95% Cl) by the estimated 
number of infected mosquitos and the storage lime, among non-immunc patients bitten on only 
one day. x = stored < 10 days, 0 = stored 10-19 days, a = stored i  20 days.
In c u b a tio n  p e r io d  (d a y s )
i
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Figure 3.3.8. P vivax. Geometric mean incubation periods (with 95% Cl) by the estimated 
number of infected mosquitos and the storage time, among non-immune patients bitten on only 
one day. x = stored < 10 days, 0 = stored 10-19 days, a = stored 2  20 days.
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Figure 3 3 .9 . P  vivax. The relationships between the estimated number o f infected mosquitos,
and prepatent period with the pretreatment peak parasitaemia, among non-immune patients
bitten on only one day.
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Figure 3.3.10. P  vivax. The relationships between the estimated number o f infected mosquitos,
and prepatent period with the pretreatment peak temperature, among non-immune patients
bitten on only one day.
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Figure 33 .11 . P vivax. The relationships between the estimated number o f infected mosquitos,
and prepatent period with the number o f peaks over 103°F pretreatment, among non-immune
patients bitten on only one day.
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Figure 3-3.12. P vivax. The relationships between the estimated number of infected mosquitos, 
and prepatent period with the number of peaks over 103°F pretreatment as a proportion of the 
number of days between patent parasitaemia and treatment, among non-immune patients bitten 
on only one day.
3 3 Malaria ■ Analysis of malaria therapy records Figures 181
Figure 33 .13 . P vivax. The relationships between the estimated number o f infected mosquitos,
and prepatent period w ith the number o f days between patent parasitaemia and treatment,
among non-immune patients bitten on only one day.
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Figure 3.3.14. P vivox. Prepatent periods in trophozoite-induced malaria (selected as in text).
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Figure 3.3.15. P vivax. Mean prépaient periods (with 95% Cl) by the sporozoite number and 
storage time, among non-immunc patients, x = stored for < 20 days, 0 = stored ^  20 days.
F igure 3.3.16. P vivax. Mean incubation periods (with 95% Cl) by sporozoite number and 
storage time, among non-immune patients, x = stored < 20 days, 0 = stored i  20 days.
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Figure 3.3.15. P vivax. Mean prepatent periods (with 95% Cl) by the sporozoite number and 
storage time, among non-immunc patients, x = stored for < 20 days, 0 = stored ^ 20 days.
Figure 3.3.16. P vivax. Mean incubation periods (with 95% Cl) by sporozoite number and 
storage time, among non-immune patients, x = stored < 20 days, 0 = stored £ 20 days.
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Figure 3.3.17. P vivax. Comparison of prepatent periods for mosquito-induced and sporozoite- 
induced malaria.
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Figure 3.3.18. P vivax. Peak temperature reached in mosquito-induced malaria in non-immune 
patients.
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CONCLUSIONS
Relationship of the findings to the pathogenesis of m alaria
Overall, very little evidence of an association between dose and severity was found for malaria 
(Table 3.3.20). Most of the correlations that were found used prepatent or incubation period as 
markers of dose, and so these associations could be due to confounding by susceptibility.
From theoretical knowledge of the pathogenesis of malaria a dose-severity relationship might 
be predicted. Observations on patients show that in the early stages of infection parasite 
numbers closely follow the predicted logarithmic increase (MaeGraith 1948). A smaller 
inoculum size should multiply at the same rate and follow a parallel curve to a larger one, 
reaching a threshold level at a correspondingly later time. Hamilton Fairley’s sub-inoculation 
experiments demonstrated that this occurs in  practice, (Hamilton Fairley 1947) and the time 
taken to reach the level where the parasitaemia is just detectable - the prepatent period - has 
been seen to depend on dose. After a given time, during this stage of initial multiplication, the 
parasite load will be smaller after small inocula than after large ones. Since the immune 
response is time-dependent, after smaller inocula it will start to take effect while the parasite 
load is lower, and should therefore be more effective in limiting the severity of disease 
(Greenwood et al 1991, Marsh 1992). In this context, the failure to detect an association 
between dose and severity is perhaps surprising. How can this lack of association be 
explained?
It is useful to consider what is happening in  two stages. The first relates the dose to the level 
of parasitaemia attained, and the second relates the parasitaemia to the other measures of 
severity. If parasitaemia is a poor predictor of severity then any relationships with the initial 
dose will be intuitively less likely.
The failure to find associations at the first stage, between dose and the maximum parasitaemia 
reached, is perhaps the most unexpected. However, the relationships between the measured 
infecting dose and the true dose and the measured blood parasitaemia and the true parasite load 
are both imprecise, in my analyses and in the published studies. The reasons for this have 
already been addressed. This imprecision causes non-differential misclassifi cation and therefore 
underestim ation of any association. In only one of the data sets examined (mosquito-induced 
vivax malaria where mosquitos were used over 2-3 days) was any relationship between dose
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and peak parasitacmia found. In none was a relationship between prepatent or incubation 
period and peak parasitacmia demonstrated, even though confounding by susceptibility would 
be expected to lead to such an association. A strong correlation between dose and peak 
parasitaemia seems unlikely.
In an individual person, changing levels of parasitaemia are reflected in the fever and 
associated symptoms (Kitchen 1949). Between individuals, associations between parasitaemia 
and other measures of severity are also found but are less clear (Lowe 1934). In patients with 
chronic infections parasitaemias are higher in periods of fever than in periods without (Ross & 
Thomson 1910, Sinton et al 1931). Among schoolchildren in the Congo where around 80% 
have detectable parasitaemias, those thought clinically to have malaria had higher parasite 
densities than those thought to have other diseases or asymptomatic controls (Trape et al 
1985). Among malaria patients, correlations have been found between the parasitaemia and the 
peak temperature (Gillespie et al 1991) and the proportion of patients with high temperatures 
(Ejezie & Ezedinachi 1992). In induced malaria, the maximum parasite density has been 
related to the duration of the clinical attack (Boyd 1938). In natural falciparum malaria, very 
high parasitaemias have been associated with increased case fatality rates (Field & Niven 1937) 
and poor outcome from cerebral malaria (Molyneux et al 1989). However the relationships are 
not consistent (Walker et al 1992, Kwiatowski et al 1990, Grau et al 1989), and even where an 
association is demonstrated at very high parasitaemia levels, the similarity in the overall 
distributions of presenting parasitaemias among those with full recovery and those with poor 
outcome is striking (Molyneux et al 1989). Some of the variation in falciparum malaria can be 
explained by the tremendous fluctuations in blood parasitaemia levels which occur within 24 
hours, but this is much less of a problem with vivax (Lowe 1934).
Tumour necrosis factor (TNF) and interleukin-1 a  levels are higher in severe malaria, and 
correlate with parasitaemia levels (Kwiatowski et al 1990, Grau et al 1989, Shaffer et al 1991). 
Within an individual the fever closely follows changes in TNF levels (Karunaweera et al 
1992). Higher parasitaemias have also been associated with increases in acute phase proteins 
(Gillespie et al 1991) and changes in haematological factors towards a procoagulant state 
(Hemmer et al 1991).
In induced malaria it is possible to measure the number o f parasites associated with the first 
temperature (the pyrogenic threshold). Taking 100®F (37.8°Q as the cut-off, Boyd (1938, 
1940c, 1944b) found considerable variation in the initial pyrogenic threshold, with a range
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from undetectable to over 1000 parasites per |xl (median 10-50) for vivax (Boyd 1938). Longer 
incubation periods were associated with higher parasite densities. The parasite count associated 
with the first temperature of 104°F was also highly variable (Boyd 1944b) but in nearly 90% 
of patients the parasilaemia on the day of the first temperature of 104°F was higher than that 
on the day of the first temperature of 100°F. During the infection the tolerance of the patient 
increases, so that the last fever of over 100°F in the attack was associated with much higher 
parasitaemias (median level of 2000-4000 per pi) than those found at the time of the first fever 
of 100°F (Boyd 1938).
The picture is of a trend towards more severe disease at higher parasitaemia levels but with 
considerable variation. Both the results from natural infections and Boyd’s reports of induced 
malaria are likely to be confounded by variations between different strains of malaria and in 
immunity of the patients. (Boyd’s observations pool the results of more than one strain of 
malaria and may include some semi-immune patients, although this is not mentioned.)
In the Honon data the analysis has been restricted to single strains and non-immune patients. 
The relationships between the pretreatment peak parasitaemia and various measures of severity 
are summarised in Table 3.4.1. For the 80 patients infected with P ovale the peak parasitaemia 
was correlated with the peak temperature, with the number of peaks over 103°F, and with the 
duration of the infection. There was no correlation with the type of fever or whether 
spontaneous recovery was recorded.
For Madagascar strain vivax malaria correlations were found with the number of peaks over 
103°F but not with the peak temperature. Modifying treatment was associated with lower peak 
parasitaemias; it may be that the treatment prevented the development o f higher parasitaemias.
For the American falciparum data no correlations were found between the pretreatment peak 
parasitaemia and the peak fever but for one o f the two main strains the number of peaks over 
103°F increased with the peak parasitaemia.
Overall there is some evidence of a relationship between parasitaemia and other measures of 
severity, but the associations are generally weak, and, although some o f the lack of association 
can be attributed to inaccuracies of measurement, as described above, these results emphasise 
the variability in response even of non-immune individuals given a single strain of malaria. 
There is very little evidence for a relationship between dose and parasitaemia. The lack of
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consistent associations between direct measures of dose and measures of severity, while marred 
by inaccuracies of measurement, suggests that any true effect of dose is unlikely to be strong 
in comparison to all the other causes of variation in severity of disease between individuals.
Implications for natural malaria
The finding that insecticide-impregnated bednets decrease symptomatic malaria and death more 
than infection has been interpreted as providing evidence that dose influences severity o f 
disease in malaria (Snow et al 1988, Greenwood et al 1991, Bermejo and Vecken 1992). The 
more direct evidence discussed above suggests that a strong dose-severity effect is unlikely, but 
little of it relates to falciparum malaria.
What does "infecting dose" mean?
In terms of natural malaria what is meant by infecting dose? The dose which we want to 
consider is the number of sporozoites inoculated that can be associated with a particular 
episode of malaria. This will vary with the number of sporozoites transmitted per mosquito and 
with the frequency of mosquito bites. The period of time over which the doses from separate 
infective bites can be considered to add together to constitute a single infective dose is not 
known. Mosquitos appear to transmit a median of less than 20 sporozoites, (Rosenberg et al 
1990, Bcicr et al 1991a,b, Ponnundurai et al 1991). Multiplication in the liver increases 
parasite numbers in the order of 2000-40000 times, depending on species (McGregor 1965).
The liver cycle is a fixed length, so parasites embarking on it two days later than parasites 
from a previous bite will, on average, be released as merozoiles two days later. By this time 
the progeny of the first bite will have been through a cycle of erythrocytic multiplication (for 
falciparum, vivax and ovale malaria) and so will have multiplied a further 16-24 times 
(Gamham 1988). These parasites are therefore likely to outnumber the newcomers unless the 
number of sporozoites from the second bite was much greater than the first The time period 
over which the sporozoites from separate bites can be considered to add to form a single 
infective dose is therefore likely, on average, to be less than the length of one or two 
erythrocytic cycles. Therefore, in most situations, episodes are likely to arise from a single bite.
In endemic areas where most of the population have some level of parasitaemia most o f  the 
time, the incoming number of parasites associated with being rebitten is small compared with 
the total body load (Lines & Armstrong 1992). Nevertheless, there is evidence that new 
infections do trigger disease in these conditions. In The Gambia, parasitaemia prevalence rates
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decrease only slightly during the dry season, but the clinical malaria and mortality from 
malaria occur almost entirely during the wet season (Greenwood et al 1987, Alonso ct al 
1991). Controlling mosquito transmission by using impregnated mosquito nets - that is, 
preventing some new infective bites - decreases clinical episodes and mortality (Snow et al 
1987, 1988, Alonso et al 1991). If new inocuations trigger disease more readily than the 
parasites already in the host, the host must be less able to limit the multiplication of the new 
parasites than of the old ones. This would occur if immunity is strain specific and the new 
parasites were of a different strain. It would still be possible, in theory, for the inoculum size 
(of the new strain) to influence severity (Lines & Armstrong 1992).
How could impregnated bednets influence the infecting dose?
Impregnated bednets could decrease the infecting dose per episode by decreasing the frequency 
of infected bites and therefore the number of infective bites per episode and/or by decreasing 
the number o f  sporozoites transmitted per mosquito. It has been suggested that impregnated 
nets may prevent a mosquito from feeding normally and from transmitting a full dose of 
sporozoites (Snow et al 1988, Greenwood et al 1991). Whether this occurs is important but 
unknown. If the frequency of infectious bites is low enough that most cases of malaria are 
likely to arise from the bite of one infected mosquito, then the effects of the intervention 
would be to decrease the chance of that single bite. Only if the intervention also influences the 
number of sporozoites inoculated per mosquito would the dose per episode be affected. Even 
in areas with a high prevalence of malaria, only a proportion of infected mosquitos would 
carry "new" strains, and most cases of malaria might still arise from the bite of a single 
mosquito. In this case, unless the intervention decreased the dose delivered per mosquito then 
it would have no effect on the dose per episode.
Difficulties in interpreting the results o f bednet studies
If bednets reduce the "infecting dose" and dose determines whether infection or disease results, 
then dose-effects could explain the disproportionate decrease in disease and asymptomatic 
infection seen in bednet studies. Dose is not, though, the only possible explanation. The 
disproportion may arise quite simply from saturation. As the frequency of infection-causing 
bites increases, a greater proportion fall on already-infected people; the same happens with 
disease-causing bites, but since these are rarer, the degree of saturation is less at any given 
transmission intensity. The resulting disproportion in protective efficacies against the different 
outcomes can be illustrated with a numerical example.
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Suppose, during the study period, those without nets are bitten by a mean of 2 infected 
mosquitos and those with nets with a mean of 1 infected mosquito and that the probability of 
the outcome per bite is 90% for parasitaemia, 50% for symptoms and 1 % for severe symptoms. 
Assume that the chance of being bitten and of a particular outcome occurring are random 
processes. 'The mean number of events per person (m) is then:
Mean events per person per study period
Without net With net
Parasitaemia 1.8 0.9
Symptoms 1.0 0.5
Severe symptoms 0.02 0.01
The chance of not getting 
event occurring is 1 - e". 
is then:
a random (Poisson) event of mean m is e"“ , so the chance of an 
The probability per person of each outcome during the study period
Probability of outcome per person per study period (%)
Without net With net
Parasitaemia 83.47 59.34
Symptoms 63.21 39.35
Severe symptoms 1.98 1.00
In a population these probabilities are equivalent to the proportion of people with each 
outcome, and the protective efficacy of bednets against each outcome can be calculated as (1 - 
relative risk)- The protective efficacy is 28.9% against parasitaemia, 37.7% against symptoms 
and 49.5% against severe symptoms.
The calculations can be modified to take account of different probabilities of the various 
outcomes in different groups of the population, or to incorporate more than one strain of 
malaria. The general principle that the protective efficacy is greater against the less common 
outcome remains.
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These calculations are concerned only with the presence or absence of an event during the 
study period, assume that single infections and multiple infections are equally likely to give 
symptoms and ignore any changes in immunity during the study period. They also assume that 
bites are random although aggregation is likely. Even so they demonstrate that in the absence 
of a dose-severity relationship, the protective efficacy cannot be assumed to be the same 
against all the different outcomes.
In a study of impregnated bed nets in The Gambia, (Snow et al 1988) the protective efficacy 
against parasitaemia was 32% (95% confidence interval -14% to 60%). This was calculated 
from cross-sectional surveys either side o f  the transmission season. Impregnated bednets may 
decrease the rate of re-establishment of parasitaemia after it is artificially cleared at the start of 
a study, but if parasitaemia rates are only measured from comparison of cross-sectional surveys 
carried out too late, after all or most of the susceptibles are infected, this may be missed. In the 
same study the protective efficacy against febrile episodes associated with parasitaemia was 
found to be 70% (95% confidence interval 41% to 87%) but this was calculated from incidence 
rates derived from weekly morbidity surveillance, so the two protective efficacies should not 
be directly compared.
So far we have assumed that the outcomes can be measured accurately, but defining malaria in 
the field is notoriously difficult. Using fever with parasitaemia as a defintion of mild malaria is 
likely to include fevers due to other causes. If this kind of misclassification occurs and is non­
differential between intervention and control groups, this will lead to underestimation of the 
protective efficacy of the intervention. Misclassification is likely to be more of a problem for 
mild episodes than severe episodes. If the true protective efficacy were the same against mild 
and severe malaria, this difference in misclassification could give rise to an apparent but 
spurious greater efficacy against severe than total malaria. Misclassification may explain the 
results found in Kenya where, using weekly surveys for both symptoms and parasitaemia, the 
protection provided by impregnated bednets or curtains against new parasitaemias was greater 
than that against symptoms (Sexton et al 1990).
Confounding by age could also give rise to a greater decrease in severe than in mild malaria. 
Nets would be expected to be more effective in preventing bites among those who spend more 
time under them; this is likely to be the younger children, and younger children are more likely 
to get severe malaria. Socioeconomic status is also a potential confounder since it could 
influence both net use and outcome.
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Conclusions
If there is a dose-severity relationship for malaria then in controlled trials of impregnated 
bednets the estimated protective efficacy against severe malaria might be expected to be greater 
than that against mild malaria, which in turn may be greater than that against parasitaemia. 
These trends have been found in some of the few studies which provide sufficient information 
on different outcomes, but explanations other than a dose-severity effect are possible.
On the basis of simple probability theory disproportionate decreases in symptomatic and 
asymptomatic malaria would be expected even without a dose-effect. These results may also 
arise due to other factors such as misclassification, confounding and study design. Dose may 
influence severity in  malaria but the evidence from induced malaria suggests a strong 
relationship is unlikely. The results of bednet trials will not allow us to resolve the issue.
Co
Table 3.4.1. The relationship between pretreatment parasitaemia and various measures of severity in the different data sets of 
induced malaria. All the results are from non-immune patients not treated within the first 5 days of patent parasitaemia
0 = No relationship
+ = positive association (or outcome more common with higher parasitaemia)
+ = p < 0.05, ++ = /)< 0.001
- = negative association (or outcome less common with higher parasitaemia)
- = p < 0.05, -  = p < 0.001
P vivax P vivax P vivax P vivax P ovale P falciparum
Mosquitos 1 day Mosquitos 2-3 days Trophozoites Sporozoites Trophozoites Mosquitos
(n -  289) ( n -  110) (n -1 0 7 ) ( n -5 7 ) (n -  80) (n « 82)
Pretreatment peak 
temperature
0 0 0 0 ++ 0
Peaks over 103°F 
pretreatment
+ + (0)’ + (0) + (0) ++ + / 0 J
Modifying treatment * - 0 ' 0
Spontaneous
recovery
0 - - 0 0
Tertian fever 
pretreatment
0 0 0 0 0
1. Result after adjusting for time to treatment (given only if it differs from the crude result)
2. Two different strains
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SECTION 4 
DISCUSSION
THE RELATIONSHIP BETWEEN INFECTING DOSE AND 
THE PATHOGENESIS OF DISEASE
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"Every infection is a race between the ability of the invading microbe to 
multiply and cause disease and the ability of the host to mobilise specific and 
non specific defences - a delay of a day or so on the part of the host can be 
critical." (Mims 1987)
A larger infecting dose of a microbe is more likely to reach "the critical levels of growth that 
give tissue damage and disease" (Mims 1987) before it can be limited by the immune response. 
This is reflected in the well known relationship for many infections between infecting dose and 
attack rate - higher doses giving higher attack rates. The idea of multiplication of the inoculum 
until a critical load is reached also explains the inverse relationship between dose and 
incubation period: larger inocula have a head start and so give rise to symptoms earlier. This 
simple relationship has been illustrated by Meynell (1963), see my Figure 4.1a).
It seems intuitively reasonable that the race should continue beyond the onset of illness and 
that therefore the head start given by higher doses should continue to have an effect. If one 
critical load determines the initial response, another higher one may determine a more severe 
response, and this second level may be reached more frequently by higher doses.
Models of microbial infection
The relationship between dose and outcome is likely to be more complex than this, and 
discussion of it has given rise to various models of microbial infection. The fact that more than 
one inoculated bacterium is usually required to produce a response or to kill a host can be 
explained in two different ways (Meynell & Stocker 1957). Either the bacteria could act co­
operatively so that the response is the result of their joint action, or they could act 
independently but more than one is usually needed because the probability for any single 
bacterium of producing a response is less than one.
The extreme form of the first hypothesis gives rise to the concept o f an individual effective 
dose • a dose above which a given host will certainly respond - and is therefore deterministic 
in nature (Armitage ct al 1965). The second hypothesis, the "hypothesis of independent action" 
is stochastic and states that p, the mean probability per inoculated bacterium of multiplying 
sufficiently to produce a response, is independent of d, the number of bacteria inoculated 
(Meynell & Stocker 1957). Intermediate models involving partial synergism can also be 
defined, in which inoculated bacteria act independently at any given dose but where p  increases
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as d  increases. Though possibly more realistic (Meynell & Meynell 1958) they have been 
studied less, perhaps because they can only be distinguished from complete independence 
experimentally if the hosts do not differ in resistance (Meynell & Stocker 1957).
Armitage et al (1965) subdivide stochastic models according to the assumed reason that p  is 
less than one:
1) The culture from which the inocula are drawn contains a mixture of completely 
virulent and completely avirulent organisms so that p  is actually the proportion of 
virulent organisms. This is thought to be unlikely.
2) The fate of an organism depends on the site it reaches after inoculation and p  is the 
probability per inoculated organism of reaching the interior.
3) Both (1) and (2) imply that there is one decisive stage and that the heterogeneity of 
the host response is decided soon after inoculation. In contrast, the birth-death model 
assumes that "the outcome is determined by successive random events which 
continually operate as long as even one organism remains viable in its host”. The 
model depends on the probabilities of organisms dividing and dying.
The models have been tested in various experimental systems, mostly bacterial infections of 
small rodents. The hypothesis of independent action predicts that the slope of the probit- 
mortality/log dose curve will be £ 2 at the LD50 pjoint (Meynell & Stocker 1957). (The 
derivation is given by Peto (1953). It would equal 2 if the hosts have homogeneous resistance). 
This had been demonstrated using salmonellae in  mice (Meynell & Stocker 1957, Meynell 
1957), and is in contrast to the values greater than 2 estimated in experiments on dose-resp>onse 
of toxic chemicals and killed organisms, in which "co-op>eration" must be occurring (Armitage 
et al 1965).
Independent action also predicts that at low challenge doses, the resulting response may be the 
result of the multiplication of few, or sometimes one organism. For doses £  LD50 most fatally 
infected hosts will die as a result of the multiplication of only one bacterium (Meynell & 
Stocker 1957). This has two implications which can be tested. One is that for low doses the 
time to death will tend to become constant because it relies on the multiplication of only one 
organism (Meynell & Meynell 1958). The other is that if a mixture of variants of equal
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virulence of a microbe is given, at low doses only one variant should usually be found at post 
mortem (Meynell & Stocker 1957). Testing time to death at low doses proved difficult: few 
hosts died so the confidence intervals were wide. The results, using salmonellae in mice, were 
inconclusive, both from Meynell's and more recent experiments (Meynell & Meynell 1958, 
Hormaeche 1975).
Experiments using mixtures of variants of salmonellae in mice have shown that as the dose 
decreased the composition of the post mortem samples varied more in composition from mouse 
to mouse, with a few mice at low doses giving pure or nearly pure cultures of any one variant 
(Meynell & Stocker 1957, Meynell 1957). That fewer hosts than predicted showed pure 
cultures of a single variant was explained on the basis of a terminal breakdown in host 
resistance. Single variant blood cultures following mixed inocula have more recently been 
demonstrated in experiments using rats infected with E coli (Pluschke et al 1983), H influenzae 
(Moxon & Murphy 1978, Rubin & Moxon 1984) and a Group B streptococcus (Rubin 1987).
Further evidence in support of the hypothesis of independent action comes from experiments 
with respiratory infections of mice altering the time over which the inoculum was given. Using 
Streptococcus zooepidermicus and Klebsiella pneumoniae the proportion of mice dying was 
similar for each organism when the same dose was given as a single challenge or was divided 
and given as small daily doses over one month (Goldberg et al 1954). If co-operation between 
organisms were important the single challenge would be expected to be more effective.
The strongest evidence against the simpler stochastic models (1 and 2 above), but compatible 
with birth-death models, comes from viable counts carried out during experiments with 
intraperitoneal inoculations of salmonellae in mice. It was shown that multiplication of the 
whole inoculum occurred and that the growth of the whole inoculum determined the latent 
period. In mice given doses which they were likely to survive, there was initial multiplication 
of the whole dose before a fall in the counts (Meynell & Meynell 1958, Armitage et al 1965).
The basic birth-death model is unsatisfactory because of inconsistencies between its predictions 
and the experimental evidence (Aimitage et al 1965, Meynell & Maw 1968) and because it 
predicts that if inoculated organisms succeed in increasing even slightly they arc virtually 
certain to increase to an infinite extent (Williams & Meynell 1967). The model can be 
modified - for example, by allowing the birth and death probabilities to change with time or 
with the number of organisms (Williams & Meynell 1967). Viable counts on the lungs of mice
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infected by intranasal inoculation of Bordetella pertussis suggested that growth rates were 
faster after small inocula (Dolby et al 1961). Maw and Meynell (1968) used a non-replicating 
phage in S typhimurium to calculate the number of bacterial divisions which had taken place 
after intravenous inoculation into mice. The multiplication rate was faster in the first hour than 
in the subsequent 2 days. By comparing bacterial generations with the individual colony counts 
they showed that both birth (division) and death rates varied between mice.
None of the models fit the data perfectly, but the points of interest here are the implications of 
the basic models for the relationship between dose and severity, and in particular, whether any 
of the models preclude a dose-severity relationship. If there is "co-operation" between microbes 
then a dose-severity effect seems likely. The challenge to the hypothesis of a dose-severity 
effect comes if independent action is assumed, with the implication that infections with low 
doses are often due to the progeny of a single organism. (Closes less than the ID50 may very 
well be those frequently encountered in natural infections (Blaser & Newman 1982).) Dose 
could still influence severity within this range of low doses, if the single organism is likely to 
establish itself and start to  multiply earlier following a larger dose. This is discussed further 
below. First I shall consider the assumption of the critical load which is common to all models.
The problems of critical loads and end-points
The different models all describe the multiplication of the inoculum, or part of the inoculum up 
to a certain critical level. The assumption of a critical load determining response is rarely 
challenged, although Meynell (1963) does suggest the possibility that the level may increase 
with time (Figure 4.1b). The models are generally constructed around a single end-point, be it 
response or death, but a "mortality threshold" can be defined at a level corresponding to a load 
at an arbitrary point above the "morbidity threshold" (Williams & Meynell 1967). This 
assumes not just that a certain load o f microbes in the host is necessary to produce response, 
but that a larger load gives a more severe response.
Fairly constant terminal loads of bacteria have been found in experiments with rodents using S 
typhimurium (Meynell &  Meynell 1958), Staphylococcus aureus (Smith et al 1960. Gorrill and 
McNeil 1963) and anthrax (Smith et al 1954). In experiments with intranasal infections of 
Bordetella pertussis in mice (Dolby et al 1961), the critical viable counts in the lungs at the 
time of death were higher when death was mote ptolongued. Following intracerebral 
inoculation the critical level in the brain decreased with time (Standfast A  Dolby 1961).
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It remains to be seen whether load correlates with lower levels of morbidity, or w ith death in 
less artificial situations. Certainly the evidence from malaria, discussed in Section 3.4, suggests 
a poor correlation between parasite load and severity. Malaria also provides evidence of the 
"critical level" for morbidity changing over time, in terms of the parasite load associated with 
fever increasing during the course of the illness (Boyd 1938), and of very different critical 
levels (or pyrogenic thresholds) in different individuals (Boyd 1938).
Another problem with the concept of critical loads is that the models tend to assume an all or 
nothing response. This is obviously appropriate when death is the outcome, but for lesser 
degrees of illness is at best an approximation to reality. Illness can usually be thought of as a 
continuum from asymptomatic to "cases" to death (Rose 1992). Definition of illness is to some 
extent arbitrary and yet we know for many diseases that dose determines the attack rate for the 
level of illness that happens to have been chosen; that is, the dose determines the proportion 
above a certain point on the continuum.
In experimental human infections with enteric organisms (eg McCullough & Eisele 1951a,c,d, 
Homick et al 1970), increasing the dose increases the proportion of people with positive stool 
cultures and higher doses are required to increase the proportion with clinical disease. In this 
system two levels of response have been distinguished. One is "infection" and is identified by 
positive stool cultures. The other is "disease" and is identified by clinical symptoms or signs. 
The "attack rate” could be determined for either outcome, and both are dose-dependent. Is this 
equivalent to dose determining the severity of disease itself or is disease truly a different 
process from infection?
In any study some individuals with positive stool cultures (infection) are likely to  have minor 
symptoms but fail to meet the variable criteria chosen to represent disease. Some cases will be 
difficult to define and it is worth considering to what extent the distinction is real. Classically, 
infection implies multiplication of the organisms (in the bowel in this case) and disease implies 
some pathogenic effect of the organisms on the host, usually associated with some degree of 
invasion. Yet presumably the two processes overlap in time, and a certain amount of invasion 
and pathogenic activity is required before signs and symptoms are perceived, so the distinction 
in practice is at the point of detection rather than at the level of a change in pathogenesis. 
Defining illness is difficult but, as we saw in the typhoid volunteer data (Section 2.5), the 
definition of illness used can have a critical role in determining whether or not a  true dose- 
severity relationship is detected, or whether a spurious dose-severity relationship is produced
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by misclassification.
The more the pathogenic process appears to be part of the same continuum - one process 
determining "disease" and more of the same determining severe disease - the more likely it 
would seem to be that load, and therefore perhaps dose, should determine severity. If different 
disease processes occur at different stages, for example if the next stage of a disease depends 
on a small proportion of the microbes moving elsewhere in the body, then the total body load 
and the initial inoculum size are less obviously relevant.
The animal experiments using mixed variants of bacteria give us some insight into the point at 
which the pathogenic process may change. Intranasal inoculation o f infant rats with mixtures of 
streptomycin-sensitive and streptomycin-resistant strains of Haemophilus influenzae type b of 
equal virulence gave rise to nasopharyngeal colonisation, bacteraemia and meningitis (Moxon 
& Murphy 1978). The nasopharyngeal cultures were predominantly mixed, except with very 
small doses, but the blood cultures were usually of a pure strain even with high doses. 
Bacteraemia occurring within the first 6 hours was more often mixed, but this early 
bacteraemia often resolved spontaneously. Cerebrospinal fluid cultures were only positive in 
those with bacteraemia, and usually contained the same strain as the blood. Two thirds of those 
with mixed bacteraemias gave pure CSF cultures. It was suggested that, following initial 
nasopharyngeal colonisation, which could be accompanied by transient bacteraemia, a focus of 
infection was established by one bacterium which gave rise to the blood infection.
Mixed inoculation experiments with E coli in infant rats showed a similar pattern (Pluschke et 
al 1983). The rats were fed mixtures of a single dose of lactose-fermenting and non-lactose- 
fermenting strains o f an enteroinvasive E coli. Most of the animals developed mixed infections 
in the gut. Infections in the mesenteric lymph-nodes were similar to those in the gut, and 
therefore usually mixed, but only pure cultures (of either strain) were obtained from the blood. 
Meningitis was only observed in animals with high levels of bacteraemia. Here, although 
meningitis was related to blood load, since bacteraemia seems to derive from a single 
bacterium (presumably after lymph-node invasion) a relationship between dose and the 
proportion with meningitis might not be expected.
In these rat experiments there was a clear distinction between colonization and disease, but for 
a disease such as cholera in which the pathogenic events take place in the gut, then a more 
continuous relationship might be expected. In contrast, in typhoid the processes of disease are
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very different from those of the initial colonization; a close association between dose and 
severity is intuitively less likely, and no association was found when mortality was used as the 
outcome (Section 2.3). In the volunteer experiments, however, in which fever was used to 
define disease and peak fever was a measure of severity, a correlation with dose was found. A 
direct relationship with load is also less likely if the damage to the host relies principally on 
inflammatory or immune responses. The relationship with dose could also be complex, in that 
both very large and very small doses can alter the nature o f  the immune response and induce 
tolerance (Bretscher 1992).
A simple com partment model
It may be useful to think of the body as a series of compartments, suiting at the exterior 
(which includes the gut) and working in. The probability o f organisms reaching and 
multiplying in each compartment depends on the number o f organisms in the compartment 
immediately preceding it in the series, how easily they can penetrate the compartment, and 
how readily they can multiply once there. To esublish an infection, organisms usually have to 
multiply at their point of entry which is usually an exterior surface. For the next suge of the 
pathogenic process they may need to move to another compartment, such as the blood or 
lymph nodes. If all o f the dose and its progeny, or a fixed proportion o f it, moves to the next 
compartment, then the initial dose can be expected to influence what happens next. If 
movement to the next compartment is "difficult" such that very few organisms penetrate and 
manage to multiply, then the load in the first compartment will influence the chance of this 
happening, but the next suge of the infection will arise from the progeny of the few organisms 
which manage to reach and multiply in the second compartment
In other words, if there is a bottle-neck in the system due to difficulty in entering a 
compartment and/or managing to multiply there, then only a few of the progeny of the original 
dose can be expected to make i t  In the extreme case only one organism is likely to get 
through and succeed in multiplying for each successful episode of disease. The further progress 
of the disease will depend on the organisms on the far side of the bottle neck. Of course there 
may be further bottle-necks, but it is the position of the first one which should determine 
whether, in this simple model, the initial dose affects ju st the attack rate or may also influence 
severity. If the first bottle-neck occurs at a point in the pathogenic process before symptoms 
arise which define the disease, then die infecting dose w ill determine only the attack rate. If 
the first bottle-neck occurs later, after the pathogenic processes in the compartment which gave
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rise to some symptoms then the infecting dose will influence both the attack rate and the 
probability of proceeding to the next stage which may be interpreted as severity.
In the rat experiments with H influenzae (Moxon & Murphy 1978) the first bottle-neck appears 
to operate between nasal colonization and bacteraemia. There may be a second bottle-neck 
between blood and CSF infection (most mixed infections in the blood gave pure cultures in the 
CSF) but the infecting dose would no longer be expected to have an influence. In the 
experiments with E coli (Pluschke et al 1983) the first bottle-neck appears between mesenteric 
lymph-node infection and bacteraemia. If symptoms were experienced at the stage of the 
lymph-node infection, then the infecting dose might be considered to influence severity of 
disease; with a larger dose there would be an increased probability of proceeding beyond this 
level of infection to bacteraemia.
According to this hypothesis, for infectious agents which multiply only in one compartment, 
such as V cholerae, infecting dose should be able to influence severity. This does not mean 
that it necessarily does, as there could be other limiting factors: for example, if  all the toxin 
receptors were saturated, a further increase in bacterial load would have no effect. (Similarly, 
for intracellular parasites, such as viruses, saturation of available cells could in theory occur.)
A disease process involving more than one compartment may be subject to more sources of 
host variation: different factors could limit microbial multiplication in each compartment. Even 
if dose did influence severity it might be harder to detect.
The nature of bottle-necks and the role of time
My use of the term "bottle-neck" is not meant to imply a physical barrier to microbes - 
although this could be part of the mechanism. The bottle-neck refers not just to  the passage of 
the microbe into the next compartment but its survival and multiplication. In this respect, the 
effectiveness of the bottle-neck could change over time, increasing as host immunity increased, 
or decreasing in the late stages of a terminal illness, as suggested by Meynell and Stocker 
(1957). With a larger dose there should be a greater chance of a microbe reaching and 
multiplying in the next compartment, purely stochastically. Perhaps more importantly, this 
chance event is likely to happen earlier following a large inoculum, which could increase the 
chances of the microbe’s success in multiplying in the next compartment Indeed a microbe 
arriving earlier may have the opportunity to multiply more, giving a larger load which may
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have greater pathogenic effects itself or have a greater chance of transferring again into the 
next compartment for a further stage of the pathogenic process. Adding time and associated 
changes in immunity to the model therefore has the effect of allowing the infecting dose to 
influence events beyond the bottle-neck even if the disease results from  the multiplication o f a 
single microbe.
In general, organisms with faster doubling times have shorter incubation periods and will have 
multiplied more times before the onset of the immune response. If the incubation period is 
very short compared to the time taken for the immune response to start then the infection will 
already be well established before the immune response starts to take effect, at least in non- 
immunes, and the change in the effectiveness of bottle-necks may come too late to affect the 
disease. If the incubation period is longer than the immune response then the bottle-necks may 
already be fully effective before they are challenged. In these conditions the simpler model 
may be more appropriate.
How well does the model fit the facts?
For the infections which I have discussed in detail in the thesis, how well does the model fit 
the relationships with dose which have been observed?
The food poisoning salmonellae give rise to diseases with short incubation period in which the 
pathogenic process occurs essentially in one compartment with only local invasion. Further 
penetration is rare (Mims 1987). Dose should be able to influence severity, and there is some 
evidence that it does so (Section 2.3-4).
In contrast, typhoid has an incubation period of 1-3 weeks and involves several compartments. 
After entering the gut the organisms invade the intestinal mucosa, passing into the lymphatics 
and then into the blood, probably via the thoracic duct They then multiply in several organs, 
notably the liver, before returning to the gut via the bile duct, where they invade and multiply 
in Peyer’s patches. Although death is an uncontentious measure of severity it can occur in 
many different ways involving different organ systems: haemorrhage or perforation of the gut 
central nervous system involvement pneumonia, or haematological complications. There are 
numerous opportunities fo r bottle-necks in this system and it is perhaps not surprising that the 
initial dose appears to have little influence on the later course of the disease (Section 2.3).
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In malaria there are other dimensions to consider the magnitude of the multiplication that 
occurs, and the change in the form of the parasites in the body which influences the immune 
response. The models of infection were established primarily for bacterial infection assuming 
binary fission. In malaria one sporozoite in the liver gives rise to 2000-40000 merozoites, 
depending on species, (McGregor 1965) and each subsequent erythrocytic cycle increases the 
number by 16-24 times (Gamham 1988). The incubation period is long, but it is not until they 
emerge from the liver, after the first huge phase of multiplication that merozoites are available 
to trigger the immune response. Vivax malaria can be considered as a three compartment 
disease (prehepatic, hepatic and erythrocytic).
When rats or mice were inoculated with large numbers of sporozoites of Plasmodium berghei, 
there was a positive correlation with the number of extra-erythrocytic forms per mm3 of liver 
tissue (Verhave 1975, Vanderberg 1977). In rats about 30% of inoculated sporozoites gave rise 
to extra-erythrocytic forms, and in mice about 4% (Vanderberg 1977). When mosquitos were 
used and each animal was bitten by 50 mosquitos there was a correlation between the mean 
intensity of salivaiy gland infection and the number of extra-erythrocytic forms (Vanderberg 
1977). To demonstrate extra-erythrocytic forms in human volunteers. Shorn et al (1948, 1949) 
used very large inocula in order to ensure that extra-erythrocytic forms would be present in the 
small amount of tissue available by liver biopsy. These experiments with artificially high 
inocula suggest that, although not all the sporozoites gave rise to hepatic schizonts, the 
infecting dose influenced the number which did occur.
In experiments with human volunteers bitten by 5 mosquitos infected with P falciparum , Davis 
et al (1989) used the measured parasitaemia and prepatent period to calculate the number of 
infected hepatocytes and hence the number of sporozoites from which the infections originated. 
These calculations assumed that one sporozoite infected one liver cell giving rise to 30000 
merozoites, each of which infected one erythrocyte giving rise to 16 merozoites every 48 
hours. Among 4 volunteers the calculated number of infected hepatocytes ranged from 4 to 
over 300 with a mean of 120, suggesting an average inoculum of 24 sporozoites per mosquito. 
Direct in vitro measurements o f  sporozoite transmission suggest that the median number 
transmitted per mosquito is similar to this (Rosenberg et al 1990, Beier et al 1991 a & b, 
Ponnundurai et al 1991). If this is applicable in vivo, it suggests that there is very little loss in 
the predicted number of parasites before the blood stage is reached. In terms of the 
compartment model, there does not appear to be a significant bottle neck before the blood 
stage, and dose could therefore, theoretically, influence severity. Possible reasons why this was
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not found were discussed previously (Section 3).
The lack of a demonstrable association does not imply that dose does not influence 
severity
This thesis has concentrated on methods of investigating whether dose influences severity and 
on trying some of them in practice. The only way to get a straightforward answer to the 
question would be to conduct experiments in genetically and environmentally identical animals. 
Such experiments would tell us whether, everything else being equal, dose could influence 
severity of disease. They would not however give us the answer to the far more important 
question of whether, given the natural variation in hosts and conditions, dose has an 
appreciable influence on severity, nor the relative importance of any such influence. 
Epidemiological methods provide the tools for answering the question in natural situations, but 
in  practice are beset by biases, particularly misclassification in the measurement of dose, and 
by confounding when indirect measures are used. Induced infections in humans provide the 
best data but their scope in terms of different diseases, range of doses used, severity of 
symptoms allowed before treatment is started, and numbers of subjects is obviously limited.
Findings of no association between dose and severity in these studies is difficult to interpret as 
implying a true lack of association because much of the bias is towards underestimation of an 
association. However, when incubation period is used as marker of dose, confounding by 
susceptibility will tend to overestimate an association.
It is unlikely that there is a single answer to the question of whether dose influences severity.
It may be that dose influences severity in all diseases (except those where one microbe is 
uniformly fatal) and that it is only the relative importance of this influence which varies in 
relation to all the other causes of variation between individuals. The conclusions that can be 
reached from the diseases which have been studied in detail are that a strong dose-severity 
effect is unlikely in typhoid but may occur in food-poisoning salmonellae, and that if there is a 
dose-severity relationship in malaria, it is less strong than is generally supposed.
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Figure 4.1. Hypothetical growth curves from infected hosts given doses d, and d2. The curve 
for the mean rate in each group is shown between the curves for rates O.S and 2.0 times the 
mean. C is the critical level for response, (a) Constant multiplication rates and critical level 
over time, (b) Increase in critical level with time, (c) Fall in rate of increase of org ansi sms 
over time. (From Meynell 1963.)
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APPENDIX I. EPIDEMICS USED IN THE ANALYSIS OF TYPHOID EPIDEMICS 
(SECTION 23)
Reference Year Place Vehicle Median
incubation
(«toy»)
Attack rate 
% No.
Case tataity rate 
% No.
Scon 1934 1881 Blackburn Water 0.61 ?/?20000 13.19 24/182
Stalybrass 1931 1885 Pennsylvania Water 12.55 1004/8000 1135 114/1004
Scon 1934 1893 Worthing Water 8.33 1298/15579 12.48 162/1298
Scon 1934 1893 Worthing Water 3.87 113/2919 2134 24/113
Greenwood 1935 1897 Maidstone Water 808 7/720000 6.81 132/1938
Butetrode 1902 1902 Winchester Oysters1 14 820 10/122 40.00 4/10
Bufetrode 1902 1902 Southampton Oysters' 16 9.17 10^  09 10.00 1/10
Ledingham 1910 1904 Brislington TCamer1 7222 26/36 769 2/26
Scon 1934 1904 Lincoln Water 195 1058/54204 1191 125/1058
Bracken etal 1911 1906 Minnesota Water 15 4.40 440/10000 692 30/440
Johnstone 1910 1909 Conway IMk1 11.11 26/234 18.18 10(55
Camwath 1912 1910 Oakenshaw M*T 11.78 53/450 794 5*3
Grover 1912 1911 Iowa Water 2.83 170/6000 1000 17.170
Wheaton 1913 1912 Stood. Kent Water 051 69/13428 1159 8*9
Mace wen 1912 1912
H a rtT **1
Water1 5000 23/46 17.39 4/23
Hufchinson 1913 1912 Colne, Lancs M*1 7.44 67/900 8.57 6/70
Jordan & Irons 1912 1912 Rockford. II Water 20 042 199/47500 12.06 24/199
Lumsden 1912 1912 Iowa Water 14 0.71 11/1550 2 7 2 7 3/11
Ridton 1912 1912 Texas M*1 128 25/1950 2.94 1/34
Manby 1914 1913 Kenifoorth Water 084 44/5258 9.09 4/44
Jordan & Irons 1913 1913 Quincy, II Water 26 0.55 202/37000 7.92 16/202
Sawyer 1914 1914 Hanford. Ca Spaghetti1 7 5667 85/150 323 3*3
Geiger 1917 1915 Colusa. Ca IMk1 12 358 23/643 0.00 0/23
Cumming 1917 1916 Helm. Ca Icecream1 6 9593 23/24 13.04 3/23
Geiger etal 1917 1917 CaHomia Water 2000 52/260 0.00 0*2
Anon 1921 1920 Salem, Ohio Water 7.85 785/10000 153 12/785
Shaw 1922 1921 BotorvDeame Water 0.67 137/20497 11.68 16/137
Shaw 1922 1921 BohorvDeame Water 726 260/3581 11.15 29/260
Bondesen 1925 1924 Chicago Oysters 12 12.40 16/129
Lumsden 1925 1924 Tennessee IMk1 33.33 100/300 8.00 8/100
Ramsay 1926 1925 Michigan Food1 13 14.00 35/250 17.14 8/35
Murats 1926 1925 Japan TFood1 18 48.68 37/78 20.45 9/44
Stalybraae 1931 1926 Hanover Water 059 2500/425000 10.40 260/2500
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Reference Year Place Vehicle Median
incubation
period
(days)
Attack
%
rate
No
Case fatality rale 
% No.
Anon 1928 1928 Royal Navy Lettuce1 12* 1022 95/930 737 7/95
Dean 1931 1928 New York State Water 1.15 246/21599 10.06 25/248
Lessa 1930 1929 Rio da Janeiro Water1 16.31 39/213 12.82 5/39
Miner A Forsbeck 1929 1929 Massachusetts Chicken1 19 4462 29/65 6.90 2/29
Garrido Morales A Cosu 
Mandry 1931
1931 Porto Rico Water1 3333 10/30 10.00 1/10
Anon 1932 1932 Dertoy Dale Water 5.07 71/1400 8.45 6/71
Mag fia no 1935 1932 Genoa Water 2.51 42/1672 7.14 3/42
Gomez Jimenez 1934 1932 N Spain Water 7.79 87/1117 4.60 467
Leader 1932 1932 Massachusetts Mil1 39.68 25/63 7.14 2/28
Rfchie A Armstrong 1932 1932 Dumfriesshire Water 5.50 3.13 264
Shaw 1933 1933 Mahon, Yorks Water 522 235/4500 652 23/270
Moms 1935 1933 New South 
Wales
Food1 11.00 33/300 2727 9/33
Homung 1934 1934 Black Forest Water1 17 9.09 3/33
Anon 1935 1935 Lourdes ? 682 75/1100 533 4/75
Johnson 1936 1935 Philadelphia Salad1 33.77 77/228 6.98 666
Anon 1936 1936 England r 35.00 14/40 1428 2/14
Watson Smith 1942 1936 Bournemouth M* 14* 518 518/10000 985 51618
Roelcke 1937 1936 Mittetoaden Icecream1 13 0.00 0/24
Lembecks A von Haesseier 
1936
1936 Massachusetts Salad1 9 37.14 13/35 769 1/13
Holden 1939 1937 Croydon Water 075 ?/?42000 1337 43610
Caudil 1937 1937 Kentucky Water1 2286 16/70 12.50 2/16
Landau 1938 1938 S Africa M*1 3006 52/173 2090 1467
Old A GA 1940 1939 Louisiana Oysters1 9 7500 87/116 920 867
Sima 1942 1942 Canada M*1 27.50 66/240 1029 768
Constam A Steiner 1945 1943 Switzerland Water1 33.75 27/80 3.70 1/27
Galea 1944 1943 Malta Water 099 1275/128788 1220 156/1275
Jordan A Everley Jones 
1945
1944 Middte East ’ Food1 34.35 79/230 1125 960
Marmion et al 1953 1950 Egypt RAF Unit Mock cream 7* 34.06 234/687 05 0/234
Nefletal 1968 1968 Monark Wteer 21 6.18 34650 254 164
CarawayA Bruce 1961 1961 Lousiana Chicken 20 32.00 31/97 0.00 061
Bernard 1965 1963 Zermatt Water 17 437 437/10000 039 3/437
MaHory et M1969 1966 Audrain, USA Water 19* 23.36 25/107 0.00 0/25
Taylor et «11974 1971 Trinidad Icecream 19 120 0.00
Haneon et al 1972 1971 Petmsytamie TFood 17 2536 33/130 956 263
C h a m a M  pra-IMS outxw ta (sm  mm)
■--- - .1- -MOOJu ncuoauon penoa
■«--- ■ ■—  -»■—  — »--*Average ncuDHK>n penoa
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APPENDIX 2. SALMONELLA EPIDEMICS FROM CDC SALMONELLA 
SURVEILLANCE (SEE SECTION 2.3)
(References give issue and page no. Incubation period is median, in hours)
Ref Place Date Vehicle
S enleritidis
38:5 New Jersey 1965 7
77:4 Ohio 1968 Icecream
93:2 Alaska 1969 Whale
99:5 Columbia 1970 Picnic
101:4 Pennsylvania 1970 Salad
102:2 Florida 1970 ? Turkey
103:2 Michigan 1970 Prison cafe
104:2 Georgia 1970 Icecream
104:2 Nebraska 1970 Roast meat
116:2 California 1972 Ham ?
116:2 Rhode Island 1972
117:2 Oregon 1972
123:2 Indiana 1974 Icecream
S infantis
71:5 Kentucky 1968 Ham
85:2 Tennessee 1969 Smoked turkey
85.3 Texas 1969 Turkey
116:3 Kansas 1972 Icecream
117:2 Illinois 1972 Bread dressing
120.2 Oregon 1973 Roast beef
123:2 Texas 1974
S thompson
44:3 St Louis 1965 Icecream
95:2 New Orleans 1969 Church supper
99:1 Tennessee 1970 Barbecued pork
102.2 New Jersey 1970
112:2 Maine 1971 Chicken salad
113:2 Iowa 1971 Restaurant
1163 Pennsylvania 1972 Coconut cream
119:2 Florida 1973 Inflight food
120:2 Los Angeles 1973 Custard pie
1203 Pennsylvania 1973 Roastbeef
AR % (No.) HR % (No.) Incubation
50.0 (65/130) 4.6 (3)
100.0 (12/12) 8.3 (1)
95.9 (93/97) 9 '
48.1 (181/376) 1.1 (2) 28 '
(130/. ) 23.1 (30) 18
15.4 (139/900) 14.4 (2)
40.3 (353/876) 6.2 (22)
92.3 (12/13) 100.0 (12)
12.6 (252/2000) 6.8 (17)
41.0 (41/100) 0.0 (0)
5.8 (10/172) 20.0 (2)
12.9 (17/132) 5.9 (1)
25.0 (25/100) 32.0 (8)
67.3 (37/55) 27.0 (10) 20
64.7 (11/17) 18.2 (2) 29'
53.9 (28/52) 14.3 (4) 11
100.0 (12/12) 91.7 (11)
12.7 (38/300) 26.3 (10)
27.3 (123/450) 0.0 (0)
12.5 (50/400) 6.0 (3)
92.3 (12/13) 18
99.5 (200/201) 25.4 (18)s 13'
(303/ ) 17.8 (54) 54
65.0 (130/200) 20.0 (26)
51.5 (17/33) 0.0 (0) 29'
43.2 (95/220) 23.2 (22)
3.1 (31/1000) 38.7 (12)
14.8 (17/115) 11.8 (2)
100.0 (23/23) 0.0 (0)
80.7 (25/31) 12.0 (3)
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Ref Place Date Vehicle AR % (No.) HR % (No.)
S lyphimurium
30:8 New Jersey 1964 Wedding 14.9 (35/235)
33:4 Michigan 1964 Icecream 81.8 (9/11)
38:2 California 1965 Water 12.7 (14000/110000) 0.5 (75)
43:7 N Carolina 1965 Potato salad 50.0 (244/488) 4.1 (10)
59:4 Montana 1966 Turkey 54.4 (31/57) 6.5 (2)
63:5 Tennessee 1967 Potato salad 35.7 (215/602)
77:2 N Carolina 1968 Icecream 89.5 (17/19) 0.0 (0)
77:4 New Jersey 1968 Cafe 42.0 (245/583) 0.0 (0)
83:2 New York 1969 Spaghetti 50.0 (13/26) 15.4 (2)
102:2 N Carolina 1970 Barbecued ham 74.7 (56/75) 32.1 (18)
104:2 Missouri 1970 Icecream 100.0 (11/11) 0.0 (0)
105:1* Tennessee 1970 Barbecued pork 95.2 (40/42) 10.0 (4)
105:14 Tennessee 1970 Barbecue 70.6 (12/17) 8.3 (D
105:1* Tennessee 1970 Turkey 87.3 (144/165) 2.8 (4)
110:2 Michigan 1971 Smoked fish 75.7 (28/37) 10.7 (3)
112:2 New Jersey 1971 Roast beef 61.1 (22/36) 27.3 (6)
115:2 New Jersey 1972 Bakery cakes 12.5 (150/1200) 2.0 (3)
118:2 Wisconsin 1972 Hamburger ? 26.7 (20/75) 10.0 (2)
116:3 Virginia 1972 Icecream 60.0 (45/75) 6.7 (3)
' Incubation is mean 1 Information for 71 cases only
2 Incubation Is "average’  * Same restaurant
Incubation
15
19
96
482
32
21'
34'
24’
30
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